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Feline tooth resorption (TR) is a common and painful disease characterised 
by loss of mineralised tissues of the tooth. Due to the progressive nature of the 
disease the only available treatment is to extract affected teeth. Odontoclasts are 
specialised cells that resorb teeth and they share many similarities with osteoclasts, 
the bone resorbing cells. The main physiological role of these cells is to resorb 
deciduous teeth to allow for the permanent tooth replacement. In some cats these 
cells become dysregulated and attack the permanent teeth later in life. However, the 
aetiology of tooth resorption is still unclear.  
The aim of this PhD project was to identify transcriptomic changes between 
TR negative and TR positive teeth, set up a TR model to study odontoclast 
dysregulation in vitro and to use this system to test a novel therapeutic target for the 
treatment of TR. In this study, a successful RNA isolation procedure for feline teeth 
collected in a clinical setting and at post-mortem was developed. To elucidate the 
role of inflammation and vitamin D involvement in TR, quantitative PCR was 
performed but there was no statistically significant difference in the expression of 
any inflammatory cytokines, vitamin D receptor or receptor activator of nuclear 
factor kappa-B ligand (RANKL) between TR negative and TR positive teeth. Feline 
osteoclasts were successfully generated from feline bone marrow in vitro. I also 
found that primary feline periodontal ligament cells could induce osteoclast 
formation. Osteoclast precursors from TR positive cats formed higher numbers of 
osteoclasts when co-cultured with periodontal ligament cells compared to TR 
negative cats. Transcriptome analysis by RNA sequencing identified many 
differentially expressed genes between TR negative and TR positive teeth from the 
same cat. I also found that up-regulated genes in TR positive teeth, from the 
literature, are known to be associated with osteoclast differentiation and calcium 
signalling pathways. Apart from the genes related to osteoclast biology, I also 





suggests TR positive teeth undergo repair or bone formation in response to tooth 
resorption.   
Based on RNA sequencing data and quantitative PCR, I was able to identify 
a list of genes which may be involved in odontoclast dysregulation in TR. Among 
those, matrix metalloproteinase 9 (MMP9) was of great interest due to its potential 
role in osteoclast biology. High MMP9 expressing odontoclasts were found in tooth 
sections undergoing tooth resorption by immunohistochemistry. In functional 
studies, MMP9 inhibitor reduced both osteoclast formation and resorption activity 
in vitro. Furthermore, feline MMP9 siRNA inhibited osteoclast differentiation but 
showed little effect on dentine resorption activity.  
These results confirm the hypothesis that the transcriptome of TR positive 
teeth was locally different from TR negative teeth. The results revealed an up-
regulation of genes in pathways associated with osteoclast formation in TR positive 
teeth. Further testing of candidate genes as potential therapeutic targets in feline TR 






Lay summary  
Tooth resorption is an oral problem that causes tooth loss. Although tooth 
resorption affecting several teeth is rare in humans, it is very common in cats. 
Odontoclasts are specialised cells that resorb the milk teeth during tooth shedding 
in the young. This is their normal function, but sometimes these cells start to attack 
teeth when they are not supposed to, for example when they start attacking the 
permanent dentition later in life. This unregulated cell activity invades into teeth, 
and causes pain and loss of the tooth. The only available treatment is to remove the 
affected tooth. We do not know why this is happening. The aim of this research was 
firstly to detect the genetic changes of feline teeth, try to find out which genes 
promote odontoclast activity and test the role of target genes by blocking their 
function. It was hoped that this approach will provide a better understanding of the 
aetiology of this disease. In this study, there was no change in the expression levels 
of inflammation and vitamin D related genes with tooth resorption. More 
odontoclasts were formed in tooth resorption affected cats than tooth resorption 
unaffected cats, and a number of genes showed a different level of expression in cats 
with the disease when they were compared to cats free of the disease. Some of these 
genes with altered expression are known to be involved in odontoclast activation. 
One gene that makes a specific protein, matrix metalloproteinase 9 (MMP9), was 
chosen for further study. Its function in cat odontoclasts was tested using a drug 
that blocks MMP9 activity, and this approach resulted in fewer odontoclasts and it 
reduced their ability to break-down tooth tissue. Lastly, microscopic observation of 
thin teeth slices with tooth resorption showed that tooth odontoclasts expressed a 
lot of MMP9. In summary, this study was the first to report whole genome 
expression changes associated with tooth resorption in cats. Their changes revealed 
that the expression of genes associated with odontoclast formation pathways were 
increased in tooth resorption affected teeth. More of the differentially expressed 





resorption and towards this goal the cat tooth resorption model system developed 
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Chapter 1 Introduction 
1.1 Tooth Biology 
1.1.1 Tooth structure and its supporting apparatus  
Teeth constitute approximately 20% of the surface of the mouth and serve 
several functions including mastication, a tool of attack and defence, protection of 
the oral cavity, and one of the speech organs especially in humans (1). The basic 
mammalian tooth consists of four major tissues: enamel, dentine, cementum and 
dental pulp (1, 2). The most common type is a brachyodont tooth that has a short 
crown and root ratio which is illustrated in Figure 1.1. Teeth are attached to the 
bones of the jaw by the periodontium consisting of cementum, periodontal 
ligament, the alveolar bone forming the tooth socket, and gingiva (gums). The 
crown of the tooth is the visible part exposed above the gingiva where a thick layer 
of dentine with the pulp chamber inside is covered by enamel. The neck of the tooth 
is the area between the crown and the root, also referred to as the cementoenamel 
junction (CEJ). The anatomical root is the part that extends into the tooth socket 
below the CEJ. It is composed of the pulp canals and dentine covered with 
cementum.  
Enamel extends just beneath the soft gingival tissues and is the hardest 
tissue in the body consisting of more than 96% of inorganic material by volume and 
weight. The thickness enamel was found to be various from 0.1 mm to 1 mm in cats 
and dogs, which is thinner than that of human teeth (up to 2.5 mm)(3).   
Dentine occupies the crown part of the tooth (coronal dentine), and extends 
into the tooth socket (radicular dentine). It is less mineralised than enamel 
consisting of approximately 70% mineral with an organic component made up of 
mainly collagen fibres. It possesses closely packed tubules traversing its entire bulk, 






 The dental pulp is the soft connective tissue which occupies the pulp cavity, 
the central part of the tooth. The pulp cavity is divided into the pulp chamber of the 
crown and the root canals (Figure 1.1). The volume of the pulp cavity gradually 
decreases with age due to deposition of the secondary dentin deposition in the pulp 
cavity (1, 4). Dentine and pulp comprise endodontium, the dentine-pulp complex. 
Both tissues develop from the same origin, the dental papilla and they maintain an 
intimate structural and functional relationship. The root canal terminates at the 
apical foramen where the nerve and blood vessels that supply the dental pulp enter 
the tooth. Immature apical foramen (open apex of tooth) becomes a closed apex 
around the time of completion of root development followed by tooth eruption (5). 
A tooth can have a single root or multiple roots depending on the type of the tooth. 
The nerve fibres extend into the dentine of the tooth allowing for transmission of 
stimuli including pain, heat, cold and pressure from the oral environment to the 
pulp when the dentine loses its protective enamel covering (6).  
Cementum is a bone like avascular connective tissue with approximately 
50% mineral (1). The cementum covering the upper portion of the root is acellular 
and the lower portion of cementum (apical third) is cellular rendering its self-repair 
to a limited degree (Figure 1.1). Dentine and cementum have limited capability for 
repair and regeneration, whereas enamel has no capacity for repair because the 
enamel producing cells are lost upon tooth eruption (1, 6).  
Periodontal ligament is a fibrous connective tissue with neural and vascular 
components. The roles of the periodontal ligament are a supportive function 
through the principal fibres attaching the tooth to the surrounding alveolar bone 
proper, a remodelling function by providing stem cells, and a sensory and a 
nutritive function (1, 7). 
The alveolar bone or process is the thickened ridge of bone that contains the 
tooth sockets. It comprises fibres, a variety of cells, intercellular substances, nerves, 
blood vessels, and lymphatics (1, 8). 





widely studied, the tooth structure and its composition are generally similar to 
brachyodont teeth of other mammals based on limited studies (6, 9). There are some 
structures highlighted in cats including deficient mineralisation and well developed 
vascular networks between gingiva and periodontal ligament, thin layer and low 
microhardness of enamel, vasodentine-like structures in circumpulpal dentine and 
osteodentine-like structures in root dentine and gingival plexus (3, 9, 10). A detailed 
description of these features will be discussed in section 1.4 and 1.5. 
 
Figure 1.1 A diagram to show the structure of a mammalian (feline) brachyodont tooth. The 
tooth can be divided into the externally visible part (crown) over the gingiva, the extended 
part into the bone of the jaw (root), and the junction between the crown and root (neck). 
The crown is covered by enamel, the hardest tissue in the body. Dentine located beneath 
the enamel and cementum makes up the bulk of the tooth. Dentine possesses over 
40,000/mm2 dentinal tubules and form a dental-pulp complex which lines the pulp cavity. 
Pulp is a soft connective tissue and possesses nerves, lymphatics and blood vessels which 
enter via a passage at the root apex (apical foramen). The tooth is tightly anchored to the 






1.1.2 Diversity and dentition of the mammalian tooth  
Most mammals are diphyodonts which have two sets of teeth, the deciduous 
teeth (commonly known as baby teeth or milk teeth) and permanent teeth. The 
deciduous teeth are gradually replaced by a new set of permanent teeth. In contrast 
to diphyodonts, polyphyodonts have their teeth replaced throughout life. 
Polyphyodonts include the toothed fishes and many reptiles but also rarely 
mammals (e.g. elephants and manatees). Mammalian teeth are typically heterodont 
possessing a variety of tooth shapes including incisors, canines, premolars, and 
molars while non-mammalian vertebrates (e.g. sharks and crocodiles) have only one 
tooth shape in their dental arcades referred to as a homodont dentition. The dolphin 
is the best example of a homodont mammal (2). In horses, premolars and molars are 
collectively termed cheek teeth as premolars have evolved to become 
morphologically identical to the molars to adapt to grinding (11). Another feature is 
that horses have hypsodont (long crowned) teeth that slowly erupt throughout life 
(11). The slow eruption of permanent teeth compensates physical wear (attrition) of 
the occlusal surface of the tooth during grinding of coarse foods (11).  
There are considerable variations in the numbers of tooth types between 
species and this is described in Table 1.1 (11-14). The dentition of mammals is 
described by dental formulae which describe the number of each of the tooth types 
from one side of the upper and lower jaw.  
In veterinary dentistry, the modified Triadan System is widely used across 
different animals for dental nomenclature. The modified Triadan system allocates a 
three digit number to each tooth. The oral cavity is divided into four quadrants 1-4, 
indicated by the first digit, then the next two digits indicate the tooth in each 
quadrant (01-03, 04, 05-08, 09-11 for incisors, canine, premolars and molars 





1.1.3 Cells of the tooth 
1.1.3.1 Ameloblasts 
Ameloblasts are derived from the inner dental epithelium of the enamel 
organ. The ameloblasts cover the entire surface of the crown and are responsible for 
enamel formation during tooth development. These cells are lost when the tooth 
emerges into the oral cavity. The loss of these cells makes enamel non-vital and 
insensitive so that enamel cannot be replaced or regenerated when it is damaged or 
worn away (1, 2).  
Species 
Dental formula by number 
I.C.P.M 
I.C.P.M 





























Horse (permanent)  
3.1.3-4.3 
3.1.3.3 


















Table 1.1 Dental formulae and total number of teeth in mammals. Typical mammalian teeth 
are heterodont possessing a variety of tooth shapes: incisors, canines, premolars, and 
molars. The number of each type of tooth and total number vary depending on the species. 







Figure 1.2 The Modified Triadan System for dental nomenclature in veterinary dentistry. 
Images available at https://www.rvc.ac.uk/review/dentistry/basics/triadan/dog.html 
 
1.1.3.2 Odontoblasts 
Odontoblasts are differentiated from ectomesenchymal cells of the dental 
papilla during foetal development and are present throughout life. Undifferentiated 
preodontoblasts are small and have central nuclei with few organelles. The inner 
dental epithelial cells produce signalling molecules and growth factors to induce 
differentiation of odontoblast precursors. The precursors enlarge and elongate in 





odontoblasts. Odontoblasts form a single layer at the external boundary of the 
dental pulp and extend their cytoplasmic processes into canals in the dentine, called 
dentinal tubules (Figure 1.3). The tubules extend through the entire dentine from the 
dentinoenamel junction to the pulp (1, 11).  
Odontoblasts are responsible for the deposition of dentine and this process is 
called dentinogenesis (1). Odontoblasts continue to produce dentine throughout life 
although their secretory activities are largely reduced following tooth eruption. The 
morphology of odontoblasts reflects their functional activities. During the active 
phase, cells are polarised and elongated possessing basal nuclei, prominent Golgi 
complex and increased cytoplasm containing protein synthesising organelles. By 
contrast, during their resting phase odontoblasts are smaller and stubby with scant 
cytoplasm.  
During the first step of dentinogenesis odontoblasts secrete a layer of 
unmineralised matrix, predentine, consisting of collagen and non-collagenous 
components. The predentine is similar to osteoid in bone and it is further 
transformed into mineralised dentine (Figure 1.3). Primary dentine is formed before 
the root formation is completed. The mantle dentine is the first deposited dentine at 
the outer layer close to enamel. It is less mineralised than the majority inner layer of 
primary dentine (circumpulpal dentine). The circumpulpal dentine is secreted after 
the mantle dentin by the odontoblasts. Secondary dentine forms after completion of 
root formation by slow deposition (Figure 1.3). Tertiary dentine, also referred to as 
reactive or reparative dentine, is produced in response to various stimuli such as 
caries or tooth wear. The structure and the quantity of the tertiary dentine depend 
upon the intensity and duration of the stimuli. While primary or secondary dentine 
is  formed along the dentine-pulp border, tertiary dentine is formed at specific sites 
where stimuli induce the activity of pre-existing odontoblasts or newly 
differentiated odontoblasts from pulp (16). Within the dentinal tubules, there are 
terminal branches of neural fibres that form an extensive plexus of nerves, called the 





the dentine and pulp sensitive to certain stimuli. Due to this anatomically close 
relationship, the odontoblast was considered as a receptor cell that mediates 
changes via synaptic junctions with nerves. However, the direct innervation theory 
or odontoblast receptor theory has not been proven experimentally (17). The most 
widely accepted theory to explain mechanism of dental sensitivity (intense and 
transitory pain or discomfort) is the hydrodynamic theory (17, 18). This proposes 
that stimuli abrupt dentinal fluid movements within the dentinal tubules, which 
distorts mechanical deformation of the local pulpal environment and activates nerve 
endings. Although clinical evidence-based research has been performed to 
investigate dentine hypersensitivity, the pain mechanism responsible is not fully 
understood. Dentine is sensitive to not only pain but also mechanical, thermal and 
tactile stimuli (1).    
1.1.3.3 Osteoclasts/Odontoclasts/Cementoclasts  
Odontoclasts and cementoclasts are multinucleated cells responsible for the 
resorption of hard tissues of teeth. These cells share similar characteristics with 
osteoclasts in bone. Bone constantly undergoes remodelling by a balance of bone 
formation and resorption by osteoblasts and osteoclasts respectively throughout life 
(19). Unlike bone, teeth do not remodel and have limited repair capacity. However, 
teeth can be degraded during normal physiological or as a consequence of 
pathological conditions. During tooth development, osteoclasts resorb the alveolar 
bone to aid tooth eruption, whereas odontoclasts and cementoclasts resorb and 
exfoliate primary teeth during tooth shedding (20-23). Researchers have reported 
some differences of odontoclasts in vivo (e.g. smaller cell size and smaller lacunae 
formation) compared to osteoclasts (21, 24). However, there is no clear evidence to 
prove that odontoclasts are morphologically and functionally different from 
osteoclasts (14, 21, 23, 25, 26). Thus, in vitro bone and tooth resorbing clastic cells can 
be referred to as osteoclasts in general, and current knowledge of odontoclasts is 
based on osteoclast biology (Figure 1.4 and Figure 1.5). Both cells are derived from 





marrow, spleen, and circulating blood (Figure 1.4). These progenitors migrate 
through blood vessels and undergo similar differentiation pathways at their 
respective resorption sites, in bone at the trabecular and endosteal cortical bone 
surfaces and in dental hard tissues at the edge of the cementum, dentine and pulp 
cavity (20, 23) (Figure 1.5). 
 
Figure 1.3 Histology of dentine-pulp complex of the feline tooth. (A) A diagram of observed 
area. (B) Dentine-pulp complex in boxed area (H&E). (C) Dental-pulp border contains a layer 
of odontoblasts (dotted box) and predentine (arrowheads). Secondary regular dentine 
occupies majority of dentine forming dentinal tubules. Dental pulp contains many cells 
(fibroblasts, undifferentiated mesenchymal stem cells and immune cells) in 






Figure 1.4 A schematic diagram showing the differentiation of the osteoclast lineage from 
haematopoietic stem cells. Haematopoietic stem cells give rise to common lymphoid and 
myeloid progenitors. Myeloid progenitors further generate megakaryocyte erythroid 
progenitors and granulocyte macrophage progenitors. Granulocyte macrophage 
progenitors give rise to granulocytes and monocytes then monocytes further differentiate 
into macrophages, dendritic cells and osteoclasts. Differentiation of macrophages, 
osteoclasts and dendritic cells is stimulated by GM-CSF and M-CSF. Additional RANKL is 






Osteoclasts are terminally differentiated cells which usually form as 
multinucleated giant cells that are incapable of self-renewing. Osteoclastogenesis is 
induced by a number of cytokines and transcription factors which starts to commit 
myeloid lineage cells to an osteoclast lineage. Osteoclast precursors are induced to 
express various receptors and undergo cellular changes and cytoplasmic fusion of 
cells via multiple differentiation steps (Figure 1.5). It has not been fully understood 
which specific sub-populations in bone marrow or circulating blood are committed 
to become osteoclast precursors and what attracts osteoclast precursors to the 
resorption sites (27-29).  
However, it has been well documented that there are two essential key 
molecules that control osteoclast differentiation: colony stimulating factor-1 (CSF-1) 
also called macrophage colony-stimulating factor (M-CSF) and receptor activator of 
nuclear factor κ-B ligand (RANKL) (Figure 1.5) (30, 31).The discovery of three 
molecules, receptor activator of nuclear factor κ-B (RANK), RANKL and 
osteoprotegerin (OPG) and its RANK/RANKL/OPG axis pathway contributed a 
major advance in osteoclast biology especially the mid-to-later stages of 
osteoclastogenesis (Figure 1.5) (23, 32). It has been reported that many cell types are 
capable of RANKL expression including osteoblasts, osteocytes, chondrocytes, 
stromal cells, T and B lymphocytes in bone and cells of the dental follicle in 
developing teeth and periodontal ligament cells in adult teeth (33, 34). In this 
respect, osteoclast formation is regulated by the bone and tooth microenvironments. 
There are also co-stimulatory molecules that mediate osteoclastogenesis. The earliest 
required molecules to promote a myeloid lineage are the transcription factors PU.1 
encoded by SPI1 and the microphthalmia associated transcription factor (MITF) (35-
37). PU.1 and MITF regulate expression of the CSF-1 receptor called c-Fms on the 
early stage pre-osteoclasts (Figure 1.5). CSF-1 mediates the survival and 
proliferation of osteoclast precursors and osteoclasts. Since osteoclast precursors 
share a common monocyte/macrophage lineage with phagocytic immune cells, CSF-





important role of CSF-1 in osteoclastogenesis is to promote the expression of RANK 
on osteoclast progenitors. When RANKL binds to its receptor, RANK, it can fully 


















































































































































































































































































































































































































































































Negative regulation of osteoclastogenesis occurs via OPG, a glyco-protein that acts 
as a decoy receptor for RANKL. When OPG binds to RANKL, it prevents RANKL 
from interacting with RANK expressed on osteoclast precursors which results in 
reduction of the number of osteoclasts. Osteoclast formation is largely influenced by 
the ratio of RANKL to OPG present in the bone microenvironment (Figure 1.5) (40).  
RANK signalling mediates further downstream signalling pathways in the 
osteoclast precursors (Figure 1.6). As RANK lacks intrinsic kinase activity to 
phosphorylate and activate downstream pathways, it recruits tumour necrosis 
factor receptor associated factors (TRAFs) 1, 2, 3, 5 and 6. TRAFs are adaptor 
proteins that recruit protein kinases (35, 36). Of these, TRAF6 is the most powerful 
molecule for osteoclast formation and bone resorption whereas other TRAFs have a 
complementary role since only deletion of TRAF6 resulted in severe osteopetrosis 
due to impairment of osteoclast formation (41, 42). At least four TRAF-mediated 
protein kinase signalling cascades have been identified: including the activator of 
nuclear factor (NF)-kappaB (NF-κB) signalling as the main pathway, mitogen-
activated protein kinase (MAPK) signalling, phosphoinositide 3 kinase (PI3K) 
signalling via Src, and calcium signalling (Figure 1.6) (36, 37, 43-46). Formation of a 
signalling complex containing RANK, TRAF6 and transforming growth factor β-
activated protein kinase 1 binding protein-2 (TAB2) results in transforming growth 
factor β-activated protein kinase 1 (TAK1), which is essential for NF-κB and MAPK 
pathways (47). Under non-stimulated conditions, NF-κB exists as a complex with 
inhibitory κB protein (IκB) in the cytoplasm and it is released by IκB kinase (IKK) 
(48). In a canonical NF-κB signalling pathway, the TRAF/TAK1/TAB2 complex leads 
to trigger IKKα, β and γ to phosphorylate IκB (36, 47). A non-canonical pathway 
involves NF-κB inducing kinase (NIK) and mediates through IKKα (36, 49). IκB is 
then degraded by the proteasome, which allows to release and activate NF-κB to 
translocate to the nucleus where it stimulates transcription of osteoclastogenic genes 
(35, 37). There are 5 main NF-κB subunit proteins including RelA (p65), p50 (NF-





canonical signalling and RelB/p52 heterodimers are recruited in the non-canonical 
signalling (36, 48). NF-κB activates nuclear factor of activated T-Cells 1 (NFATc1), a 
key transcription factor of osteoclast differentiation. The activation of NFATc1 is 
also regulated by the activator protein-1 (AP-1), c-Fos and calcineurin (50). In MAPK 
signalling, the RANK/TRAFs complex activates c-Jun N-terminal kinase (JNK), p38 
and extracellular signal-regulated kinase (ERK) mediating MAPK kinase (MKK)7, 
MKK6 and MAPK/ERK kinase (MEK) to induce activation of their downstream 
targets such as AP-1, Mitf and c-Fos, respectively (Figure 1.6) (22, 46, 47). 
Downstream signal of TRAF6 also activates Src kinase dependent PI3K/Protein 
kinase B (PKB also known as Akt) pathway. The PI3K/Akt and MEK/ERK pathway 
mediates proliferation, survival and cytoskeleton arrangement of osteoclast (46, 51). 
Taken together, not only RANKL mediated signalling but costimulatory signalling 
pathways mediated by hormones and inflammatory cytokines (e.g. IL-1, TNF. CSF-
1) also induce osteoclast differentiation (20, 37, 43, 52). Terminal differentiation of 
osteoclasts and further osteoclastogenesis occur via regulating expression of 
osteoclast-specific genes including tartrate-resistant acid phosphatase (TRAP), 
cathepsin K (CTSK), calcitonin receptor (CALCR), osteoclast-associated receptor 
(OSCAR), dendritic-cell-specific transmembrane protein (DC-STAMP), d2 isoform 
of vacuolar ATPase (Atp6v0d2, V-ATPase D2) and integrin αVβ3 (vitronectin 
receptor) in cooperation with other transcription factors (Figure 1.6) (20, 37).  
Osteoclasts are highly motile and capable of formation of integrin complexes. The 
integrin αv3 forms a complex with actin, known as the podosome which is 
responsible for the formation of the sealing zone between the osteoclasts and the 
bone/dentin matrix. Following osteoclast attachment to the bone surface, osteoclasts 
fuse intracellular vesicles with the cell membrane and consequently release 
hydrogen ions and proteolytic enzymes within a lacunae called Howship’s lacunae, 
at the resorption site (Figure 1.5). This highly acidic environment results in 
dissolution of inorganic mineral while the proteolytic enzymes such as matrix 





differentiated osteoclasts possess numerous lysosomal and membranous enzymes 


































































1.1.3.4 Cellular components of periodontal ligament    
The predominant cells of the periodontal ligament are fibroblast-like cells 
which are capable of production of collagen, mainly type I. The collagen fibres 
consist of larger extrinsic fibres, some of which form tight bundles of Sharpey’s 
fibres that cross the periodontal space to become anchored in the alveolar bone. The 
periodontal ligament also possesses a variety of cells including epithelial cell rests of 
Malassez (ERM) which are clusters of residual cells from proliferating epithelial 
cells in developing teeth, vascular cells, sensory nerve cells, and stem cells that can 
differentiate into osteoblasts and cementoblasts (Figure 1.7) (2, 53). From the blood 
vessels, osteoclast/odontoclast precursors can be recruited into cementum and 
alveolar bone surfaces of the periodontal ligament.   
1.1.3.5 Cementoblasts and cementocytes  
Cementoblasts are derived from dental follicle/dental sac during tooth 
development. Their characteristics are similar to osteoblasts. Cementoblasts 
differentiate to cementocytes which deposit the organic matrix of cementum 
(cementoid) that becomes secondarily mineralised (Figure 1.7). Cementum is 
deposited in increments similar to bone and dentine (53).  
1.1.3.6 Mesenchymal stem cells in the tooth 
The dental tissues have been considered a rich source of mesenchymal stem cells 
that have the potential to differentiate into several cell types. Mesenchymal stem 
cells were demonstrated in dental tissues including in the dental papilla and dental 
follicle in developing teeth as well as in the dental pulp and in the periodontal 














































































































































































































































































































































































































1.1.4 Organic and inorganic components of tooth 
Hard tissues of the body including bone, cementum, and dentine have many 
similarities in their formation and structure. They are all specialised connective 
tissues that undergo biomineralisation where specialised cells secrete proteins to 
form an extracellular matrix (ECM) consisting of mainly collagen fibres that attract 
and organise calcium and phosphate ions in composition to calcium hydroxyapatite 
[Ca10(PO4)6(OH)2] (1, 8, 53). Although enamel has no collagen, its hard tissue 
formation follows a similar principle (53). Amelogenin as the most abundant ECM 
protein in enamel is believed to play an important role to organise a basic unit of 
enamel crystals during enamel formation (55). During crown formation, ameloblasts 
become polarised in the pre-secretory phase and then secret organic matrix proteins 
including amelogenin and non-amelogenins (ameloblastin, enamelin, tuftelin and 
amelotin). As the majority of the ECM proteins are proteolytically removed prior to 
maturation of enamel, fully formed enamel contains only 4% organic material 
(amelogenin and non-amelogenins and matrix proteinases), water and 
hydroxyapatite (96%).  
Dentine is less mineralised than enamel and harder than bone. It is made up 
of 70% inorganic minerals (mainly hydroxyapatite), 20% organic materials including 
collagen, non-collagenous proteins and matrix proteinases, and 10% water. The 
organic materials constitute approximately 30% collagen (type I with small 
proportions of type III, V and VI), lipids and various non-collagenous proteins. The 
composition of non-collagenous matrix proteins in dentine are similar to bone, 
including dentine phosphoprotein, dentine sialoprotein, dentine phosphoprotein, 
dentine matrix protein-1, bone sialoprotein, osteopontin, osteocalcin, osteonectin, 
proteoglycans and matrix extracellular phosphoglycoprotein, all of which are also 
found in bone (1).  
Cementum is similar to bone in terms of degree of mineralisation and 
constituents containing 45 to 50% of hydroxyapatite and 50% collagen and non-





organic matrix. Other types of collagen including type III, XII and XIV are also 
found in cementum. Non-collagenous proteins identified in cementum are bone 
sialoprotein, proteoglycan, osteocalcin, osteonectin, osteopontin, proteoglycan and 
vitronectin (1). Phosphatases known to be required for matrix mineralisation such as 
alkaline phosphatase and phosphoethanolamine/phosphocholine phosphatase 
encoded by Phospho1 have been localised to various cell types within the tooth (56, 
57).  
Enamel is the first line of defence due to its hardness and high mineral 
content. It plays the role of a physical resistance and barrier against the masticatory 
forces (e.g. tooth wear and tear, dental attrition). However, enamel is also brittle. 
Therefore it requires a more resilient structure in combination with it. Dentine is less 
mineralised compared to enamel, and this reduced hardness of dentine 
compensates for enamel as a supportive structure of the tooth.  
1.1.5 Tooth development and physiological tooth resorption 
1.1.5.1 Tooth formation  
Although teeth share their mineralised nature with bone, tooth formation is 
markedly different from bone (8, 58). Tooth formation largely relies on odontogenic 
epithelial-mesenchymal interactions and integration of the root with the jaw bone, 
blood supply and nerve innervations. The importance of epithelial-mesenchyme 
interactions has been well denoted by Lumsden’s mammalian tooth formation 
study (59). It demonstrated that tooth formation was only elicited when neural crest 
cells interacted with mandibular epithelium. If limb epithelium was used or just 
neural crest cells or mandibular epithelium on their own, no tooth formation 
occurred (59). Tooth formation starts with the thickening of the ectodermal 
epithelium in the position of the future upper and lower jaws during gestation. 
Neural crest cells migrate to under the oral epithelium and become 
ectomesenchyme. The thickened band of epithelium gives rise to two subdivisions: 
the vestibular lamina and the dental lamina. The cells in vestibule lamina proliferate 





gingiva. The dental lamina continues to produce epithelial outgrowths to form 
placode underlying the ectomesenchyme at regular intervals along the dental 
lamina at the sites of the future deciduous teeth (Figure 1.8, A). From this stage, 
tooth development proceeds in three stages: the bud, cap and bell stage (11, 53, 58).  
In the bud stage, proliferative epithelial cells invaginate into the underlying 
ectomesenchyme and then the ectomesenchymal cells condense (Figure 1.8, B). In 
the following cap stage, the epithelial bud enlarges by cell division shaping a convex 
cap-like surface (Figure 1.8, C). The epithelial cells undergo differentiation into 
several cell layers to form the enamel organ including the outer enamel epithelium, 
the inner epithelium lining the concavity, and the stellate reticulum formed within 
the cap. Enamel knots are clusters of non-dividing epithelial cells that express many 
genes for signalling molecules to proliferate surrounding cells. As the 
ectomesenchyme becomes further condensed, the ball shaped dental papilla is 
formed below the enamel organ and surrounded by the condensed dental follicle 
(Figure 1.8, D). The enamel organ, dental papilla, and dental follicle together 
compose the tooth germ. The dental papilla contains cells that develop into 
odontoblasts responsible for formation of dentine as well as the mesenchymal cells 
developing into the pulpal cells. The dental follicle is a loose connective tissue that 
gives rise to three important entities: cementoblasts, osteoblasts and fibroblasts 
which all together form the future periodontium. The tooth crown shape is 
determined during the bell stage, and the terminally differentiated dental secretory 
cells start to deposit the hard substrates of the crown, dentine and enamel (Figure 
1.8, D). The bell shape is established by folding of the inner enamel epithelium while 
dentine and enamel begin to form at the crest of the inner enamel epithelium. 
Crown formation continues until it reaches its complete size and is followed by root 
formation (Figure 1.8, E). One important event during the bell stage is that the 
dental lamina is separated from the primary tooth germ to initiate the permanent 
tooth bud. The permanent teeth are also formed by the proliferative activity of the 





After crown formation, root formation is initiated by proliferation of epithelial cells 
from the cervical loop where the inner and outer epithelial cells join at the edge of 
the enamel organ (Figure 1.8, E). This double layer of cells further proliferate and 
form the Hertwig epithelial root sheath (HERS). It has been widely accepted that the 
role of  HERS is related to induce root formation by regulating the size, shape and 
number of the roots even though the precise mechanism of these cells remains 
unclear (62, 63). HERS extends around the dental pulp until it encloses the basal 
portion of the pulp and the rim of this sheath surrounds the primary apical 
foramen. The inner epithelial cells of HERS give an inductive message to 
differentiate radicular dental papilla cells into odontoblasts that lay down the 
dentine of the root. While the crown of the tooth rapidly grow away from the bony 
socket of the jaw, the root sheath does not grow at the same speed so it rather 
stretches and eventually fragments to form a number of clusters of epithelial cells. 
Then HERS is separated from the root allowing the newly formed predentine to 
come in contact with dental follicle cells. Some cells in the outer layer of HERS in the 
coronal root region induce to differentiate dental follicle cells into cementoblasts 
that lead to cementum formation. HERS eventually undergoes apoptosis and the 
remnants of HERS form discrete masses surrounded by a basement membrane. 
These clustered cells are known as the epithelial cell rests of Malassez (ERM) which 
remain within the mature periodontal ligament along the cementum as previously 
discussed in section 1.1.3.4 and Figure 1.7. While cementogenesis initiates, fibroblast 
precursors from dental follicle make contact with predentine matrix and deposit 
bundles of collagen fibres to form extrinsic Sharpey’s fibres. During the late stage of 
cementogenesis, cementoblasts and cementocytes are involved in the secretion of 
intrinsic fibres. In addition to collagen, non-collagenous proteins are secreted to 
maintain the space of periodontal ligament. Alveolar bone develops during the 
eruption of teeth to provide the osseous attachment to the developing periodontal 
ligament (2, 53, 58). The developmental biology of tooth root and periodontium 











































































































































































































































































































































































































































































































































































































































































































1.1.5.2 Signalling pathways during tooth development   
To understand tooth formation, the genes and molecular signals that control 
cell proliferation, migration and differentiation also need to be considered. Like 
other organ development (e.g. limb, kidney and bone), the molecular signals and 
gene expression cascades in the developing tooth are unique and very complex. 
Hundreds of genes have been identified for each development stage. The most 
conserved signalling pathways involved are the bone morphogenetic proteins 
(BMPs) belonging to the TGF-β superfamily, fibroblast growth factor (FGF), sonic 
hedgehog (SHH) and WNT ligands and their receptors. These are all involved 
during tooth development and in epithelial–mesenchymal interactions (53, 61, 64).  
1.1.5.3 Tooth eruption, shedding and the role of osteoclast/odontoclast  
After root formation is initiated, the tooth begins to erupt moving in an axial 
direction (14). Physiologically, osteoclasts are essential for eruption of the 
developing tooth in this critical embryonic period (23). The congenital osteoclast 
deficient osteopetrotic (op/op) mutant mice suffer from osteopetrosis due to the lack 
of functional CSF-1 and display a complete failure of tooth eruption (65). Similarly, 
reducing the number of odontoclasts by injecting CSF-1 receptor antagonists during 
tooth eruption resulted in a complete or partial failure of tooth eruption (66). 
Mononuclear osteoclast precursor cells are recruited into the dental follicle prior to 
the onset of eruption. When eruptive movement begins, the enamel of the crown is 
still covered by ameloblasts and the three layers of the enamel organ. The 
ameloblasts and the adjacent cells of the enamel organ together form the reduced 
dental epithelium. The reduced dental epithelium and dental follicle produce 
signals to recruit osteoclasts. While the connective tissue of the mucosa breaks down 
and the oral epithelium and the reduced dental epithelium fuse, the alveolar bone 
covering the erupting tooth is resorbed by osteoclasts so that the crown passes 
through the bone and overlying epithelium. During eruption, the central cells of the 
fused epithelium lose their nutritive supply and degenerate for formation of the 





be resorbed and exfoliated. This is known as deciduous tooth shedding or 
colloquially as shedding of the milk teeth. The resorption process is achieved by 
odontoclasts. While resorption starts at the root and coronal pulp leaving the 
odontoblast layer within the pulp chamber intact until completion of root resorption 
at which point the odontoblasts degenerate and odontoclasts actively engage in the 
resorption of dentine. The internal resorption by odontoclasts in the pulp initiates at 
the predentine surface and proceeds to the dentine. An intriguing question is how 
permanent teeth are protected from osteoclastic/odontoclastic resorption and how 
these cells recognise and resorb only the deciduous cells.  
1.1.5.4 Signalling pathways during tooth eruption and shedding  
The clear pathways of tooth eruption and shedding have not been well 
defined. However, tooth eruption and shedding are recognised to be localised 
events and the patterns of differential gene expression involved in physiological 
tooth resorption are both chronological and spatial (14, 67, 68).  
Extensive studies have shown that the dental follicle is required for tooth 
eruption (14, 23, 26, 69). The dental follicle that surrounds the un-erupted tooth has 
a dual role of alveolar bone resorption and bone formation. The major key for this 
process is how the molecular pathways are processed in a distinct temporal and 
spatial manner.  
The coronal region of the dental follicle induces osteoclast mediated alveolar 
bone resorption whereas the basal dental follicle promotes the alveolar bone 
formation at the base of the crypt for tooth eruption (67). These spatial effects of the 
dental follicle are the result of regional differences in gene expression (67). The 
expression of RANKL was greater in the coronal part than the basal part whereas 
the expression of bone morphogenetic protein-2 (BMP-2), the bone formation 
marker was greater in the basal region than in the coronal half (67, 69). Dental 
follicle also gave signals to recruit osteoclast precursors via expression of 
chemokines including CSF-1, monocyte chemotactic protein-1 (MCP-1) and 





chemokine, EMAP-II induced to upregulate the gene expression of both CSF1 and 
MCP-1, which indirectly promoted mononuclear cell recruitment in vitro (70). 
RANKL expression of the alveolar bone stromal cells adjacent to the dental follicle is 
considered to stimulate the fusion of the osteoclast precursors in the follicle (71). 
The chronological changes of gene expression in the dental follicle largely 
controls osteoclastogenesis for alveolar bone resorption (67, 72). In rat and mouse 
studies, it has been shown that a major and minor influx of osteoclast precursors 
into the dental follicle exist at a specific time prior to the onset of eruption which is 
subsequently followed by a burst of osteoclastogenesis on alveolar bone (71). The 
maximal expression of CSF-1, EMAP-II and MCP-1 in the dental follicle 
corresponded to the time of the major burst of osteoclastogenesis (70, 73, 74). The 
period of major osteoclast formation was influenced by the down-regulation of OPG 
in the dental follicle rather than the upregulation of RANKL (67, 71). Although 
RANKL was also expressed in the dental follicle at this time, its gene expression 
was not upregulated (72). The difference in gene expression is the result of an 
increase in the RANKL/OPG ratio that supports osteoclastogenesis (67). This 
chronological and spatial process is believed to be a programmed event  and this 
concept has been applied to primary tooth shedding (26). For root resorption of 
primary teeth, the dental follicle of permanent teeth is involved and the pressure of 
the erupting permanent teeth play a contributory role (75). RANK and RANKL are 
both expressed predominantly in the periodontal ligament from actively resorbing 
primary teeth, whereas OPG expression is decreased compared to non-resorbing 
deciduous teeth and permanent teeth. In contrast, OPG is highly abundant in non-
resorbing deciduous teeth and permanent teeth (33, 76). Expression of RANKL in 
many other cells including pulpal fibroblasts, odontoblasts, cementoblasts, and 
ameloblasts in deciduous teeth may support the osteoclast resorption of primary 
teeth (23, 77-79).  
In summary, physiological tooth resorption during tooth eruption including 





microenvironment of the tooth. Furthermore, the RANK/RANKL/OPG axis plays an 
important role during this process together with many co-stimulating factors. 
1.2 Tooth resorption in cats 
1.2.1  Definition and classification 
Feline tooth resorption (TR), previously referred to as feline odontoclastic 
resorptive lesions (FORL) or neck lesions, is a common and painful oral pathologic 
condition in domestic cats. A similar problem has been reported in a wide range of 
mammals including humans, dogs and horses as well as wild cats (80-85). TR in 
other animals will be discussed in section 1.3. Since caries also destroy dental hard 
tissues, the early studies focused on distinguishing TR from caries. Hopewell-Smith 
was the first to report the histopathological differences between feline TR and caries 
in 1930 (86). TR lesions lack the typical histological features of caries (e.g. presence of 
bacteria in the dentinal tubules, liquefaction foci and pipe stem appearances in the 
dentine) as demineralisation, as a result of caries, is due to toxins produced by 
carbohydrate-fermenting bacteria. Dental caries are common in humans, however, 
they are rare in cats and dogs, and only a few studies have explored why cats and 
dogs are protected (87-89). The reasons proposed include (1) pH of saliva in cats and 
dogs is higher than that of humans so that it is able to buffer acids produced by 
bacteria causing caries, (2) carnivore’s teeth have less pits and fissures with a conical 
shape of crown, (3) their diets are low in fermentable carbohydrates and (4) 
differences in oral flora may contain less bacteria responsible for caries (89, 90).    
TR was not actually recognised as a separate condition until the 1970’s 
following a microscopic study that conclusively differentiated TR from dental caries 
(91, 92). According to a thorough review of Hopewell-Smith’s early report by Reiter 
(93), Hopewell-Smith used the terms osteolysis and odontolysis of the tooth which 
is now referred to as tooth resorption in both physiological deciduous tooth 
resorption and pathological permanent tooth resorption. It was noted that 





degrees of dentine or pulp loss and the defects were often replaced with granulation 
tissues. However, Hopewell-Smith failed to identify the cells responsible for the 
odontolytic process and this according to Reiter was due to a lack of knowledge of 
the osteoclast/odontoclast in the early 1900’s. More recent investigation of seven 
feline mandibles and one skull from an archaeological excavation revealed domestic 
cats living in the 13th to 14th centuries possessed lesions characteristic of TR 
suggesting that TR is not a recent disease (94).  
According to the accumulated knowledge over the last several decades, TR 
is defined as loss of dental hard tissues (92) and this progressive condition is caused 
by dysregulation of odontoclasts. The destructive lesion initiates on the external 
surface of the tooth root and extends into enamel, dentine and pulp in the advanced 
stage (9). The lesions are seen most often at the gingival margin of the tooth and 
they are commonly covered by granulation tissue or plaque (Figure 1.4, E). At 
advanced stages of the disease, inflammation is frequently involved and the tooth 
structure is significantly resorbed leading to crown fractures and loss of dentition (9, 
93, 95). It is noteworthy, however, that some lesions are not accompanied by 
inflammation which is similar to idiopathic root resorption in humans (96).   
The diagnosis of TR is made by clinical oral examination including visual 
inspection and tactile exploration, often combined with radiography (97). Teeth 
undergoing early TR lesions can be difficult to diagnose. The current gold standard 
for diagnosis is a combination of oral examination and full mouth radiography 
where each tooth is properly represented in at least one view using a series of dental 
films (98).  
Current TR classification follows the criteria suggested by the Nomenclature 
Committee of the American Veterinary Dental College (AVDC) based on the 
severity of the resorption (Stages 1-5) (Figure 1.9, Table 1.2) and on the location of 
the resorption sites by radiographic appearance (Types 1-3) (99, 100). Depending on 
the progression of TR, affected cats show varying clinical signs including anorexia, 
































































































Table 1.2 Descriptions of the severity of tooth resorption observed by dental radiographs 
based on a classification method described by the AVDC. 
1.2.2 Prevalence of TR and other oral diseases  
Although TR in cats was first reported in 1930, TR received little attention in 
veterinary dentistry until feline tooth surveys from the 1980’s onwards reported 
increasing incidence and high prevalence. The sudden rise of TR in cats was likely 
due to several factors including the lengthened lifespan and rise population of aging 
cats, development of small animal practice and, increase of awareness and detection 
of this condition by systematic clinical examination and increased accessibility of 
dental radiology for diagnosis. During the last few decades, several epidemiological 
reports have been performed (Table 1.3). Reported prevalence varied depending on 
the sample population: 29 to 58% (average 43%) in the general population of cats 
(102-105) and 49 to 67% (average 56%) in cat populations with dental problems (98, 
106-109). One survey of the general cat population revealed a difference of 
prevalence between breeds. In mixed breed cats, reported prevalence was 38% but it 
increased 70% in purebred cats (103, 106). The mandibular third premolars are the 
most commonly affected teeth and are thought be sentinel for a rapid screening for 
Stage Radiographic characteristics 
 
1 Mild loss of dental hard tissue (cementum and enamel)   
2 








Extensive loss of dental hard tissue (cementum, enamel, dentin 
and pulp cavity) 
  
   4a Crown and root are equally affected   
   4b Crown is more severely affected than the root   
   4c Root is more severely affected than the crown   
5 
Remnants of dental hard tissue are visible only as irregular 
opacities on radiographs, and gingiva completely covers the 






TR since 90 % of TR cats were diagnosed by only assessing these two premolars (97). 
However, TR can affect any tooth (e.g. incisors, canines, other premolars, and 





































































































































































































































































































































































































TR lesions are often diagnosed at the same time as other dental problems 
when cats are presented for dental treatment. The most common dental problems in 
cats are gingivitis, gingivo-stomatitis and periodontitis (108, 112). These three 
diseases are all inflammatory lesions at the corresponding anatomical sites. 
Periodontitis includes inflammation of the gingiva, periodontal ligament, cementum 
and alveolar bone. This causes gingival inflammation, recess of gingiva and 
periodontal ligament inflammation. In the advanced stage, inflammatory induced 
tooth resorption can lead to alveolar bone loss and this loss of bone is observed as a 
radiolucency feature in radiograph (99). The oral cavity is a moist environment and 
contains a reservoir of nutrition suitable for bacterial colonisation which eventually 
can result in dental inflammation. When inflammation progresses, cytokines are 
released locally which may attract osteoclast progenitors and progress TR. 
Therefore, TR sometimes presents with other inflammatory diseases and TR lesions 
are frequently observed with localised gingival inflammation. However, TR is a 
distinct condition from other oral inflammatory diseases in terms of non-
inflammatory features. Some TR lesions are not associated with inflammation and 
this has been reported more in the early stage or in Type 2 TR (113). For this reason, 
whether TR is an inflammatory disease has not been conclusively determined yet, 






Study Prevalence Mean or 
median# age 
(years) 
Population studied  
Lund et al. 1998 (104) 48% (66/145) - General population 
Ingham et al. 2001 (103) 29% (66/228) 4.9 General population 
Girard 2008 (102) 38% (15/40) 6.2 General population 
(mixed breeds) 
70% (48/69) 3.6 General population 
(pure breeds) 
Mestrinho et al. 2013 (105) 58% (41/71) 6.5# General population 
van Wessum 1992 (107) 62% (268/432) - Dental patients 
Lommer and Verstraete 
2000 (106) 
60.8%(161/265) - Dental patients 
Lommer and Verstraete 
2001 (109) 
67% (98/147) - Dental patients 
Harvey et al 2004 (110) 49.3%(107/217) 9# Dental patients 
Farcas et al 2014 (108) 49%(49/101) 6# Dental patients with 
chronic 
gingivostomatitis 
Table 1.3 Reported prevalence in the veterinary literature. 
1.2.3 Treatment  
There is no known treatment that prevents the development of TR due to its 
progressive nature and the lack of knowledge of the cause of this condition (114). 
Therefore, the aim of current TR treatment is to relieve pain and prevent TR related 
infection. The suggested treatments are conservative management, total tooth 
extraction or coronal amputation depending on the presence of clinical symptoms 
and the type of TR. Conservative management includes monitoring the lesions 
clinically and radiographically. It is usually applicable for the early lesion whose 
resorption is confined to the root but has not progressed into the oral cavity with no 
evidence on clinical examination. Repair or restoration of the tooth surface can occur 
for the accessible lesions that extend only into the dentine by formation of 
mineralised tissue especially bone like tissues (114). This management requires 
further monitoring on a regular basis (every six to twelve months) to decide a 
surgical intervention (114, 115). However, several studies have shown that tooth 





the use of restoration cannot be recommended as a major treatment technique for 
feline tooth resorption. In the general practice situation, extraction of entire tooth or 
crown coronal amputation is suggested. Restoration of the defects (e.g. removal of 
resorption and dental filling) is not indicated in cats. Total tooth extraction is the 
gold standard treatment to ensure removal of all resorbed and infected substance. 
However, teeth, especially those possessing Type 2 lesions, are notoriously difficult 
to extract since roots are extensively resorbed and replaced by bone tissue resulting 
in ankylosis between alveolar bone and tooth. In this case, crown amputation is 
often indicated. Crown amputation involves raising a gingival flap to expose and 
remove crown and upper part of root (1-2 mm below bone level) just enough to 
ensure retained root. The gingival flap is then replaced and sutured in place. In 
Type 3 TR, Type 1 root is extracted while Type 2 root can be amputated. 
A pilot study attempted to use alendronate, a class of bisphosphonates (BPs) 
to prevent development of TR in cats (117). BPs are used to treat osteoporosis in 
humans and act via binding to hydroxyapatite in bone to inhibit osteoclast 
recruitment and resorptive activity, ultimately inducing osteoclast apoptosis (118). 
Alendronate predominantly accumulates on subgingival surfaces and adjacent 
alveolar bone around tooth roots where TR arises most commonly (117). At a dose 
of 9 mg/kg twice weekly for 27-weeks, alendronate-treated cats showed slowed or 
arrested the progression of tooth resorption with decreased radiographic area of 
resorption (22 % average change) during the post alendronate treatment period 
from 4 to 11-months compared to vehicle-treated cats (117).  
Another study showed that topical application of BPs reduced root 
resorption and odontoclast formation in a rat model for orthodontic related tooth 
disease where the resorption was mediated by interleukine-1β (IL-1β) and tumour 
necrosis factor-α (TNF-α) (119). These findings may suggest that BPs may be a 
potential anti-resorptive drugs for the treatment of tooth resorption in the future 
(119). However, BPs have been associated with bisphosphonate-related 





to long term use of these medications (120). Further studies are required for the local 
application of BPs to target odontoclasts and prevent TR.  
These studies on the effect of BPs on TR have however demonstrated a 
couple of important things about TR. The high deposition of BPs in calcified tissues, 
especially in tooth resorption areas after intravenous or local injection, and their 
anti-resorptive efficacy via a reduction of odontoclast formation, support the 
hypothesis that dysregulated odontoclasts are responsible for TR (117). 
1.3 Tooth resorption in animals other than cats 
1.3.1 Humans 
TR, or more specifically root resorption, has been reported in humans. 
Although TR has been more recognised in the last few decades, the first report of 
TR-like lesions date-back to 1859 where Tomes called the process absorption (83, 
121). He described that the crown of the tooth was relatively intact but the root was 
absorbed. Resorption can occur both internally and externally. However, the 
phenomenon of multiple teeth being affected is rare in humans. Therefore multiple 
external resorption can be considered as the corresponding condition to feline TR 
(96, 122). Andreasen’s classification is the widely accepted description that 
resorptions are classified into seven types based on their radiographic appearance: 
external surface resorption, external replacement resorption, external inflammatory 
resorption, external cervical root surface resorption, internal surface resorption, 
internal replacement resorption, and internal inflammatory resorption (Table 1.4) 
(83, 123). The initiation and progression of TR is related to many factors including 
pulpal necrosis, trauma, periodontal treatment, orthodontic treatment and tooth 
whitening agents (83). Regardless of the cause of TR, the process is largely related to 
inflammation in terms of odontoclast involvement and cellular mediators (83, 124). 
If caries or mechanical trauma are present within the pulpal tissue, they elicit an 
inflammatory process resulting in the production of nonspecific inflammatory 





resorption by pulpal infection) progresses, treatment requires removal of resorbed 
substance and damaged pulp followed by preservation of vital pulp if possible and 
dental fillings with various mineral materials (125, 126). External resorption can be 
triggered by mechanical injury, local inflammatory or unknown causes. Depending 
on the duration and degree of stimuli TR lesions present various features. If stimuli 
are temporary and no further odontoclasts are involved, resorption is limited to a 
focal area and self-limiting root repair occurs within 2 to 3 weeks as a result of 
deposition of cementum-like tissue and reattachment to periodontal ligament (e.g 
external surface resorption) (126). If stimuli are prolonged, and a large area is 
resorbed including alveolar bone as well as dentine and pulp (e.g. external cervical 
root or inflammatory resorption), bone cells start to make new bone to cover the 
defect between root and alveolar bone forming ankylosis (e.g replacement 
resorption) (126, 127).  
Tooth movement by orthodontic treatment is characterised by a remodelling 
process in both dental and paradental tissues. Orthodontic forces cause stress and 
pressure on the periodontal ligament in a certain direction and this leads to cellular 
responses that leads to osteoclast mediated alveolar bone resorption, tooth 
movement and complimentary bone formation to fill the bone defect and finally 
periodontal ligament rearrangement (128). This alveolar bone remodelling is the key 
to the success of orthodontic treatment. However, orthodontic treatment can cause 
off target effects such as massive alveolar bone or root resorption of the teeth. 
External apical root resorption (EARR) refers to a specific type of external 
inflammatory resorption characterised by a shortening of the apical third of the root 
(81, 129). EARR is believed to be related to various factors including orthodontic 










Table 1.4 Descriptions of the types of TR reported in humans based on the Andreasen’s 
classification method (123, 125). 
1.3.2 Dogs  
Only a few reports of canine TR have been documented, and they are mainly 
epidemiological reports or case reports (130-134). This might be because TR in dogs 
is relatively subclinical, usually found by chance. According to the reported 
prevalence, it could be called a clinically neglected condition, in comparison to cats 
(130, 135), but it might also be a reflection of the level of severity between the 
conditions with it rarely progressing beyond the subclinical stage in dogs. Hence 
canine TR has been poorly evaluated, despite reported prevalence ranging from 
17.9% up to 56%. One epidemiological study reported 18% (6/33) dogs (> 10 years 
old) without clinical dental signs had one or more TR lesions identified on 
radiographs (130). Another  study reported that 17.9% (29/162) of randomly selected 
dogs revealed TR lesions at post mortem (131). In a hospital cohort of 224 dogs 
undergoing dental treatments, the prevalence of TR was as high as 56% (80). This 
Stage Radiographic characteristics  
External surface resorption Shallow resorption lacunae (cementum and 
dentin) 
  
External replacement resorption  Gradual disappearance of the periodontal 
ligament space with progressive replacement 
of root tissues 
  
External inflammatory resorption  Loss of dental tissues adjacent to areas of 
loss of alveolar bone secondary to 
inflammatory conditions or prolonged 
stimuli 
  
External cervical root resorption  
 
Invasive resorption process that starts at the 
cervical area of the tooth and invades in both 
the coronal and apical directions 
  
Internal surface resorption  Oval-shaped enlargement located in the 
apical third of the root canal, related to 
traumatic injuries 
  
Internal replacement resorption  Irregular enlargement with a tunnel-like 
appearance adjacent to the root canal  
  
Internal inflammatory resorption  Oval-shaped enlargement typically found in 
the cervical third of the root, inflammatory 






study used human TR classification criteria described in Table 1.4 for evaluation of 
TR in dogs (80). The human TR classification criteria was applicable in 96.3% of TR 
teeth in dogs. Unclassified TR lesions (3.7%) were caused by mixed types of TR. The 
most common two types of TR were external replacement resorption (34.4%) and 
external inflammatory resorption (25.9%) followed by external cervical root 
resorption (5.8%), external surface resorption (4.5%), internal replacement 
resorption (4%) and internal surface resorption (0.4%) (80). External replacement 
resorption is a less common type in humans but it is known to be common in cats 
(83, 99). Although the aetiology of external replacement resorption has been poorly 
understood, several factors have been suggested including damage of root surface 
and periodontal ligament, and homeostatic process of periodontium which is bony 
remodelling following union of bone and dentine known to as ankylosis (83, 126). 
Except for external replacement resorption, frequency of other types of TR can be 
correlated to common dental diseases such as periodontal or endodontic disease 
given that the two diseases cause inflammatory TR involving cementum, dentine, 
pulp as well as alveolar bone. Inflammatory resorption and its clinical correlation is 
a similar finding in humans (80, 126). The authors of this study performed a parallel 
study using the same radiographs to apply veterinary TR classification criteria 
which is discussed in section 1.2.1 (136). They re-classified previously typed canine 
TR into the 5 stages of TR (1-5) and 90.2% of TR was applicable in this system. 
Although the major type, external replacement resorption was totally applicable in 
this classification, half of external inflammatory resorption and internal resorption 
failed to match this classification method. The majority of TR lesions in dogs was 
stage 2 (90.2%) followed by stage 4 (6.4%), stage 5 (2%) and stage 3 (1.4%) (136). This 
implies that TR in dogs is relatively less severe, that the progression is slow, and 
that only rare cases of TR will result in total loss of dentition. Based on these studies 
therefore it might be suggested that human TR criteria might be more suitable for 
canine TR classification. It also implies that the characteristics and aetiology of TR in 





similarities to the scenario found in cats; dogs diagnosed with other dental problems 
also had more TR lesions than a random population of dogs, and the percentage of 
TR increased significantly with age (103, 108). One important note is that although 
most cases of TR in dogs are subclinical and they rarely develop to progress it is 
increasingly noted in radiographic and epidemiological reports which might require 
further investigations.  
1.3.3 Horses 
 In horses, an equivalent disorder to feline TR has been reported named 
equine odontoclastic tooth resorption and hypercementosis. Equine odontoclastic 
tooth resorption and hypercementosis shares similar features with TR in humans 
and cats representing multiple resorptive lesions extending into the cementum, 
enamel, dentine or pulp cavity in severe cases (85). However, gross and histological 
observations identified some different pathological changes with distinct 
periodontal inflammation and predominant deposition of cementum by a highly 
reparative reaction (85). The basic anatomy of the equine dentition helps us get a 
better understanding of equine odontoclastic tooth resorption and hypercementosis. 
As mentioned earlier in section 1.1.2, horses have evolved to have hypsodont teeth 
that possess high crowns that erupt slowly to adapt to a rough diet (e.g. high fibre 
grass). To endure attrition on the occlusal surface of hypsodont teeth, there is an 
extensive distribution of calcified dental tissues on the occlusal surface. Unlike the 
single layer of enamel on the surface of brachyodont teeth, the crown of equine teeth 
is made up of enamel surrounded by softer dentine and cementum. As the softer 
tissues wears away quicker, the enamel forms sharp ridges on the surface, ideal for 
grinding down the horse’s rough diet. The surface area of enamel is further 
increased by extensive enamel infolding and the presence of one (incisors) or two 
(maxillary cheek teeth) infundibula (11). As cementum is the most adaptable 
calcified tissues in teeth due to the presence of cementoblasts and  a rich blood 
supply, this can be deposited quickly in response to stimuli (e.g. infection or trauma) 





crown is entirely covered in a layer of cementum. These anatomical features of 
equine teeth make them prone to hypercementosis in response to TR.   
Incisor teeth are most frequently affected followed by canine teeth and 
reported cases are mainly in old horses (> 15 years old) (85). Mechanical stresses on 
the periodontal ligament factor has been suggested by Staszyk and colleagues (85), 
as an initiation however, the aetiology of equine odontoclastic tooth resorption and 
hypercementosis remains unclear (84, 85).  
1.3.4 Wild cats 
TR has been also reported in wild cats (82, 137). Macroscopic and 
radiological investigations revealed TR lesions in the dentition of one captive and 
one wild leopard, and two wild lions (82). Microscopic investigations were 
performed on two canine teeth and one molar collected from three animals. 
Although the sample size was small, it was possible to distinguish TR lesions from 
dental caries. At the ultrastructural level differences in the staining pattern of 
Rhodamin B, a caries detecting dye, and the width of the dentinal tubules was 
observed to identify typical features of caries. In terms of dentine hardness, the 
measured values were low in teeth with caries but remained normal in TR affected 
teeth. Finally, a larger study investigated dental disorders in 73 skulls from wild 
cats (8 caracals, 39 cheetahs, 14 leopards, 11 African wildcats, and 1 lion) and 
reported a 16% prevalence rate in wild cat species with varying stages of TR. This 
implies TR is not only confined to domestic cats, although the frequency was lower 
than those reported in the domestic cat populations (137). The authors could not 
make any conclusions on what the relevant factors causing TR were in wild cats. 
1.4 Pathogenesis of tooth resorption 
1.4.1 Histological manifestations of tooth resorption 
Primary tooth resorption is the normal physiological process responsible for 
tooth eruption and shedding. The process is aided by osteoclasts/odontoclasts and 





permanent dentition is largely pathological (83). In pathological TR there is no 
dental follicle involved as the entire follicle is shed during tooth eruption. Factors 
responsible for pathological TR may differ from those of physiological resorption. 
One important fact to note is that TR develops anywhere on the root surface and not 
only at CEJ (110). Although some authors have reported internal TR to be initiated 
within the pulp space (98, 138), TR usually occurs externally in cats (6, 106, 108). 
Internal resorption lesions including apical and coronal dentine/pulp are usually 
due to the inwards progression of external TR.  
Early stage 1 lesions are barely detected clinically and radiographically 
because the size of the lesion is small and confined to cementum and enamel that 
are too thin to be observed radiographically (97, 106). A study revealed that 
clinically and radiographically TR unaffected teeth can possess early stages of TR 
(stage 1 TR) whose histological features include degeneration of periodontal 
ligament, a narrow periodontal ligament space and a localised resorption lesion 
such as surface root resorption with cementum resorption or replacement resorption 
(root resorption with ankylosing fusion between the tooth and alveolar bone) (113). 
This study also reported no inflammation adjacent to these early TR lesions. Stage 2 
TR can be radiographically detected but it frequently does not accompany clinical 
signs and its histological features are similar to early stage of TR.   
The histological features of active and advanced TR representing clinical 
signs detectable by oral examination (stages 3 to 5) have been described as two 
phases: resorptive phase and reparative phase. It is difficult to obtain histological 
sections from each stage due to the limited life time of the odontoclasts and their 
rapid resorbing process (9, 92, 122). The morphology of the resorptive phase (seen as 
numerous resorption pits), is similar to that of shedding deciduous teeth displaying 
multinucleated odontoclasts lining the lacunae of dentine and/or cementum (9) 
(Figure 1.11, E). Inflammatory lesions frequently accompanies TR involving the 
surrounding tissues, but there is no conclusive evidence to date to determine 





of the aetiology of TR. (9, 86). Hyperplastic gingiva and vascular granulation tissue 
fill the resorptive defects. The TR lesions are surrounded by infiltrated 
inflammatory cells including neutrophils, plasma cells, macrophages and 
fibroblasts. In the following reparative phase the actions of osteoblasts and 
cementoblasts are coordinated; rounded cementoblasts or osteoblasts produce new 
hard tissues including cementum and osteodentine to replace the defect (Figure 
1.11, E). In a prolonged stage which is the odontoclast quiescent stage, most dental 
tissues are replaced by bone-like tissue appearing as dental-alveolar ankylosis 
(Figure 1.11, F). The resorptive and reparative phases can occur simultaneously 
(Figure 1.11 E and F). The morphology of the periodontal ligament is also altered or 
destroyed by the involvement of bone resorption at the alveolar crest (Figure 1.11, E 
and F) compared to healthy periodontal ligament at the CEJ, the gingival sulcus 
(Figure 1.11, B) or at the root furcation (Figure 1.11, C). These histological findings 
highlight the importance of the dynamic property of the periodontium in the 






































































































































































































































































































































































































































































































































































































































1.4.2 The microenvironment in tooth resorption 
As discussed in section 1.1.3.3 osteoclast/odontoclast differentiation and 
activity are tightly regulated by the bone and tooth microenvironment. Although 
these cells share many similarities, sometimes they behave differently under certain 
conditions (e.g. their responses differ in the presence of thyroid hormone, 
parathyroid hormone or an inhibitor of prostanoid synthesis) (21, 24, 140, 141). 
Administration of thyroid hormone (L-thyroxine) increased bone resorption but did 
not enhance force induced root resorption in rats (140). In a study investigating the 
effect of hyperthyroidism in dogs, resorption by odontoclasts were not present. It 
also reported that parathyroid extract did not cause any morphological changes of 
odontoclasts residing in the dogs’ deciduous teeth (141). Another study reported 
that indomethacin, an inhibitor of prostanoid synthesis belonging to the group of 
nonsteroidal anti-inflammatory drugs, inhibited osteoclastic resorption but 
increased odontoclastic resorption (24). These differences in response to exogenous 
factors suggest that these two types of resorbing cells may be subjected to alternate 
regulatory mechanisms due to their niche microenvironments and resident cell 
populations. Therefore, to better understand TR, there is a need for a thorough 
investigation of the tooth microenvironment itself. Initially, TR requires stimulatory 
factors to damage the defence layer of the tooth and attract odontoclast precursors. 
For example, when the periodontal ligament is damaged by a mechanical load or 
inflammation, periodontal ligament and alveolar bone cells react via the release of 
numerous substances such as neurotransmitters, cytokines and growth factors. The 
released molecules elicit cellular responses in the various dental cells for tooth 
resorption or repair (23). The supporting role of surrounding cells on odontoclast 
differentiation has been shown by co-culturing odontoclast precursors with dental 
pulp or periodontal ligament cells, which lead to spontaneously differentiated 
odontoclasts without the addition of osteoclast stimulating factors (e.g. 
prostaglandin E2) (23, 142). Differentiated clastic cells need to attach to the tooth 





proteins (e.g. osteopontin, bone sialoprotein) mediating clastic cell attachment and 
activation (23, 143).  
Lastly, survival and activation of clastic cells largely depend on a favourable 
microenvironment for osteoclastic activity. In vitro, reduced oxygen tension and 
acidosis (low pH) lead to an increase in osteoclast and resorption pit formation (20). 
An hypoxic environment is evident in some pathological states (e.g. reduction of 
partial pressure oxygen in diseased mandibles and in fracture hematomas) (144). 
1.4.3 Odontoclast dysregulation and pathways involved in TR  
As discussed in section1.1.3.3 and 1.1.5.4 osteoclasts and odontoclasts 
differentiate via CSF-1 and the RANK/RANKL/OPG axis pathway. This central axis 
is important in both physiological and pathologic TR. However, the 
microenvironment of physiological and pathologic TR is different. Therefore there 
has been a focus on identifying co-stimulating factors (e.g. growth factors, cytokines 
and transcription factors) in pathological conditions. The precise origin and 
activation of odontoclasts during TR is presently unclear however, many possible 
candidates that directly or indirectly impact on the RANK/RANKL/OPG axis 
pathway have been postulated (20, 22).  
First of all, many intracellular factors have been reported to be involved in 
the control of osteoclast formation. For example, the disruption of genes coding for 
transcription factors, PU.1, MITF and c-Fos impaired the early stage of osteoclast 
differentiation (20, 145-147). Osteoclast stimulatory transmembrane protein (OC-
STAMP) and DC-STAMP have been reported to be involved in the fusion of 
osteoclast precursors (148). The Fos-related protein inversely controls osteoclast 
survival and size (149). The matrix metalloproteinase (MMPs) including MMP2, 9, 
12, 13, and 14 play an important role in osteoclast activity that contribute to bone 
matrix solubilisation (150). Specifically, MMP9 has been associated with bone 
resorption and many diseases including cancer, osteoporosis and fibrosis where 
MMP9 modulates the ECM (151-153). 





have been proposed as co-stimulatory factors (e.g. TRAF2, 5, 6, NF-κB and NFATc1). 
Higher expression of OPG in permanent teeth offers protection against TR (22) and 
this may be via local factors such as TNF, GM-CSF, IL-1 (IL-1α, β), IL-6, IL-12, IL-17, 
IL-18, IL-23, TGF-β (20, 43, 154). Although IL-1β is a well-known stimulator of 
osteoclast formation for example in periodontitis, cytokine expression can be 
contradictory in certain situations (e.g. non-inflammatory resorption, orthodontic 
related TR). In human TR, especially in EARR it has been suggested that genetic 
mutations of IL-1β or the purinergic-receptor-P2X, ligand-gated ion channel 7 (P2X7 
receptor) might decrease cytokine levels that modulate local inflammation (81, 155). 
In the pathological process, local damage (i.e. orthodontic treatment) of tissue 
results in ATP release which in turn activates the P2X7 receptor and further release 
of cytokines. In such cases, cytokines recruit more monocytes and macrophages to 
eliminate apoptotic cells to prevent further necrosis. However, if this pathway is 
blocked, there will be defective alveolar resorption and reduced bone turnover so 
that teeth experience a prolonged stress and strain from for example during 
orthodontic treatment (156-158). This pathway might be involved in non-
inflammatory induced TR (23). 
Other locally produced molecules such as hypoxia inducible factors and 
leukaemia inhibitory factor are involved in the stimulation of osteoclast formation 
in hypoxic conditions (149). Bone related systemic factors including both stimulators 
and inhibitors might also impact on TR: parathyroid hormone (PTH), vitamin D3, 
calcitonin, calcitonin gene related peptide, and oestrogen (159-161). Recently the 
WNT signalling pathway and its related molecules (e.g. β‐catenin, frizzled 
transmembrane receptors, Low-Density Lipoprotein receptor related protein co-
receptor, sclerostin, dickkopf-1) have been identified as important regulators of 
osteogenesis and osteoclastogenesis via indirect mechanisms (162). In summary, a 
range of molecules might be involved in the re-activation of osteoclasts/odontoclasts 





1.5 Aetiology of tooth resorption 
Even though many researchers have sought to elucidate the aetiology of TR 
in cats, the precise cause(s) remain unknown. Exhaustive studies have been 
performed to identify local and systemic factors involved (e.g. structural 
characteristics of TR, diet, gender, biomechanical stress, and anatomical defects in 
tooth morphology) (9, 92, 98, 100, 163-165). 
1.5.1 Inflammation  
As osteoclasts/odontoclasts are of monocyte/macrophage lineage, 
inflammation has been most frequently suggested as an initiating factor of feline TR. 
Inflammatory cytokines have been considered to play a role in the recruitment of 
progenitors. TR in cats has often been detected concurrent with other oral 
inflammatory diseases (99, 108, 112). A study reported that messenger RNA 
(mRNA) levels of inflammatory cytokines including IL1B and IL6 increase in the 
areas of active dental resorption concurrent with feline TR (163). Although these 
cytokines are known as potent stimulators of osteoclast/odontoclast differentiation 
in vitro and in vivo (23), it is worth noting that increased expression of these 
cytokines can be a result of inflammation due to TR rather than an initiation factor. 
Also these stimulators fail to alter the expression of downstream regulators of 
osteoclast/odontoclast differentiation, RANKL and OPG. Moreover, this 
inflammatory cytokine study in feline TR possesses technical limitation in terms of 
measurement of gene expression since mRNA of cytokines were measured by semi-
quantitative RT-PCR (163).  
Recently another study addressed the involvement of inflammatory 
cytokines and the possible role of vitamin D in the pathophysiology of TR using 
quantitative PCR (100). This study reported increased mRNA expression of 
stimulatory cytokines including IL1B, IL6 and TNF, and the nuclear vitamin D 
receptor (VDR) in tissues from TR lesions compared to those of healthy controls. 





(IFNG) possessing an inhibitory effect on osteoclastogenesis, or anti-resorptive 
cytokines also increased in TR affected teeth and mRNA levels of RANKL and OPG 
were not different between TR and control group (100). Therefore, at present it is 
difficult to conclude if inflammatory cytokines lead to tooth resorption via increased 
osteoclastogenesis. One study demonstrated the potential role of mast cells and 
compared the three most common periodontal diseases (chronic gingivostomatitis, 
periodontitis and TR) in cats (112). All three conditions revealed increased mast cell 
populations in gingival tissues compared to the gingiva of specific pathogen-free 
cats. Therefore, it is possible the presence of mast cells might be correlated to these 
oral diseases. Another finding of this study was the inflammatory scores were 
significantly lower in TR compared to chronic gingivostomatitis or periodontitis 
(112). Although most TR lesions are associated with inflammatory cells, the early 
lesion covered by an apparently normal gingiva does not seem to be. This has led 
some researchers to believe that the appearance of inflammatory cells is a secondary 
rather than primary event during development of TR. Concurrent inflammatory, a 
two feline osteoclast studies demonstrated that hypoxia and local change of pH may 
play an important role in pathogenesis of feline TR (166, 167).  
1.5.2 Diet 
TR has been reported in wild cats as described in section 1.3.4, but due to the 
higher prevalence of TR in domestic cats, it has been suggested that their diet is an 
aetiological factor. According to a previous study TR may be correlated with low 
calcium or low magnesium intake from homemade food and this is consistent with 
another cross sectional study where cats fed a high content of minerals (e.g. 
magnesium, calcium, phosphorus, and potassium) experience less TR (104). 
However as most cats are fed commercially prepared foods, which are balanced in 
both calcium and magnesium  this should no longer be an issue (164). A 
consumption of foods containing cheese, milk and butter has been associated with 
an increased risk of TR whereas dry food with an acid surface was  not found to 





which have less chance to hunt prey, were found to have a higher risk of developing 
TR but commercial treats reduced the risk approximately threefold (165). The 
current findings on the effects of domestic diets on the incidence of TR are 
inconsistent which might be due to bias or incorrect data collected via 
questionnaires of owners. At present there are no longitudinal studies reporting the 
incidence of feline TR on defined diets with known mineral concentrations and 
therefore it is unknown whether TR prevalence can be modulated by diet.  
1.5.3 Bone turnover markers and hormonal influences  
Bone resorption by osteoclasts is largely associated with endocrine and 
metabolic imbalances in humans. One of the most well-known stimulators of 
osteoclastic bone resorption is chronic PTH which stimulates the RANK/RANKL 
system (169). The thyroid hormones, and PTH-related peptides (PTHrP) also 
increase osteoclastic activity in bone (169). These hormones play critical roles in the 
maintenance of calcium and phosphate homeostasis as well as maintenance of bone 
health (78, 169, 170). Although the anabolic and catabolic actions of these hormones 
and their derivatives are complicated due to their dual roles of bone formation and 
resorption depending on given situations (e.g. primary and secondary 
hyperthyroidism and osteoporosis), hyperparathyroidism primarily causes 
extensive bone loss and resorption (171). Primary osteoporosis has not been 
reported in cats and dogs yet. Cats and dogs are also resistant to oestrogen 
deficient-related bone loss corresponding with postmenopausal osteoporosis in 
elderly women (172).  
Thyroid hormones are also known as stimulators of osteoclastogenesis (173). 
Various systemic levels of bone turnover markers including the bone formation and 
degradation markers can be used to assess specific bone pathology.  
It is not fully known whether TR is correlated with systemic hormonal 
related bone diseases in cats (98). Similarly, in humans the relationship between TR 
and systemic bone disorders are not clear. Only limited literature is available 





periodontitis in hyperparathyroidism, delayed tooth eruption in childhood 
hypothyroidism, and maxillary and mandibular osteoporosis in hyperthyroidism 
(174, 175).  
To investigate a link between pathological bone remodelling and feline TR, 
biochemical bone turnover markers were measured in aged cats with or without TR. 
The bone formation marker, bone alkaline phosphatase (BAP) produced by 
osteoblast was measured by wheat germ lectin precipitation and human enzyme-
linked immunosorbent assay (ELISA). In terms of bone resorption markers serum 
deoxypyridinoline (DPD) was measured by an automated analyser and urine DPD 
was measured by a human ELISA. Another resorption marker carboxy terminal 
telopeptide (CTx) was measured in urine using high-performance liquid 
chromatography (HPLC) and in serum CTx was quantified by a commercial human 
ELISA. Serum DPD levels were inconsistent, possibly due to lack of cross-reactivity 
with the human DPD antibody. Although there were technical limitations to 
measuring cat serum and urine levels of DPD, there was no difference reported of 
the three bone turnover markers in serum or urine between control and TR cats 
(176). In another study on systemic hormonal imbalances, serum calciotropic 
hormones were measured by previously validated gold standard 
immunoradiometric assays in cats (177). There was no significant difference in PTH, 
PTHrP and free thyroxine between control and TR affected cats (178). For other 
systemic biochemical factors, the mean serum level of blood urea nitrogen and 
phosphorus were higher in TR cats but multivariate logistic regression model 
revealed that higher concentrations of these might be due to other factors, such as 
age. Low urine specific gravity was correlated with TR status but the importance of 
this has not been determined (178).  
It is therefore unlikely that a link exists between systemic bone diseases and 
TR. This implies that the dentition is generally resistant to resorption under 
systemic bone resorption. As previously mentioned, bone resorbing stimulators 





activity in the local dental environment (43, 179). In one orthodontic study in cats, 
the level of PGE2 and IL-1β secreted from gingival fluid increased with 
experimentally induced orthodontic tooth movement (180). Another finding of this 
study was that in a group of cats where oestrous was induced by gonadotropin 
hormone injection, it resulted in reduced PGE2 and IL-1β levels and less tooth 
movement. This suggests a potential ovarian protection activity on orthodontic 
tooth movement. However, other epidemiological studies in cats have shown there 
is no correlation between TR and neuter status or gender (98, 103, 178, 181). Due to 
the limitations of the available studies and the tools available for measuring feline 
hormone levels any links between these hormones and feline TR remain speculative.  
1.5.4 Vitamin D and its metabolites  
Vitamin D is a known stimulator of osteoclastic bone resorption and an 
essential ingredient of commercial cat foods and therefore the role of Vitamin D has 
drawn a great deal of interest in the aetiology and progression of feline TR (92, 100). 
Vitamin D is a calciotropic hormone and together with PTH they cooperatively 
mobilise calcium from the bone and conserve calcium from urine (170). Although 
vitamin D exists in the diet as two forms: ergocalciferol (vitamin D2) and 
cholecalciferol (vitamin D3), the major source of vitamin D3 in herbivores and 
omnivores including humans, rats, pigs and sheep is photosynthesised from 
cholesterol in their skin under sufficient sunlight (182). However, cats and dogs 
cannot produce sufficient vitamin D3 precursors (7-dehydrocholesterol) and lack the 
ability for synthesis of vitamin D3 in their skin (183). Cats and dogs therefore require 
supplementation of vitamin D2 or vitamin D3 in their diets. Dietary or synthesised 
vitamin D (D represents either D2 or D3) is converted to 25-hydroxyvitamin 
(25(OH)D) by 25-hydroxylases (e.g. coded by the genes CYP2R1 or CYP27A1) in the 
liver and transported in blood by the vitamin-D binding protein. 25(OH)D 
comprises the major metabolite of vitamin D in serum as the most useful index of 
vitamin D status (184). 25(OH)D is further metabolised to its biologically active 





(coded by the gene CYP27B1) (160). Both 25(OH)D and 1,25(OH)2D are catabolized 
by 24-hydroxylase (coded by the gene CYP24A1) (184). 1,25(OH)2D acts via its 
receptor VDR which is expressed in many tissues including kidney, bone, and skin 
as well as in immune cells (185, 186). The role of 1,25(OH)2D in bone is complex; it 
has a dual activity of bone formation and resorption regulating calcium levels 
depending on body conditions (170). In vitro, 1,25(OH)2D indirectly increases 
osteoclast activity via RANKL expression but paradoxically, in vivo 1,25(OH)2D 
increases bone mineral density via increased calcium absorption and the subsequent 
suppression of bone resorption and therefore it has been used as a therapeutic drug 
for osteoporosis (160). Reiter et al. (2005) first suggested that vitamin D and their 
metabolites might be involved in the pathogenesis of feline TR. They found that the 
mean serum level of 25(OH)D in TR cats was significantly higher than controls 
although both mean serum levels were within the normal reference range (178). 
Providing high vitamin D3 in diet caused an increase in serum 25(OH)D3 in kitten 
and adult cats and therefore it was speculated that excessive supplement of 
vitamin D3 can lead to hypervitaminosis D and renal impairment that might be 
correlated with TR (92, 187). However, several vitamin D3 diet studies demonstrated 
that high vitamin D3 diets (up to 63 times of the maximum recommended vitamin 
D3) did not cause any apparent adverse effects in kittens and adult cats (188, 189). In 
addition, results of other studies on vitamin D and their metabolites in TR were not 
consistent. Girard et al (2010) revealed that there was no significant difference in 
serum 25(OH)D3 between control and TR cats with at least one or more TR teeth, 
instead it was mentioned that cats possessing multiple (> 5) TR lesions had lower 
serum 25(OH)D3 concentrations than controls (190). Booij-Vrieling and colleagues 
reported there was no difference in 25(OH)D serum levels whereas 1,25(OH)2D 
levels were higher in the controls than TR cats (122). There have been many 
methods developed to measure total serum 25(OH)D (e.g. competitive binding 
methods, high-performance liquid chromatography, and radioimmunoassay) (191). 





used in many reference laboratories in the past decades (192). Recently, newer 
chromatography methods have been developed which improved sensitivity and 
enabled measurements of all forms of vitamin D (191). One of the new methods, 
liquid chromatography tandem mass spectrophotometry (LC-MS/MS) is a 
recommended method for vitamin D analysis by UK Food Standards Agency 
Workshop Consensus Report (193) and this method has been used in a veterinary 
diagnostic laboratory (NationWide Laboratories accredited by United Kingdom 
accreditation Service). Although it is now possible to measure various vitamin D 
metabolites, vitamin D status was typically only assessed by measuring 25(OH)D 
because the life span of 25(OH)D is long (approximately 2–3 weeks) and it exists in 
serum at levels more than 1,000 times higher than 1,25(OH)2D (184). This means that 
serum 25(OH)D directly reflects dietary vitamin D intake and/or cutaneous vitamin 
D synthesis. It is therefore assumed that  25(OH)D provides the most meaningful  
information regarding vitamin D sufficiency or deficiency in the body (184). 
However, as it is not the most active form of vitamin D, it would be desirable to 
measure both 25(OH)D and 1,25(OH)2D.   
In feline TR studies, various methods were used for measuring 25(OH)D 
which may account for the different results and variations between the various 
studies (100, 178, 190). Unfortunately, although there many efforts have been made 
to measure 1,25(OH)2D in feline serum using new techniques including LC-MS or 
LC-MS/MS, currently there are currently no one gold standard assay for 
measurement of 1,25(OH)2D in cats and its reference range has not been 
documented in text although different labs have developed their own cat reference 
intervals (personal communications, Prof. Danielle Gunn-Moore). Hence, feline 
studies did demonstrate that systemic levels of vitamin D including 25(OH)D and 
1,25(OH)2D varies greatly and that the impact on bone and dentition is unclear. 
Until further studies can firmly confirm its role, vitamin D still has to be considered 
to possibly play a role in TR (185).  





microenvironment in cats (194). Following repeated injections of 1,25(OH)2D  into 
the periodontal ligament of teeth which had gentle orthodontic traction applied to 
them, the 1,25(OH)2D treated teeth had moved 60% further than the controls. An 
increase in osteoclast numbers and resorption could be seen histologically in 
1,25(OH)2D treated teeth (194). Booij-Vrieling and colleagues demonstrated 
increased levels of both VDR gene and protein expression in TR affected teeth, 
which may imply possible involvement of vitamin D signalling in TR progression 
(100, 122). To answer whether vitamin D and their metabolites are involved in TR 
progression, further investigations on vitamin D metabolism and signalling 
pathways in the dental environment are required. 
1.5.5 Mechanical load 
Mechanical load, microfracture of cementum and malocclusion have been 
proposed as possible cause of TR in cats (92). In humans, the occlusal stress theory 
emerged to postulate tooth wear at the cervical portion of teeth; repeated 
compressive and occlusal stress during mastication or due to malocclusion disrupt 
the bond between enamel and dentine, resulting in a form of non-carious tissue loss 
(195). This can lead to cemental or periodontal ligament inflammation and the 
attraction of odontoclast progenitors to the site. In vitro, human periodontal 
ligament cells expressed odontoclastic factors, RANKL and OPG (142). RANKL 
expression constitutively increased depending on occlusal stress (196, 197). In a 
similar way, occlusal stressors could develop TR in cats. Some orthodontic 
treatment studies have previously been performed in cats (180, 194, 198). After 
application of mechanical forces to the canines, numerous resorption lacunae were 
found in the apical region of the alveolar bone socket and wide areas of root 
resorption were clearly visible. The histological patterns corresponded to those seen 
in mice and human following orthodontic treatment. This suggests that mechanical 





1.5.6 Other factors  
TR increases with age (92, 102), and older TR affected cats have significantly 
more teeth missing (92), which is similar to aging related tooth loss seen in humans. 
There are possible anatomical features of the feline dentition that might contribute 
to this age related onset. As previously mentioned in section 1.1.1, feline teeth have 
relatively poor levels of mineralisation on their surface. An electron scanning 
electron microscopy study of feline permanent teeth revealed a thin enamel and 
cementum, and exposed dentine at the ECJ with evidence of tooth wear. The areas 
with lowest dentine mineralisation were the ECJ and cervical roots. These 
observations indicate that the ECJ and the cervical dentine may be at a greater risk 
of odontoclastic resorption compared with other regions of the tooth (199).  
An early study on the role of viral infections as a possible factor focussed on 
some commonly diagnosed feline viruses; they reported that feline 
immunodeficiency virus (FIV) infection may be involved in feline TR aetiology 
(200). However this study was performed in a small number of cats and it was not 
clear how they confirmed the presence of TR. Despite the weakness of the study, 
their findings of a possible involvement of immune deficiency is potentially 
interesting (200). Oral bacterial infections were also investigated in several studies 
but there is no clear evidence of a correlation between bacterial infections and TR 
(92). The cumulative evidence suggests that the initiation and progression of TR is 
complex and multifactorial and is also mediated by local rather than a systemic 
mechanisms.   
1.6 Genetic investigations into tooth resorption 
1.6.1 Gene expression studies of dental environment  
As discussed in section1.1.3 and 1.1.5 dental tissues contain specialised cells 
and their differentiation and fate are programmed spatiotemporally during tooth 
development. Studies using transgenic animals (usually single gene knockouts) 





mammalian dentition, however, the level of complexity quickly becomes evident 
and a single gene null mouse is not sufficient to determine the function of sets of 
genes especially when they are correlated with each other or members of a large 
family with potential functional crossover (201). Moreover, the anatomic difference 
between species (e.g. type of tooth, variation of dentition) might have impact on 
species-specific disease or different response to the microenvironment, as 
demonstrated for example by the extensive cementosis observed in equine 
odontoclastic tooth resorption and hypercementosis. For these reasons, gene 
expression studies using dental tissues in the same species is of great interest to help 
map normal dental physiological pathways as well as dissect out the pathways 
involved in pathological conditions at the cellular and molecular level. Recently, 
dental gene expression studies have started to fill in the gaps in our knowledge of 
the already well defined molecular complexity of the dental microenvironment (201-
203).  For example, gene expression profiling studies of human tooth buds which 
included odontoblasts and ameloblasts identified the involvement of a much larger 
portion of the human genome in the development of the human tooth than 
previously known (201, 202). Although the majority of gene expression and genetic 
studies in dentistry have been perform to gain knowledge of tooth development, 
one clinical exploratory study reported differential gene expression in human 
pulpitis and these findings enhance our understanding of pulpal inflammation. It 
also provides a biological reference for future treatment strategies based on pulpal 
biology (203). 
1.6.2 Genetic studies of TR  
In humans, EARR is a relatively common adverse complication of 
orthodontic treatment and 30% of orthodontic patients have more than 5 mm 
resorption at the end of treatment (129, 204). Risk factors for root resorption have 
been suggested including patient gender, severity of malocclusion, force and 
duration of treatment together with a genetic predisposition (23, 205). Variable 





observed within families and populations, so a potential genetic predisposition was 
predicted (206). The hypothesis that siblings experience similar levels of EARR in 
response to orthodontic treatment was supported by estimation of heritability in the 
sib-pair model (206). As heritability is defined as the proportion of the phenotypic 
variance attributable to genetic control , its estimation is the first step in the genetic 
study of a quantitative trait (155). The estimation of heritability averaged about 50% 
for the total phenotypic variation in EARR (155, 206).  
Genetic variables of IL1B, RANK, RANKL, OPG and P2X7R and heritability 
including a combination of environmental and host factors have been suggested 
predispositions to develop the complex phenotype of root resorption in orthodontic 
patients (81, 156, 157, 207). IL1B (rs1143634) and P2X7R (rs1718119) polymorphisms 
have been reported as EARR susceptible markers in several sibling pair studies (156, 
207). The cytosine (C) variant of IL1B accounted for 15% of total variation of EARR 
in maxilla incisors and this genotype was associated with decreased levels of IL-1β 
expression (155, 156). Although positive associations between IL1B and P2X7R 
polymorphisms and EARR have been reported in other similar studies and 
confirmed in knockout animal models, IL1B polymorphisms have not always been 
replicated whereas more consensus has been observed with the P2X7R (rs1718119) 
polymorphism (158, 207). This inconsistency in the IL1B might be due to use of 
different population (e.g. families vs. extended random populations), size of 
population and complexity of analysis models (e.g. multivariate analysis) (156, 158, 
207). Determining genetic causes of TR is complicated, and it is likely that it is a 
multifactorial trait. Future studies should therefore aim to include additional genetic 
factors beyond the current candidate genes. 
 In terms of feline TR, there has been no studies to elucidate possible genetic 
predispositions. A cohort study demonstrated that there were a high incidence in 
purebred cats and a widespread presence in siblings within the population, which 





1.6.3 Next generation sequencing  
Traditional genetic studies like the ones reported in previous section 1.6.2 
usually utilise DNA samples from a defined population, use genotyping based on 
PCR, Sanger sequencing or restriction fragment length polymorphism followed by a 
final analysis of genotype and phenotype taking account of variables. This process is 
time consuming and can only be performed on a limited number of genes. Next 
generation sequencing (NGS), also known as high-throughput sequencing 
technologies) refers to a technique of sequencing massive amounts of DNA at once. 
The advent of this has led to remarkable progress in genetics. RNA sequencing also 
called whole transcriptome shotgun sequencing (RNA-seq) is a recently developed 
NGS approach which aids us in the understanding of the functional elements of the 
genome by mapping and quantifying the transcriptome. This technique has 
revealed tissue-specific alternative splicing, novel transcripts and genomic 
variations in structure (208). The data from RNA-seq allows researchers to measure 
differential gene expression with greater sensitivity than microarrays (208). It is 
particularly useful for studying non-model organisms with genome sequences that 
are yet to be fully determined or annotated. In addition, it can be applied to identify 
SNPs in the transcribed regions. The major challenges with RNA-seq are how to 
properly analyse the massive data sets generated with a biological meaningful 
interpretation (209). Recently bioinformaticians have contributed to the 
development of a variety of algorithms and analytic soft wares (e.g. SAMtools, 
Picard, Pysam, Galaxy and R etc.) leading to the successful application of RNA-seq 
to elucidate biological findings in a wide range of animals. Using next generation 
sequencing, around 300 novel miRNAs as regulators of gene expression were 
identified in equine osteochondrosis physiopathology and in the cellular response 
to biomechanical stress in cartilage and bone between healthy and osteochondrosis 
affected foals (210). The successful application of this new technique produced 
results in agreement with the findings of a previous preliminary proteomics study 





defects (210).   
In another RNA-seq  study, transcriptome analysis of ameloblasts during 
amelogenesis disclosed differentially expressed genes and provided a good starting 
point to identifying genes and proteins that are critical for dental enamel formation 
(202). RNAseq was also used to investigate the transcriptional changes that take 
place during diet-induced phenotypical changes in cichlid fish (211). The study fed 
the fish two types of diet (hard and soft), and RNA samples were collected 
simultaneously to allow the analysis of the whole transcriptome of the two groups. 
The data displayed significantly differentially expressed genes in response to diet 
induced mechanical strain. These massive data sets are hugely beneficial when 
elucidating comprehensive pathways and when identify novel genes involved in 






1.7 Aims and Hypothesis 
The general aims of this study was to design and optimise a method for 1) 
RNA-seq of feline tooth samples, 2) develop a model to study odontoclast 
dysregulation, 3) identify candidate genes correlated with feline tooth resorption 
and 4) test genes in vitro for a better understanding of odontoclast biology and 
microenvironment in feline TR. These aims will test the hypothesis that feline teeth 
with TR reveal transcriptomic differences compared to feline teeth without TR. 
Specifically, I will: 
 Optimise a method of RNA isolation from feline teeth collected in a clinical 
setting and at post mortem to produce high quality RNA suitable for gene 
expression studies.  
 Determine mRNA expression of pro-inflammatory cytokines, VDR, and 
RANKL using quantitative PCR. 
 Establish an in vitro feline osteoclast differentiation system to investigate the 
functional role of candidate TR proteins and others identified via the RNA –seq 
approach 
 Perform RNA-seq from feline teeth with or without TR to generate a list of 
differentially expressed genes and verify their expression by quantitative PCR 
to identify a short list of candidate genes related to TR and osteoclast biology. 
 Further analyse the gene sets by propriety software to identify gene pathways 
and circuits and provide a biological context to the transcriptome analysis. 
 Identify protein expression of candidate genes in histological tooth sections. 
 Test the functional role of one of the candidate gene (MMP9) identified from the 
RNA-seq data in its ability to influence osteoclast biology and bone resorption. 






Chapter 2 Materials and methods 
2.1 RNA and DNA methods 
2.1.1 RNA extraction from cells 
Total RNA was isolated from cells utilising the RNeasy Mini kit (Qiagen, 
Sussex, UK) with or without QIAshredder according to the manufacturer’s protocol. 
To minimize DNA contamination of RNA samples, a DNase on-column digestion 
step was included using RNase-Free DNase Set (Qiagen). This commercial kit is 
based on the principle that combines the RNA selective binding properties of a silica 
membrane column with microspin technology. In brief, up to 1×107 cells were lysed 
in 350 μl to 600 μl of RLT lysis buffer containing guanidine thiocyanate which 
stabilises RNA by inactivating RNases. Alternatively, the cell monolayer in the 
culture vessel was lysed by adding RLT lysis buffer directly to the well. Samples 
were mixed thoroughly by pipetting or vortexed. The cell lysate was homogenised 
in a QIAshredder by centrifugation at full speed for 2 min before 70% of ethanol 
was added and mixed thoroughly. The lysate was applied to the spin column and 
centrifuged at 8,000 x g for 15 s. The flow through containing protein and cellular 
debris was discarded. A wash step using 350 μl of RW1 buffer was performed at 
8,000 x g for 15 s. To decontaminate DNA, a mixture of 10 μl of DNase and 70 μl of 
RDD buffer was added directly to the spin column membrane. After 15 min of 
incubation at room temperature (RT) a further wash step with 350 μl of RW1 buffer 
was performed. Two wash steps with 500 μl of RPE buffer containing 80% of 
ethanol were then performed at 8,000 x g for 15 s and for 2 min respectively. To 
evaporate the ethanol, a further centrifugation step at full speed was performed for 
1 min. RNA was eluted in 30 μl to 50 μl of RNase-free water by centrifugation at 
8,000 x g for 1 min. RNA was stored at -80C until analysed. 
2.1.2 Determination of quantity and purity of RNA  
Yield of RNA was determined based on absorbance at 260 nm (A260) using a 





the ratios of absorbance at 260 and 280 nm (A260:280 ratio) and 260 and 230 nm (A260:230 
ratio). 
2.1.3 Reverse transcription reaction 
For first strand complementary DNA (cDNA) synthesis, Omniscript® 
Reverse Transcription kit (Qiagen) was used. RNA was diluted in 7 μl of RNase free 
water containing 0.25 to 0.5 μg of RNA. Aliquots were denatured at 65°C on a heat 
block and cooled on ice. A master mix was prepared consisting of 10× RT buffer, 0.5 
μM of dNTP mix, either 1 μM of Oligo-dT primer or 10 μM of random hexamers 
(Qiagen), 10 unit of RNasin®Plus RNase inhibitor (Promega), RNase-free water and 
4 unit of the Omniscript reverse transcriptase (Omniscript RT) and 100 mM of 
dithiothreitol (DTT, Thermo Fisher Scientific) according to the manufacturer’s 
instructions. The denatured RNA was added to a master mix with a total volume of 
20 μl. The cDNA was reverse transcribed at 37°C for 1 h in G-Storm Thermal Cycler 
(Labtech Ltd, Sussex, UK) and stored at -20C. 
2.1.4 Primer design  
Primers used in this study were chosen based on published data or designed 
using online tools. To design effective primers, two online tools of PCR primer 
design were used: PCR Primer Design Tool (Eurofins Genomics) and Primer-BLAST 
combining Primer3 and Basic Local Alignment Search Tool (BLAST) (National 
Center for Biotechnology Information). To screen complementarity and secondary 
structure of primers including self-dimers and hetero-dimers against the two 
primers, online OligoAnalyzer software was used. BLAST searches were performed 
for primers against the feline whole genome shotgun (wgs) sequence and nucleotide 
collection (NCBI, 2017). Newly designed primers were purchased from Eurofins 
MWG Operon (eurofinsgenomincs.eu). 
2.1.5 Polymerase Chain Reaction (PCR) 
PCR reactions were performed using a commercially available kit 





protocols. The master mix was prepared on ice and each aliquot had 2 μl of cDNA 
template, 10× PCR buffer, 200 μM of each dNTP, 2.5 units  of HotStart Taq DNA 
polymerase, 0.5 μM of each primer and nuclease free water added in 25 μl total 
reaction volume. PCR reactions were performed on the G-Strom thermal cycler 
(Labtech Ltd).  To assess consistency of sample loading and PCR conditions, a 
reference gene (beta-actin) previously designed and tested for feline beta-actin and 
no RNA control (NTC) were included in every reaction. The thermal conditions 
were: initial denaturation at 95°C for 15 min, 30 to 40 cycles of denaturation at 94°C, 
annealing at 50 to 56°C and extension at 72°C for 1 min, and final extension at 72°C 
for 1 min. PCR products were analysed using gel electrophoresis with 1.2 to 3% 
agarose gels (Sigma-Aldrich®) dissolved in TAE buffer (Appendix). The solution 
was cooled and mixed with GelRedTM Nucleic Acid Gel Stain (10,000x, Biotium, 
UK). The agarose was poured into gel casting trays with gel combs and allowed to 
set. PCR products and 100 bp DNA ladder (Promega) were loaded with 6× loading 
dye (Promega, UK). The gel was run in TAE buffer at 60 to 80 V for 30 to 60 min. 
Gels were visualised utilising Kodak Gel Logic 200 Imaging (Kodak, USA) and 
images were recorded using Kodak 1D 3.6 Gel Logic software.  
2.1.6 Quantitative PCR 
A real-time PCR known as quantitative PCR (qPCR) was performed with 
high affinity, double stranded DNA-binding dye SYBR Green using Stratagene 
MX3000P qPCR system (Agilent Technologies). Two commercially available kits 
were used: 2×Takyon for SYBR Assay - Low ROX (Eurogentec, Belgium) or 
Precision™ 2× qPCR Mastermix (Primer design, Southampton, UK). Each qPCR 
reaction contained 300 nM of gene of interest or reference gene primers, 2× 
Mastermix and 4 μl of nuclease free water in a 96 well plate format. The cDNA 
template from each treatment group was diluted 1:5 or 1:10 from cDNA and 5 μl 
was added to the reaction, producing a final volume of 20 μl for each reaction. The 
thermal cycling conditions followed manufacturer’s instructions. All samples were 






2.1.7 Optimisation of qPCR primers 
All primers were tested to check efficiency of primers using Stratagene 
MX3000P qPCR system. The cDNA was serially diluted with nuclease free water 4 
or 10-fold depending on genes and primer sets. Primer efficiency and melt curve 
(association curve peak) were generated using MxPro QPCR Software (Mx3000P, 
Agilent Technologies). 
2.1.8 Quantification of gene expression 
Calculation of relative gene expression analysis was based on delta-delta 
method (212, 213). Analysis were performed using cycling threshold (Ct) values for 
each target and RGs. Relative gene expression was calculated using Microsoft Excel 
2013. The delta Ct value for each sample was calculated and the relative expression 
level of the target gene was calculated as shown in Table 2.1. Relative gene 
expression was calculated as fold change as calculation of 2-ΔΔCt. 
     ΔCt = Ct for target gene - Ct for reference gene 
     ΔΔCt = ΔCt of TR positive (+ve)  sample – ΔCt of TR negative (-ve) sample 
     Relative expression = 2-ΔΔCt 
Table 2.1 Calculation of relative gene expression based on delta-delta method 
2.1.9 Purification of PCR product 
Synthesised cDNA from PCR product was purified using the Wizard® SV 
Gel and PCR Clean-Up System (Promega) according to the manufacturer’s protocol. 
In brief, for direct purification of PCR products, an equal volume of membrane 
binding solution was added to the PCR reaction mix, transferred to SV minicolumn 
assembly and incubated for 1 min at RT. Then the column was centrifuged at 16,000 
x g for 1 min and the flow through was discarded. The column was washed with 
700 µl of membrane wash solution containing 95% ethanol by centrifugation at 





solution by centrifugation at 16,000 x g for 5 min. The column was set with lid open 
to dry the ethanol residue for 1 min. The column was transferred into a clean 
microcentrifuge tube and DNA was eluted with 30-50 µl of nuclease free water 
during centrifugation for 1 min at 16,000 x g. Eluted cDNA was stored at -20°C. 
2.1.10 DNA sequencing  
DNA sequencing was performed in The University of Edinburgh sequencing 
facility (Edinburgh Genomics, Kings Buildings, Edinburgh). Samples for submission 
were prepared in labelled PCR strip tubes. Varying amounts of DNA were required 
depending on the length of the DNA fragment (Table 2.2). Five μl of nuclease free 
water containing the maximum amount of DNA was added to 1 μl of nuclease free 
water containing 3.2 pmol of primer. Sequencing was performed in both directions 
using the BigDye® Terminator v3.1 (Applied Biosystems, UK) sequencing reaction 
based on the Sanger sequencing technique. It utilises dideoxy-nucleotides that 
terminate chain elongation after their incorporation into the DNA strand. This 
reaction is followed by clean-up and capillary analysis using the ABI3730 DNA 
analyser (Applied Biosystems). Sequences obtained underwent BLAST searches 
against the feline wgs sequence and nucleotide collection (NCBI, 2017). 
      For purified PCR product Amount of DNA template 
     100- 200 bp 1.5-3 ng 
     200- 500 bp 4.5-10 ng 
     500- 1000 bp 7.5-20 ng 
     1,000- 2,000 bp 15-40 ng 
     >2,000 bp 60-100 ng 
Table 2.2 DNA amount for DNA sequencing. 
2.2 RNA Sequencing (RNA-Seq) 
2.2.1 Tooth collection and TR phenotyping  
Teeth were collected from patients with full owner’s consent presented to 





University of Edinburgh, UK. TR was diagnosed by the combination of oral 
examination and intraoral dental radiography (97). The TR affected teeth were 
extracted by a veterinary surgeon using standard dental equipment under full 
general anaesthesia. Further research samples including teeth, maxilla, mandibles 
and various tissues were collected at post mortem from cats and dogs euthanized 
for a wide range of medical reasons and donated to the school for research. To 
phenotype TR status in research samples, frozen jaws were delivered to the 
radiographic facility in a liquid nitrogen carrier and radiographed. TR type and 
staging were confirmed by a veterinary dental specialist, Dr Norman Johnston 
(MRCVS. RCVS, American & European Specialist in Veterinary Dentistry, 
DentalVets, North Berwick) and Dr Susan Thorne (MRCVS, Dentistry and Oral 
Surgery Resident, DentalVets, North Berwick). 
2.2.2 Tissue processing and RNA extraction 
Clinical samples were immediately stored in RNAlater® solution (Thermo 
Fisher Scientific) at RT or snap frozen in liquid nitrogen before stored in - 80°C 
freezer. Post mortem samples, consisting of mandibles, maxilla, trimmed bones or 
soft tissues were snap frozen in liquid nitrogen before stored at -80°C until RNA 
extraction. Teeth were extracted from the alveolar sockets using dental equipment 
(214) or bone cutters and forceps while maintaining cold temperatures by working 
over dry ice. TRIzol® reagent (Thermo Fisher Scientific) was used to extract RNA 
from tissues based on a guanidinium thiocyanate-phenol-chloroform extraction 
method (215). RNA extraction method was modified from the manufacturer’s 
protocol. In brief, tissues filled with TRIzol® reagent (1 ml/100 mg of tissue) were 
homogenised in a beaded tube (Lysing Matrix D tube) placed in FastPrep FP120 
(Thermo Savant) to agitate at a speed of 4 m/s for 20 s or in a stainless steel jar and 
ball (Mixer Mill MM200, Retsch, Germany) set at 30 Hz for 2 min to perform radial 
oscillations in a horizontal position. Homogenised tissues were incubated for 30 min 
and centrifuged at 10,000 x g for 10 min at 4°C. Supernatant was transferred into a 





min. A further centrifugation step of 15 min at 10,000 x g at 4°C was performed and 
the clear supernatant was transferred into a clean tube. An equal volume of 70% 
ethanol was added to each tube and mixed by pipetting. The mixture was 
transferred to Qiagen RNeasy Mini spin column (Qiagen, Sussex, UK). RNA 
washing and DNase digestion were performed according to the manufacturer’s 
instruction. Details were described in section 2.1.1. RNA was eluted with 30 - 50 µl 
of RNase free water and stored at -80°C.  
2.2.3 RNA quantity and quality control 
Quantity and purity of RNA were measured as described in section 2.1.2. 
The RNA Integrity Number equivalent (RINe) was determined by RNA analysis 
ScreenTape kit on Agilent 2200 TapeStation for quality control. RNA samples were 
sent to Edinburgh Genomics for further quality control of RNA and RNA 
sequencing. 
2.2.4 cDNA library and RNA sequencing  
The Illumina TruSeq stranded mRNA sample preparation kit was used for 
cDNA libraries. To generate cDNA libraries, 0.8 µg - 1 µg of total RNA was used 
according to the manufacturer’s instructions (Illumina, San Diego, CA, USA). 
Briefly, purified poly-A containing mRNA molecules using poly T oligo magnetic 
beads were fragmented using divalent cations on a pre-heated block at 94°C for 8 
min. The cleaved RNA fragments were copied into first strand cDNA using reverse 
transcriptase and random primers and then followed by second strand cDNA 
synthesis using DNA polymerase I and RNase H. These cDNA fragments were 
added with a single 'A' base and underwent subsequent ligation of the adapter. The 
products were then purified and amplified in 10 cycles to create the final cDNA 







2.2.5 Mapping to feline reference genome 
Annotation and alignment were performed using STAR (version 2.5) 
comparison to the Felis catus genome (version 6.2) in the Ensembl database (216). 
Alignment files were generated in the bam format for each sample. The RNA-seq 
expression profile was represented by a table of raw read counts for tens of 
thousands of genes in all TR -/+ samples using HTSeq (version 0.6.0.1) with mode 
'union' (217). Duplicate reads were found using picard tools (version 1.141). 
Generation of MDS plot were generated using plotMDS function from edgeR 
package (version 3.12.1) to visualize the level of similarity of individual cases of a 
dataset. 
2.2.6 Differentially expressed genes 
Differentially expressed genes were identified through comparisons between 
TR -ve and TR +ve groups using edgeR (version 3.12.0) (218). Genes with less than 
20 reads were discarded from this analysis. The trimmed mean of M-values 
normalization method was used. To explore sample dispersion between control and 
TR +ve group, distance plot of biological coefficient of variation samples were 
generated and outliers were exclude for differential expression gene analysis. 
Significantly DE genes were identified using the threshold of false discovery rate 
(FDR)-adjusted p-value < 0.05. 
2.2.7 Gene sets and pathways analysis 
To identify gene sets and pathways analysis, two enrichment analyses on the 
set of up- and down-regulated DE genes were performed: Kyoto Encyclopaedia of 
Genes and Genomes metabolic pathways (KEGG) (219) and gene ontology (220).  
2.2.8 Identification of single nucleotide polymorphisms  
SNPs were identified using Genome Analysis Toolkit with mode 
‘HaplotypeCaller’ (GATK, version 3.5)(221) and the NCBI database of genetic 
variation (dbSNP build ID 148) (222) performing local realignments and base quality 





were merged to create a single gVCF file using GATK GenotypeGVCFs. This allows 
variants to be called on all samples simultaneously. Finally, genomic locations and 
prediction of coding effects on these SNPs were identified using SNPEff (version 
4.2) (223).  
2.3 Cell culture 
2.3.1 Reagents 
All cell culture reagents including cell culture media, supplements and foetal 
bovine serum (FBS) were obtained from Gibco (Thermo Fisher Scientific, UK) unless 
otherwise stated. Tissue culture plastics were obtained from a variety of sources e.g.  
conical sterile polypropylene centrifuge tubes (Becton Dickinson Biosciences, UK), 
cell culture flasks, multiple well plates, microplate, pipette tips, cell strainer and 
cryogenic vials (Corning® Sigma-Aldrich., UK or Thermo Fischer Scientific., UK) 
and microcentrifuge tubes (Eppendorf tubes, Axygene, VWR, USA).  
2.3.2 Cell lines 
Osteoclasts are terminally differentiated cells from haematopoietic 
progenitors, and there are no currently available immortalised osteoclast cell lines. 
To establish authentic osteoclasts, initially non-adherent mononuclear cells derived 
from bone marrow or peripheral blood were used as a source, and two critical 
cytokines, M-CSF (CSF-1) (224) and RANKL (30, 225) were added. One 
commercially available cell line, RAW 264.7 cells which were established from the 
ascites from a mouse tumour by injection of Abelson leukaemia virus (226) and are 
reported that they are capable of differentiation into osteoclasts in the presence of 
RANKL (226). 
2.3.3 Cell passaging 
Cell lines including RAW 264.7 cells and primary periodontal ligament cells 
were maintained in T25 flasks or T75 flasks. Cells were routinely passaged when 
they reached 85 to 95% confluency. To passage cells, medium was removed by 





min. Following washing, 0.25% trypsin- ethylenediaminetetraacetic acid (EDTA) 
(Table 2.3) was added to cells and incubated at 37°C until cells were detached. 
Trypsinization was terminated by adding double volume of FBS containing media 
to the cells to neutralise the trypsin. Cells were split as required (1:5 to 1:20) and 
seeded directly into new culture vessels with fresh media. 
2.3.4 Cell counting and viability 
Ten μl of cell suspension were transferred to a microcentrifuge tube, mixed 
with 10 μl of trypan blue stain, and incubated for 2 min. Ten μl of cell suspension 
was added to the counting chamber of a haemocytometer and the cells were 
counted. Dead cells were recognised as dark blue stained cells and non-refractile. 
Cell density were then determined using following formula: Cell density (cells per 
ml) = Average number of cells in one square × dilution factor × 104. 
Table 2.3 Information of a variety of cell culture vessels including cell number seeded, total 
volume of media and 0.25% trypsin-EDTA. 
2.3.5 Freezing/thawing cells 
Cells were counted, up to 1×106 were suspended in cryogenic tube vials 
containing 1 ml of 10% dimethyl sulfoxide (DMSO) in FBS. Vials were transferred to 
a Freezing Container (Mr Frosty™, Thermo Fisher Scientific) in -80°C for 24 h. This 
container enables slow cooling at a rate of -1°C/min, the optimal rate for cell 
preservation. After 24 h, the freezing container was transferred to -150°C.  
For thawing cells from frozen vial, cells were quickly defrosted in a 37°C 
water bath and transferred into Falcon tubes containing 5 ml of warm medium. The 
Cell culture vessel Surface area 
(cm2) 
Total volume of 
media (ml) 
Volume of 0.25% 
Trypsin-EDTA (ml) 
T75 75 13 3 
T25 25 8 2 
10 cm plate 55 10 3 
6 well plate 9.6 2 - 2.5 1 
24 well plate 1.9 1 0.5 





cell suspension was centrifuged at 400 x g for 5 min. The supernatant was discarded 
and the cell pellets were resuspended in their respective media, transferred to 
appropriate cell culture vessel, T25 or T75 and incubated at 37°C/5% CO2 overnight. 
2.3.6 Peripheral blood mononuclear cells (PBMCs) isolation 
and osteoclast culture 
For the primary cell culture, peripheral blood was obtained at post mortem 
from cats euthanized for clinical reasons and donated to the School for research 
purposes. This protocol was modified from previously published protocols (227, 
228). The osteoclast differentiation protocol is illustrated in Figure 2.1 and Figure 
2.2, A. Blood was heparinised and transported on wet ice. Peripheral blood 
mononuclear cells (PBMCs) sedimented at the interface between plasma and Ficoll-
paque solution with a density of 1.077 ± 0.001 g/ml (Ficoll Hypaque Plus, GE Health 
care, Buckinghamshire, UK) following  centrifugation for 30 min at 400 x g at RT 
(Figure 2.1). Mononuclear cells were carefully isolated and washed twice in alpha 
Minimum Essential Medium (α-MEM) by centrifugation at 400 x g for 5 min. 
Isolated PBMCs were resuspended in α-MEM supplemented with 10% heat-
inactivated FBS (F1 -3 of three different serum batches, Gibco), 2 mM L-glutamine, 
100 IU/ml benzyl penicillin, 100 mg/ml streptomycin and plated on plastic vessels (1 
× 105/cm2) with CSF-1 (human CSF-1, 30-100ng/ml or mouse CSF-1, 10 to 25ng/ml, 
R&D systems) at 37°C/5% CO2. On day 4, 90% of the medium was changed and, 
replaced with a new α-MEM containing CSF-1 (concentrations as above)and 
RANKL (human RANKL , 25-100ng/ml, mouse RANKL, 3-20 ng/ml, R&D systems) 







Figure 2.1 Isolation of mononuclear cells from peripheral blood. Diluted whole blood in Ficoll-
paque solution, the density gradient media is centrifuged and mononuclear cells including 
osteoclast precursors are layered at the interface between plasma and Ficoll-paque solution.   
2.3.7 Bone marrow isolation and osteoclast culture 
This protocol was modified from a published rodent/feline osteoclast culture 
protocols (228, 229) (Figure 2.2, B). The femurs, tibiae, and humeri were dissected 
from the cats, dogs or mice, washed in 70% ethanol and cut off at the proximal and 
distal ends. Bone marrow was flushed out using a 25 G needle in α-MEM containing 
10% FBS. The bone marrow suspension was passed through a cell strainer and 
followed by lysis of red cells using 5 ml of Lysis Buffer (150 mM NH4Cl, 10 mM 
NaHCO3, 0.1 mM EDTA) for 5 min, on ice. The cells were washed and resuspended 
by centrifugation at 400 x g for 5 min in α-MEM containing 10% FBS, 2 mM L 
glutamine, 100 IU/ml benzyl penicillin, 100 mg/ml streptomycin, and CSF-1 (human 
CSF-1, 30-100ng/ml or mouse CSF-1, 10 to 25ng/ml, R&D systems) and plated into T 
75 flasks for 24 h at 37°C/5% CO2 for attachment of stromal cells. On the following 
day, non-adherent cells were collected and washed once in α-MEM (concentrations 
as above)containing 10% FBS by centrifugation at 400 x g for 5 min. Resuspended 
cells were plated on new plastic vessels (1×105/cm2) with CSF-1 (at 37°C/5% CO2. On 
day 4, 90% of the medium was changed and, replaced with a new α-MEM 





100ng/ml, mouse RANKL, 3-20 ng/ml, R&D systems). The culture medium was 
subsequently change twice weekly by replacing half of the volume with fresh media 
up 10 to 14 days.   
2.3.8 RAW 264.7 cells-osteoclast differentiation 
RAW 264.7 cells have the potential to differentiate into osteoclasts in the 
presence of RANKL but independently of CSF1. This protocol was modified based 
on a published paper (226). On day 0, 1×104 cells/cm2 were plated on plastic or 
dentin discs in α-MEM containing 10% FBS, 2 mM L glutamine, 100 IU/ml benzyl 
penicillin, 100 mg/ml streptomycin supplemented with 5-10 ng/ml of mouse 
RANKL. Half of medium was changed every other day until osteoclast formation 
occurred (days 4 -6).  
 
Figure 2.2 Illustration of osteoclast differentiation from peripheral blood mononuclear cells 
and bone marrow. (A) Differentiation osteoclasts derived from blood precursors (B) 






2.3.9 Primary feline periodontal ligament cells 
Feline teeth were extracted at post mortem and dissected into small pieces. 
Periodontal ligament cells were shaved off utilising a surgical knife and gingival 
tissues near the cemento-enamel junction were dissected into small pieces. The 
periodontal ligament tissue, shattered teeth and gingival tissues were incubated in a 
15 ml conical tube containing α-MEM with 0.2% collagenase at 37°C for overnight in 
a roller incubator. All cells containing collagen digested tissues were put through a 
cell strainer with 70 µm pore size to obtain a uniform single-cell suspension and 
remove tissue debris. Cells suspension were centrifuged and pelleted cells were 
subsequently cultured in α-MEM, containing 10% FBS at 37°C/5% CO2 on dishes 100 
mm in diameter until 80% confluency. These cells were collected with 0.05% 
trypsin-EDTA and transferred to a new plastic vessel or frozen as described in 
section 2.3.5.   
2.3.10 Osteoclast-periodontal ligament cells co-culture 
For indirect culture, bone marrow derived mononuclear cells (105 cells/ well) 
as described in section 2.3.7 were seeded onto 24 well plate and Corning® 
Transwell® polyester membrane cell culture inserts (0.4 μm pore size) were placed 
on the seeded plate (Figure 2.3, A). The periodontal ligament cells were seeded onto 
transwell inserts (1×104 cells/well), and cultured in α-MEM, containing 10% FBS, at 
37°C/5% CO2 for 14 -20 days. Co-culture was also performed directly mixing the two 
cell types in 24 well plate; bone marrow derived mononuclear cells (105 cells/ well) 






Figure 2.3 Co-culture of feline osteoclast precursors and periodontal ligament cells in 
indirect or direct culture setting. (A) Osteoclast precursors are seeded and periodontal 
ligament cells were seeded onto a transwell insert in indirect co-culturing system. (B) Two 
cells are mixed and seeded in direct co-culturing. OCPs: osteoclast precursors. 
2.4 Characterisation of feline osteoclast 
2.4.1 Tartrate resistant acid phosphatase (TRAP) reaction 
Cultured osteoclasts on plastic or dentin discs were washed twice with PBS 
and fixed in 2.5% glutaraldehyde for 5 min. TRAP reactivity was performed using 
Acid phosphatise leukocyte kit (Sigma-Aldrich Ltd) according to the manufacturer’s 
protocol with some modification including reduced incubation time (30 min) and 
with or without haematoxylin staining. TRAP positive cells were imaged via light 
microscopy (Leica DM LB2, Milton Keynes, UK). Cells were considered to be 
osteoclast like cells when they were TRAP positive and contained more than two 
nuclei when manually counted.  
2.4.2 Immunocytochemistry and antibodies 
Cells were seeded onto chamber slides at a density of 5x104 cells per well 
containing 200 μl of media and incubated at 37°C/5% CO2 until to form 
multinucleated cells. Following differentiation of osteoclasts, the media was 
discarded and the cells were washed twice in cold PBS. Cells were fixed in cold 
acetone or methanol (500 μl/chamber) for 5 min at RT then washed twice in cold 





blocking solution was added. The cells were incubated at RT for 1 h and blocking 
solution was removed. Primary antibodies were diluted in 0.1% goat serum 
blocking solution and added to the chambers (100 μl/chamber) (Appendix). 
Negative controls consisted of 0.1% goat serum blocking solution without primary 
antibodies or with immunoglobulin isotype. The slides were incubated in a humid 
chamber overnight at 4°C. Following incubation the slides were washed three times 
in PBS containing 0.1% Tween 20 (PBST) for 10 min. Secondary antibodies were 
diluted in 0.1% goat serum blocking solution and added to the chambers (100 
μl/chamber). Secondary antibodies raised against the species in which the primary 
antibody was produced were chosen (Appendix). The slides were incubated at RT 
for 1 h in a humid chamber in the dark. Following secondary antibody incubation 
slides were separated, put in a staining jar covered in foil and washed with PBST 
three times for 10 min each time on the orbital shaker. Then the slides were stained 
with DAPI (Invitrogen D1306) 1:10,000 dilution in PBST for 5 min. After final 
washing with PBS three times for 2 min, the slides were mounted using the anti-
fade mount media (Vectashield hardset mounting medium) and cover slips were 
applied gently and dried overnight at 4°C covered with foil. The slides were stored 
at 4°C for a few days or stored at -20°C for long term storage.  
2.4.3 Actin ring staining  
Cultured osteoclasts on chamber slides was fixed using acetone or methanol 
and washed in PBST three times. Two drops of Actinred™ 555 ReadyProbes® 
Reagent which include high-affinity F-actin probe conjugated to the red-orange 
fluorescent dye tetramethylrhodamine (TRITC) was diluted in 1 ml of PBST. The 
diluted Actinred was directly added onto slide or place (300 µl/sample) and 
incubated for 30 min, protected from light. Cells were washed in PBST and nuclei 
was stained as described in 2.4.2 and cover slips were applied with anti-fade mount 






2.4.4 Source of mineralised substrates 
To evaluate resorption activities, osteoclasts require mineralized substrates. 
The block of dentine and discs were generous gifts from Prof. Timothy R. Arnett 
(University College London, London, UK). To generate authentic osteoclasts with 
resorption pits, osteoclast precursors were transferred onto dentine discs. To 
activate the osteoclast, culture medium was acidified to pH 7.0 by addition of 11.5 
M HCl (229). Resorption pits are normally easily detected by reflected light. If 
necessary, cells were removed from the discs using sonication for 5 min in 0.25 M 
ammonium hydroxide. Discs may require additional staining for 2 min in toluidine 
blue solution to improve visualisation of pits. Resorption pits were measured as 
area. Alternatively, Corning Osteo Assay Surface multiple well plates can be used as 
a source of mineralised substrate. This plate has bone-like mineral surface coated 
with a proprietary hydroxyapatite mineral surface that is highly uniform and 
microscopically fine-grained. This unique plate has been used for both routine 
resorption assays and high-throughput screening for the study of both osteoclast 
and osteoblast function. 
 
Figure 2.4 Osteoclast resorption activity. (A) Resorption activity of osteoclasts is tested on 
the dentine discs. (B) Alternately, osteoclasts are seeded in a mineralised plate coated with 
hydroxyapatite for resorption activity. OCPs: osteoclast precursor. 
2.4.5 Resorption activity on mineralised plate 





plates was bleached and the contrast enhanced to assess resorbed surface area. In 
brief, 10% bleach solution was added to the wells and incubated for 5 min at RT. 
After washing cells twice with distilled water, plates were allowed to dry at RT for 3 
to 5 h. Individual pits can be visualised using a microscope. The modified von Kossa 
staining protocol was performed to improve the contrast for resorbed pit by adding 
5% (w/v) aqueous silver nitrate solution to each of the bleached wells and incubated 
for 30 min at RT in the dark. The silver nitrate solution was discarded and plates 
were soaked in distilled water for 5 min. When the mineral surface turned yellow, 
5% sodium carbonate (w/v in commercial buffered formalin) was added and 
incubated for 4 min at RT. As the ionic silver (I) was reduced to metallic silver, the 
plate appeared a dark colour. The plates were dried at 50°C for 1 h. Resorption pits 
were assessed using light microscopy (Axiocam 105 color). 
2.4.6 Resorption activity on dentin discs 
Resorption pits can be visualised by reflected light microscopy following 
TRAP reactivity as described in section 2.4.1 without the removal of cells. 
Alternatively, cells from discs were removed by vigorous sonication for 5 min in 
0.25 M ammonium hydroxide. The discs were stained for 2 min in toluidine blue 
solution followed by rinsing in water and air drying to improve visualisation of pits. 
Counting of the pits or measurement of the pits surface area were performed by 
scanning the entire surface of each disc using reflected light microscopy (Nikon 
Eclipse Ni).  
2.4.7 Vitamin D treatment 
1,25‐dihydroxyvitamin D3 (1,25(OH)2 D), the biologically active form of 
Vitamin D  was purchased from Sigma-Adrich (UK). Ten mg of 1,25(OH)2D3 was 
made up to a 10 µM stock solution in ethanol and stored at -20°C. The primary 
feline, canine, murine osteoclast precursors from bone marrow were treated, in 
addition to CSF-1 and RANKL, with a range of concentrations from 0.1 nM to 





controls were treated at the equivalent concentrations of ethanol corresponding to 
the ethanol concentrations used for the highest 1,25(OH)2D3 concentration in the 
experiment. Untreated control cells were also included in each experiment. 
2.4.8 MMP9 inhibitor 
The MMP9 inhibitor containing hydroxamate (-CONHOH) group binds the 
zinc atom in the active site of the MMP enzyme. This molecule is a cell permeable, 
potent, semi-selective, and reversible MMP-9 Inhibitor (IC50 = 5 nM). At high 
concentrations, it can inhibit MMP1 and MMP13 as well. Five hundred µg 
Calbiochem (Merck Millipore, UK) was made up to 1 mg/ml stock solution in 
DMSO and stored at -20°C. The primary feline, canine, murine osteoclast precursors 
from bone marrow were treated, in addition to CSF-1 and RANKL, with a range of 
concentrations from 5 nM to 1 µM diluted in α- MEM until termination of osteoclast 
differentiation. Vehicle controls were treated with DMSO concentrations 
corresponding to the highest MMP9 concentration used in the experiment. 
Untreated control cells were also included in each experiment. 
2.5 RNA interference 
2.5.1 Designing siRNA targeting feline MMP9 
The siRNA sequence against the feline MMP9 were designed using an online 
design tool, i-Score designer (i-score web service program). Potential siRNAs were 
evaluated for GC content and Reynolds scores were obtained (230). BLAST searches 
were then performed for selected siRNAs against the feline wgs sequence and 
nucleotide collection (NCBI, 2017). DNA oligonucleotide templates were purchased 
from eurofins MWG Operon (eurofinsdna.com). DNA oligonucleotide templates 
were designed by adding an eight nucleotide T7 Promoter sequence (5’ CCTGTCTC 
3’) to the 3’ end of both the sense and antisense template strands. 
2.5.2 Construction of siRNA targeting feline MMP9 
MMP9 feline siRNA was constructed using the Silencer® siRNA 





sense and antisense DNA oligonucleotide templates were resuspended to a 
concentration of 100 μM and each aliquot of sense and antisense templates were 
mixed with the T7 promoter primer in 8 μl of the DNA hybridisation buffer in 
separate tubes. The reaction was heated to 70°C for 5 min and cooled at RT for 5 min 
to anneal the eight nucleotide leader sequence of the DNA oligonucleotide template 
with the T7 Promoter primer. Following hybridisation, Exo-Klenow Reaction buffer, 
dNTPs, nuclease-free water and Exo-Klenow were added to each reaction and 
incubated at 37°C for 30 min. Two μl of the sense and antisense siRNA templates 
were transcribed for 2 h at 37°C in separate reactions. Then the templates were 
mixed with nuclease-free water, NTPs, T7 reaction buffer and T7 enzyme mix. The 
sense and antisense transcription reactions were then mixed and incubated 
overnight. Double stranded RNA solutions were digested with RNase and DNase 
for 2 h at 37°C. Four hundred μl of siRNA binding buffer containing ethanol was 
added to the Double stranded RNA and incubated for 5 min at RT. For each siRNA 
sample a filter cartridge was placed into a 2 ml collection tube that was pre-wet with 
100 μl of siRNA wash buffer. The siRNA-binding buffer mix was added to the filter 
cartridge and centrifuged at 80,000 x g for 1 min. The column was washed twice in 
500 μl of siRNA wash buffer and centrifuged each time at 80,000 x g for 1 min. The 
filter cartridge was placed into a new collection tube and 100 μl of pre-heated 75°C 
nuclease-free water was added and incubated at RT for 2 min before centrifuging at 
8,000 x g for 2 min. Purified siRNAs were quantified as previously described in 
section 2.1.2. Each 20 µM siRNA aliquot was stored at -20°. Commercially available 
negative control siRNA, scrambled non-targeting siRNA (Silencer® Negative 
control number 1, Life Technologies™) was purchased. 
2.5.3 Electroporation of RNA and DNA 
Osteoclast precursors were seeded in fresh isolated bone marrow as described in 
section 2.3.7 or frozen vials containing bone marrow precursors in section 2.3.5. 
Cells were seeded  in 10 cm coated plate including α-MEM with GlutaMAX, 





overnight at 37°C/5% CO2 to allow stromal cells to attach. Non adherent cells 
including the osteoclast precursor enriched population was collected and 
transferred into new non-coated plates and incubated further 2 days at 37°C/5% 
CO2. On day 3, cells were detached by flushing using a syringe and needle before 
they were counted for electroporation. The cell pellet was suspended in 100 μl 
Mouse Macrophage Nucleofector™ Solution and transferred to a microcentrifuge 
tube containing siRNA. The cell suspension–DNA mixture was transferred to 
Amaxa™ electrode cuvettes and electroporated in an Amaxa™ Nucleofector II™ 
using program Y-001. Following electroporation, cells were immediately transferred 
to a bijou tube using the Amaxa™ Pasteur pipette and 2.5 ml medium containing 
10ng/ml CSF1 and 3 ng/ml RANKL was added. The cell suspension was cooled on 
ice for 5 min and seeded into 96-well plates at 2× 105 cells/ cm2 or onto dentine discs. 
Cells were incubated at 37°C/5% CO2 until formation of osteoclasts was observed in 
control cultures. Media were changed every 2 days. Green fluorescence expression 
was observed using fluorescence microscopy. For transfection efficiency test, cells 
were trypsinased and collected for flow cytometry.  
2.5.4 Liposome-mediated transient transfection 
Bone marrow derived osteoclasts cultures were performed according to a 
standard protocol in section 2.3.7. Osteoclast precursors were seeded in T 75 flasks 
and incubated  for 24 h at 37°C/5% CO2 with addition of mouse CSF-1 10 ng/ml to 
allow stromal cells attachment. On day 2, Cells were seeded on plastic (5x105 cells/24 
well) supplemented with CSF-1, and incubated further 24 h. On day 3, osteoclast 
precursors were transfected using RNAiMAX with appropriate DNA (pEGFP) or 
siRNA. medium was changed with CSF-1 (mouse CSF-1 10 ng/ml) and RANKL 
(mouse 3 ng/ml). During transfection, medium was treated without antibiotics. 
Lipofectamine reagent was mixed in Opti-MEM medium and incubated for 5 min at 
RT. Mixtures of DNA (pEGFP vector from Amaxa Cell line Nucleofector kit V) or 
siRNA and Opti-MEM medium were prepared. Then the lipofectamin mixture and 





GFP or siRNA-lipid complex was directly added to cells. Cells were further 
incubated in medium containing 10ng/ml CSF1 and 3 ng/ml RANKL until 
appearance of mature osteoclasts and media were changed every 2 days.  
Green fluorescence expression was analysed under the fluorescence microscopy. 
For transfection efficiency test, cells were collected by trypsinisation and collected 
for flow cytometry.  
2.5.5 Flow cytometry  
Flow cytometry was performed to evaluate transfection efficiency and cell 
viability using BD FACSCalibur (BD Biosciences, San Jose, USA). Cell viability was 
assessed using 7-AAD (7-amino-actinomycin D) (eBiosciences, Hatfield, UK) and 
incubated for 5 min before analysis. Data was analysed using FlowJo ™ software. 
During the process, technical helps were supported by skilled people (Mrs Iren 
Mcguinnes). 
2.6 Protein Methods 
2.6.1 Protein extraction 
Protein extraction was carried out either by lysis of cell pellets or direct lysis 
of cultured cell monolayer. To harvest cells from culture plastic, media was 
discarded and the cells were washed twice in PBS, scraped from the culture plastic 
in PBS, transferred into a microcentrifuge tube and centrifuged at 4,000 x g for 4 min 
at 4°C. The supernatant was discarded and the cell pellet was either used 
immediately or snap frozen on dry ice and stored at -70°C. Chilled urea buffer was 
added to cell pellets. The volume of urea buffer was variable depending on the 
amount of cell pellet (30 -100 µl). Monolayers of cells were scraped using urea lysis 
buffer (50 to 100 µl per well in 24 well plate). The mixture of cells and urea buffer 
was mixed gently by repeated pipetting and incubated on ice for 15 min. The 
solution was centrifuged at 10,000 x g for 15 min at 4°C. The lysate was either snap 





2.6.2 Quantification of protein 
Five μl of diluted protein lysates or known bovine serum albumin (BSA) 
protein standards were mixed with 250 μl of Quick Start™ Bradford Dye Reagent 
(Bio-Rad) in a 96 well plate. All samples were performed in duplicate and the 
absorbance at 595 nm was measured on a plate reader (Perkin Elmer 1420 Multilabel 
Counter Victor 3™) using the Wallac 1420 Manager program (Perkin Elmer). Lysate 
protein concentrations were determined from a standard curve generated from the 
known BSA concentrations.  
2.6.3 Western blot 
Protein samples were resolved on SDS-polyacrylamide gels using 
electrophoresis. Ten percent SDS-polyacrylamide gels were used.  The SDS-
polyacrylamide gels were prepared using the Bio-Rad Protean II mini-gel system. 
The resolving gel was prepared (Appendix), poured between the plates and allowed 
to set at RT. The stacking gel (Appendix) was layered on top of the resolving gel and 
a loading comb was then inserted into the stacking gel. Once the stacking gel was 
set, the comb was removed. The gel was placed into the running module and 
immersed in SDS-PAGE running buffer (Appendix) prior to protein loading. Ten to 
30 μg of protein lysates were mixed with 4x SDS sample buffer (Appendix). The 
mixtures were denatured in 95°C for 3 min and then loaded into the wells in the 
stacking gel. Five μl of a pre-stained Full Range Rainbow Marker (Amersham 
Pharmacia Biotech) was placed in parallel to indicate protein bands by size. The gel 
electrophoresis was performed at 180 V until the dye reached the bottom of the 
resolving gel. Then the resolved proteins were electrophoretically transferred onto 
nitrocellulose membranes (Hybond™-C, Amersham Biosciences, UK) in transfer 
buffer (Appendix) at 300 mA for 1 h using an ice block to reduce heat during 
electrophoresis. The nitrocellulose membrane was incubated in 5% milk in PBST 
(appendix) for 1 h at RT to reduce non-specific antibody binding. The membranes 
were subsequently probed with primary antibodies overnight at 4°C. Following 





5 min. Then the membranes were incubated for 1 h at RT with a secondary 
horseradish peroxidase (HRP) conjugated antibody diluted 1:1000 in blocking 
solution. All primary and secondary antibodies used in this study are listed in 
Appendix. The membranes were washed three times in PBST for 15 min. The 
membranes were developed using ECLTM Western Blotting Detection Kit 
(Amersham Bioscience) and protein bands visualised by exposure to X-ray film 
(Hybond™-ECL™ Film, Amersham Biosciences). For the further application of 
different antibodies, the membranes were stripped at RT for 15 min using RestoreTM 
Plus Western Blot Stripping Buffer (Thermo Fisher Scientific). The membranes were 
re-developed to ensure the bands had been removed then blocked and probed as 
previously described. 
2.7 Immunohistochemistry 
2.7.1 Tissue processing and paraffin embedding 
Feline tooth samples were collected post mortem as described in section 2.2.1 
and samples were fixed by immersion in 10% neutral buffered formalin for 48 h 
before being processed. All fixed teeth were demineralised in EDTA pH 7.0 for 4 to 
6 weeks at RT. Demineralised samples were dehydrated in a series of ascending 
alcohol dehydration steps including washing with xylene and infiltrated by 
immersion in liquid paraffin wax. From the paraffin tooth block, eight micron 
sections were cut, mounted onto electrostatically charged slides (Superfrost plus, 
Thermo Fisher Scientific), dried overnight at 60°C and stored in RT until use.    
2.7.2 Haematoxylin and Eosin (H&E) staining 
Paraffin sections were dewaxed rehydrated and stained using an autostainer 
machine (Leica Autostainer XL) according to its programmed protocol in Table 2.4. 
2.7.3 Immunohistochemistry and antibodies 
Sections were prepared as described above (section 2.7.1). Antigen retrieval 
was performed in 0.1M citrate buffer pH 6.0 for 90 min at 70°C. Endogenous 





RT. A further blocking was carried out using a normal goat serum 1:5 in 5% of FBS 
for 30 min. Primary antibodies were diluted at 1:50 to 1:200 dilution (Table 2.5) in 
5% FBS/PBS and incubated at 4°C overnight. Sections were washed and horseradish 
appropriately diluted peroxidase labelled secondary antibodies (Envision Kit, Dako 
UK Ltd.) were added to the sections (Table 2.6) and incubated for 1 h at RT. Sections 
were washed 3 times with PBS for 5 min. Labelling was developed using 
ImmPACTTM DAB (Vector Labs Ltd., UK) at RT for 10 min producing a brown 
colour in positive sections. All samples were count-stained with haematoxylin prior 
to dehydrating, clearing and mounting under PERTEX Mounting Media (CellPath, 
UK). 
 
Processing Stage Reagent Time 
Dewax Xylene 3 times for 5 min 
Rehydration 
100% ethanol 3 min 
100% ethanol 2 min 
95% ethanol 2 min 
Wash H2O 5 min 
Haematoxylin Haematoxylin 3 min 
Wash H2O 3 times for 3 min 
Eosin Eosin 2 min 
Wash H2O 45 s 
Dehydration 
75%, 95%, 95% ethanol Each 30 s 
100% ethanol 2 times for 1 min 
Wash Xylene 3 times for 1 min 
Table 2.4 Tissue processing.  
2.7.4 Cytokeratin immunolabelling  
To distinguish osteoclasts from epithelial cells, decalcified feline teeth slides 
were presented into Easter Bush Pathology laboratory for cytokeratin 
immunohistochemistry. The brief protocol follows; antigen retrieve was performed 





cytokeratin (Agilent, MNF116) was diluted 1 in 50 and incubated for 30 min at RT. 
Secondary antibody(Envision anti-mouse HRP, Agilent) was applied for 40 min at 
RT and labelling was developed by DAB for 10 min at RT.  
 
Primary Antibody Host Manufacturer Dilution 
MMP9 Rabbit 
Polyclonal 




Abcam, AB76543 1:50, 100, 200 
P2XR4 Goat 
Polyclonal 








OPG (E-10): sc-390518. 
Santa Cruz 
Biotechnology, Inc. 
1: 100, 200 





374360. Santa Cruz 
Biotechnology, Inc.  
1: 50,  100 
Isotype   Manufacturer  
Rabbit IgG  - Sigma-Aldrich, 
SAB5500149 
# 
Goat IgG - Biorad, 5160-2104 # 
Mouse IgG  - Abcam, ab37355 # 
Table 2.5 List of primary antibodies and isotypes for immunohistochemistry. #: 
Corresponding concentration to primary antibody. 
Secondary Antibody Host Manufacturer Dilution 
Anti-rabbit 
immunoglobulins 












Rabbit Peroxidase-Conjugated Rabbit 
Anti-Goat Immunoglobulins, 
Dako 
1:200 – 1:500 






2.8 Statistical analysis 
All experiments were repeated at least twice on two separate occasions 
gaining similar results (except RNA-seq). All quantitative analysis included triple to 
five technical replicates. In vitro experiment and qPCR data were analysed using 
Minitab® 15 Statistical Software (Minitab Ltd., UK) and all graphs and diagrams 
were generated using Microsoft Office® 2013 (Microsoft Corporation) or GraphPad 
prism v5 software. P values of less than 0.05 were deemed statistically significant. 
Data following a normal distribution was analysed with parametric tests, however if 
data are not normally distributed then non-parametric tests were performed. One-
way ANOVA tests were used to compare differences between more than two 
groups. The two sample t-test or Mann Whitney U-tests were used to compare 






Chapter 3 Optimisation of RNA isolation 
method suitable for gene expression study and 
RNA sequencing in feline tooth 
3.1 Introduction and aims 
The main interest of this study was to identify transcriptome changes during 
feline tooth resorption. To do this, I used RNA-seq technique on RNA extracted 
from feline teeth. RNA-seq is a widely available technique for the quantification of 
transcriptomes as well as for the identification of genetic variations (e.g. SNPs) (208, 
211). In order to obtain reliable data, very high quality of RNA as well as sufficient 
amounts of RNA are essential (231-233). There are several published RNA isolation 
protocols available but vary according to study design and mainly describe the 
extraction of RNA from soft tissues (215, 234-237). To the best of my knowledge, a 
RNA-seq study using feline teeth has not been published and therefore an 
optimised protocol for feline tooth RNA extraction does not exist. As clinical 
archived dental samples derived from animals are a valuable resource, there is a 
necessity to maximise utility of such samples. Mineralised tissues are notoriously 
difficult to obtain good quality RNA due to the added complication of extracting 
tissue itself from the whole bone or tooth (238). This makes slow permeabilisation of 
protein denaturants or RNAse retarding solutions which minimise the effects of 
RNAses during cell lysis (239). Therefore prior to performing RNA-seq from feline 
teeth, I developed a RNA extraction methodology that was capable of extracting 
RNA of RNA-seq quality from feline tooth samples.  
This chapter describes the development of an optimised RNA extraction 
protocol suitable for use on mineralised tissues to produce RNA of a high quality, 
and how to test the RNA to ensure that it was of a quality suitable for RNA-seq.  
The following manuscript was submitted to Veterinary Research 
Communications on 08/01/2018. The inclusion of this manuscript as part of this 





study, all work was performed by myself except individual contributions as 
specified: (i) Sample collection from cats and dogs, and subsequent RNA extractions 
were performed by myself with the help of Craig Johnson. (ii) RNA sequencing and 
quality control for RNA-seq were performed by Dr Urmi Trivedi at Edinburgh 
Genomics. (iii) The manuscript authors advised on the paper design and wording. 
3.2 Submitted manuscript 
The following manuscript was submitted to Veterinary Research 
Communications on 08/01/2018. 
 
This submitted manuscript is included as a part of this thesis as described in 
‘GUIDANCE FOR THE INCLUSION OF PUBLICATIONS IN POSTGRADUATE 
RESEARCH THESES’ (1.7. Articles which have been submitted for publication but 
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Advanced next generation sequencing approaches have started to reveal the cellular and molecular 
complexity of the microenvironment in many tissues. It is challenging to obtain high quality RNA in 
mineralised tissues. We developed an optimised method of RNA extraction from feline teeth 
collected in a clinical setting and at post mortem. Teeth were homogenised in phenol-guanidinium 
solution at near-freezing temperatures and followed by solid-phase nucleic acid extraction utilising a 
commercially available kit. This method produced good RNA yields and improved RNA quality based 
on RNA integrity numbers equivalent (RINe) from an average of 3.6 to 5.6. No correlation was found 
between RNA purity parameters measured by A260:280 or A230:260 ratios and degree of RNA 
degradation. This implies that RNA purity indicators cannot be reliably used as parameters of RNA 
integrity. The stability of reference gene expression varied depending on reference genes used 
rather than degree of RNA degradation. Furthermore, we investigated effect of quantity and quality 
of RNA on RNA sequencing (RNA-Seq) results. Thirteen RNA-seq data showed similar duplication and 
mapping rates (94 to 95%) against the feline genome regardless of RINe values. However one low 
yield sample with a high RINe value showed a high duplication rate and was an outlier on the RNA-
seq multidimensional scaling plot. We conclude that overall yield of RNA was more important than 
quality of RNA for RNA-seq quality control. These results guide others who wish to perform RNA 
extractions from mineralised tissues, especially if collecting in a clinical setting with the restraints 

















































































Teeth consist of connective tissues and highly specialised cells that produce a unique extracellular 
matrix composed of organic matrix proteins and inorganic minerals. Tooth development and alveolar 
bone and deciduous teeth resorption during tooth eruption and shedding is a complex process that 
is tightly regulated at the molecular level (Ten Cate and Nanci, 2003, Bei, 2009). In permanent teeth, 
mineralised tissues such as enamel, cementum and dentine do not turn over or have limited 
regeneration capacities. The hard tissues of the tooth can be resorbed and structurally damaged 
under pathologic conditions such as inflammation, mechanical trauma or idiopathic tooth resorption 
(TR) (Darcey and Qualtrough, 2013). The exact mechanisms behind the pathological resorption 
observed in idiopathic TR are still unclear. Gene expression profiling of dental samples is of great 
interest to help map physiological pathways as well as dissect out the pathways involved in 
pathological conditions at the cellular and molecular level. Recent studies of the oral and dental 
transcriptome have started to unveil the molecular complexity of the dental microenvironment 
(Simmer et al., 2014, Hu et al., 2015). Whilst in vitro studies are fundamental to the study of these 
cellular and molecular events and genetically engineered rodents have been important models in 
dentistry, there is a necessity to utilize human or companion animal derived tissues from clinical 
archives. Since both ethical and logistical considerations can limit the sourcing of human and 
companion animal derived tissues from clinics, it is important to maximize utility of collected tissue 
samples for research purposes. 
As high-throughput sequencing techniques are used more frequently and the cost of such studies is 
continuing to decrease, it is likely that more clinical veterinary studies will be able to utilise these 
evolving and cutting-edge approaches. Advanced high-throughput systems especially next 
generation sequencing, require high quality of RNA. However, in some cases it can be hard to avoid 
RNA degradation during sampling. For example, due to the practical limitations samples may be 
stored at suboptimal conditions for a period of time. Certain tissue types, in particular mineralised 
tissues, are difficult to homogenise. In addition, the collection procedure itself may accelerate RNA 
degradation, for example heat generated by a dental bur during tooth extraction can be detrimental 
to RNA quality.  
Routinely total RNA yield, purity and integrity is evaluated for RNA quality control. The most rapid 
and commonly used method for quantification of nucleic acids is to measure ultraviolet (UV) 
absorption of RNA sample using a spectrophotometer (Manchester, 1996, Desjardins and Conklin, 
2010). One commonly applied metrics for assessment of RNA purity is to calculate the ratio of 
absorbance at 260 and 280 nm (the A260:280 ratio) and at 260 and 230 nm (the A260:230 ratio). The 




































































with low volumes of sample (1 μl) through direct trace observation and automated calculation of the 
28S:18S ratio (Schroeder et al., 2006). Currently the RNA Integrity Number (RIN) algorithm is the 
industry standard for RNA quality assessment.   
Degradation of RNA might be a minor problem in hybridization-based microarray, in which each 
expressed gene is measured by a few short and distinct probes. One microarray study reported that 
only a small portion of probes (0.67%, 275/ 41,000) were significantly affected by RNA degradation 
and biological differences far outweighed RNA degradation (Opitz et al., 2010). In recent years, 
sequencing based platforms like RNA-seq have been extensively applied, in which RNA degradation 
can be more problematic as degraded RNA can distort yield of sequencing reads which represents 
abundance of transcripts. Thus RNA degradation could be a major source of variation when 
measuring gene expression using RNA-seq data (Wang et al., 2016). There is still an ongoing 
controversy as to what extent gene expression results are affected by various degrees of RNA 
degradation in order to decide which partially degraded samples to include in an analysis, but for 
some tissues, in particular mineralised tissues, it can be difficult to obtain high quality RNA with the 
conventional phenol- chloroform protocols or commercial kits. Several protocols have been 
suggested to improve RNA quality including preserving samples in liquid nitrogen (Carter et al., 
2012). The purpose of this study was to develop an improved protocol for processing samples and 
extracting RNA from hard tissues collected in a clinical setting with the limitations that entailed. Here 
we evaluate the quantity and quality of RNA extracted from feline tissues focusing on teeth from TR 
free or TR affected cats for next generation sequencing. We also assessed the impact of RNA 
degradation on reference gene expression by quantitative PCR and the quality of the RNA 
sequencing data.  
Material and methods  
Sample collection and tissue processing  
Teeth were collected from patients with full owner’s consent presented to the Hospital for Small 
Animals, The Royal (Dick) School of Veterinary Studies, The University of Edinburgh, UK. TR was 
diagnosed by the combination of oral examination and intraoral dental radiography (Heaton et al., 
2004). The TR affected teeth were extracted by a veterinary surgeon using standard dental 
equipment under full general anaesthesia (Reiter and Soltero-Rivera, 2014). Further research 
samples including teeth, maxilla, mandibles and various soft tissues were collected at post mortem 
from cats and dogs euthanized for a wide range of medical reasons and donated to the school for 
research. The clinical samples underwent one of the following processes: A) immediately stored in 




































































frozen in liquid nitrogen before storage at -80°C (Figure 1, Step 1. B). Post mortem samples 
consisting of mandibles or maxillae were snap frozen in liquid nitrogen before storage at -80°C until 
further investigation (Figure 1, Step 1. C). Bones and other soft tissues were trimmed into small 
pieces, snap frozen in liquid nitrogen and stored at -80°C until RNA extraction (Figure 1, Step 1. D). 
Teeth were collected as part of a study into TR in cats, so all teeth samples were phenotyped for 
their TR status. To phenotype TR status in research samples collected at post mortem, frozen jaws 
were delivered to the radiographic facility in a liquid nitrogen carrier, radiographed, and then 
immediately put back into the liquid nitrogen. In order to extract the teeth from the frozen jaws, a 
standard dental extraction technique using dental equipment was used (Reiter and Soltero-Rivera, 
2014). However, RNA extracted using this technique was badly degraded (average RINe = 4.0), which 
might have been caused by the heat produced by the dental burs during tooth extractions from the 
frozen samples.  An alternative method was therefore developed where teeth were extracted from 
the alveolar sockets of the jaws using bone cutters and forceps while maintaining cold temperatures 
by working over dry ice (Figure 1, Step 1. C).  
RNA extraction  
Two different RNA isolation protocols were compared. TRIzol reagent is a commonly used solution 
for soft tissues based on a guanidinium thiocyanate-phenol-chloroform extraction method 
(Chomczynski and Sacchi, 1987). Protocol 1 was a modified version of the manufacturer’s protocol 
(TRIzol® reagent, Thermo Fisher Scientific, Figure 1, Step 2). In brief, frozen tissues were placed in a 
beaded tube (Lysing Matrix D tubes, Fisher) with TRIzol® reagent (1 ml/100 mg of tissue). The sample 
tube was placed in the FastPrep FP120 (Thermo Savant) to agitate at a speed of 4 m/s for 20 s. Each 
tube was incubated at room temperature for 5 min before adding 0.2 ml of 1-bromo-3-
chloropropane (BCP B9673, Sigma). After vigorously shaking the tube by hand for 15 s, the tube was 
left to stand at room temperature for 3 min. For phase separation, samples were centrifuged at 
12,000 rpm for 15 min at room temperature and the upper aqueous layer was transferred to a new 
tube. An equal volume of isopropyl alcohol was added and incubated for 10 min on ice. To 
precipitate the RNA, the tube was centrifuged for 30 min at 12,000 rpm at room temperature. 
Supernatant was removed and the RNA pellet was washed with 1 ml of 75% ethanol. The sample 
was briefly vortexed and centrifuged for 30 min at room temperature at 12,000 rpm. The 
supernatant was removed and the RNA pellet was air-dried for 5 to 10 min before RNA was re-
suspended in RNase free water.  
Protocol 2 was modified from a previous study (Reno et al., 1997) and optimised for cartilage and 
tendon in our lab (Clements et al., 2006) (Figure 1, Step 2). To facilitate disruption and pulverisation 




































































MM200, Retsch, Germany). The grinding jar and ball were submerged in liquid nitrogen for a few 
minutes before use to keep the sample frozen during homogenisation. TRIzol reagent (0.5 ml/100 
mg of tissue) was added to the pre-chilled jar and allowed to freeze. Frozen tissue and the pre-
chilled ball were placed into the jar and the lid firmly closed. The Mixer Mill MM200 was set at 30 Hz 
for 2 min to perform radial oscillations in a horizontal position. The pulverized tissue was transferred 
to a pre-chilled centrifuge tube containing TRIzol® reagent (0.5 ml/100 mg of tissue). After a brief 
mix, the mixture was left to stand for 30 min before being centrifuged at 12,000 rpm for 10 min at 
4oC. The supernatant was transferred into a clean tube and 200 l of chloroform was added, mixed 
and left to stand at room temperature for 10 min. A further centrifugation step of 15 min at 12,000 
rpm at 4°C was performed and the clear supernatant was transferred into a clean tube. An equal 
volume of 70% ethanol was added to each tube and mixed by pipetting. RNA was washed and DNase 
digestion was performed according to the manufacturer’s instruction (RNeasy Mini Kit, Qiagen). RNA 
was eluted with 30 to 50 µl of RNase free water, and stored at - 80°C. 
Measurement of RNA yields, purity and integrity  
RNA yield was measured based on absorbance at 260 nm, and the A260:280 and the A260:230 ratios were 
used to assess the purity of RNA using NanoDrop™ 1000 Spectrophotometer (Thermo Fisher 
Scientific Inc.). The RNA Integrity Number equivalent (RINe) was determined by RNA analysis 
ScreenTape kit on Agilent 2200 TapeStation. RINe is a comparable value to RIN generated by industry 
standard 2100 Bioanalyzer system for quality assessment of RNA on a microcapillary electrophoretic 
RNA separation platform (Schroeder et al., 2006). The software produces a separate RNA integrity 
number, the correlating electropherogram, and a gel image for each sample. 
Reference gene expression by qPCR and RNA integrity  
To investigate the suitability of including the feline tooth RNA samples in our gene expression study, 
RNA samples were divided into three categories based on RINe values (High ≥ 6, 5 < Moderate < 6, 
and Low ≤ 5) and quantitative real time RT PCR was performed for each sample. In brief, 400 ng of 
RNA was reversed transcribed using Omniscript® Reverse transcription (Qiagen) with random 
primers at 37°C for 1 h according to the manufacturer’s instructions. Real-time PCR was performed 
with high affinity, double stranded DNA-binding dye SYBR green (Takyon™ qPCR MasterMixes for 
SYBR® assays, Eurogentec) using Stratagene MX3000P qPCR system (Agilent Technologies). The sets 
of reference gene primers were selected from previously validated feline reference genes (Penning 
et al., 2007) under universal cycling conditions including pre-incubation at 50°C for 2 min and 95°C 
for 3 min, 40 cycles of amplification at 95°C for 10 s, 60°C for 20 s and 72°C for 30 s, and followed by 




































































triplicate and cycling threshold (Ct) values of reference genes were generated to compare gene 
expression level of each RINe category.   
Generation of cDNA libraries and RNA sequencing 
Tested RNA samples were sent to our academic facility (Edinburgh Genomics, The University of 
Edinburgh, UK) for cDNA libraries and RNA sequencing. Briefly, one microgram of RNA from each of 
the thirteen samples and 0.8 µg of RNA from one low quantity  sample were used to generate 
fourteen cDNA libraries using the Illumina TruSeq stranded mRNA sample preparation kit according 
to the manufacturer’s instructions (Illumina, San Diego, CA, USA). Paired-end sequencing was 
performed using the Hiseq 4000 system (Illumina). The low quality reads were filtered by Phred 
quality score (Q score 30) (Ewing and Green, 1998) and 3’ adapter were trimmed with cutadapt 
(version 1.8.3)(Martin, 2011) . All the raw reads have been submitted to the European Nucleotide 
Archive (ENA) under accession PRJEB24183 (ENA, https://www.ebi.ac.uk/ena). 
Mapping to reference genome, generation of mapping statistics, and generation of 
Multidimensional scaling (MDS) 
Annotation and alignment were performed using STAR (version 2.5) comparison to the Felis catus 
genome (version 6.2) in the Ensembl database (Hubbard et al., 2002). Alignment files were 
generated in the bam format for each sample. The read counts from each sample were generated 
using HTSeq (version 0.6.0.1) (Anders et al., 2015) with mode 'union'. Reads were mapped to 
Felis_catus_6.2 using STAR (version 2.5). Duplicate reads were found using picard tools (version 
1.141). Generation of MDS plot were generated using plotMDS function from edgeR package 
(version 3.12.1) to visualise the level of similarity of individual cases of a dataset. 
Statistical analysis for RINe values and reference gene expression by qPCR 
Statistical data were analysed using Minitab® 17 Statistical Software (Minitab Ltd., UK). P values 
below 0.05 were considered statistically significant and specific P values were noted. When data 
followed a normal distribution, parametric tests were performed. If parametric tests could not be 
applied, non-parametric testing was performed. One-way ANOVA was used to compare differences 
between more than two treatment groups. Two sample t-tests or Mann Whitney U-tests were used 
to compare differences between two groups. Correlations between two groups were assessed using 







































































Good RNA yields were obtained from tooth samples regardless of homogenisation step used 
Obtaining a good yield of RNA from dental tissues is a challenge because individual teeth are 
relatively small and acellular compared to soft tissues. The wet weight of teeth varied widely and 
ranged from 10 to 500 mg depending on the type of tooth (incisors, molars, canines or premolars 
vary greatly in size) or to which extent the teeth were affected by TR. In this study, the protocols 
described produced good yields of total RNA regardless of the homogenisation step used. Samples 
between 100 - 500 mg of wet weight produced 2.0 to 12 µg of total RNA which was higher than the 
minimum requirement of quantity control for next generation sequencing. However, small teeth and 
some clinical samples weighing less than 50 mg produced low yields of RNA with total RNA less than 
1.0 µg (50 to 60 ng/µL). These samples failed to reach the minimum yield of total RNA required (1.2 
to 2.2 µg of total RNA) for assessment of RNA quality for standard RNA-seq (Genomics, 2017).  
Tissue processing at collection significantly impacted RNA integrity  
The tissue processing procedures were performed according to four different tissue processing 
protocols depending on the type of tissue and source of samples (Figure 1, Step 1. A, B, C, and D). 
Teeth preserved in RNAlater® solution (Protocol A) obtained the lowest RINe values with high 
variations (3.04 ± 1.8) indicating highly degraded RNA (Figure 2). A representative electrogram is 
shown in Figure 2 and shows how the two distinct peaks of 28S and 18S had disappeared and 
combined into one peak (Figure 2, top right panel). Tissue processing protocols B, C and D showed 
improved RINe values (Figure 2) but still with partially degraded RNA. Partial degradation of RNA can 
be seen as several extra small peaks left of the 18S peak (Figure 2, bottom right panel). The main 
difference between protocol A and the other three protocols was the method of tissue storage and 
RNA stabilisation following collection. While protocol A used RNAlater® solution for RNA stabilisation 
at room temperature, in the other protocols the tissues were immediately snap frozen in liquid 
nitrogen.  
The homogenisation steps and tissue type had a significant impact on RNA integrity 
One of the critical time points when significant RNA degradation can occur is at the time of tissue 
homogenisation. Protocol 1 (Figure 1, Step 2, homogenisation at room temperature using beaded 
tubes) resulted in incomplete homogenisation of the mineralised samples. This indicated that the 
procedure in Protocol 1 was insufficient for these highly mineralised tissues. When Protocol 2 (Figure 
1, Step 2) was applied, teeth were pulverized in cold TRIzol® reagent. RINe values were improved 




































































also obtained improved results with Protocol 2 for these tooth samples (Table 1). There were two 
reasons why we wanted to test dog tissues. One was due to the greater availability of dogs’ teeth 
available to test our protocols, and secondly to test if these protocols were applicable for dog’s teeth 
as well. Dog’s teeth are bigger and harder than cat’s teeth, and testing these teeth ensured a larger 
application of our protocol for other animals including humans and large animals.  
To compare the different homogenisation steps on different tissue types, teeth and soft tissues from 
dogs were used. Regardless of protocol used, RNA from soft tissues consistently achieved higher 
RINe values (Table 2), suggesting that the less vigorous homogenisation step using beads was 
sufficient to prevent significant RNA degradation when processing soft tissues. RNA from cat soft 
tissues such as muscle, liver, intestine and gingiva extracted using Protocol 2 also showed improved 
RINe values (average 6.9) when compared to RNA obtained from hard tissues such as bone and teeth 
(average 4.9, Table 2). In order to compare across species we processed some dog tissues according 
to the same protocols; dog soft tissues yielded higher RIN e values (average 7.1 and 6.6 with Protocol 
1 and 2 respectively) than those of tooth samples (Average 2.7 and 4.7 in Table 2) demonstrating 
how the protocols used are a lot less critical when working with soft tissues compared to mineralised 
tissues. 
There was no correlation between RNA purity parameters and RNA integrity values.  
To investigate if there is a correlation between RNA purity and integrity, extracted RNA samples 
from clinical samples collected according to protocol B (snap frozen in liquid nitrogen) and post 
mortem samples collected according to protocol C (snap frozen within the jaw) were categorised 
into High, Moderate, and Low RINe groups according to their RINe values. Five RNA samples from 
each category were chosen and shown that there was statistically difference of average RINe values 
among the groups (Figure 3, B). All samples in the high RINe group presented on the gel images and 
electropherograms with characteristics typical of intact RNA: tall 28S ribosome peaks double the 
height of the 18S peak, short 18S ribosome peaks and with only a few small peaks of small RNAs and 
minor signs of degraded RNA. The moderate RINe group showed partially degraded ribosome peaks 
with moderate height of 28S peaks and with extra peaks observed below the 18S peak. In the low 
RINe group, 28S peaks were shorter than the 18S peaks and there were several background peaks 
present. We then compared the A260:280 ratios between the three groups using Spearman’s 
correlation coefficient. There was no statistically significant difference between any two groups 
which suggests the A260:280 ratio does not correlate with or represent RNA integrity (P = 0.781, 
Spearman’s correlation coefficient). Similar patterns were observed when the A260:230 ratio was used 
(Figure 3, Table 3), and no correlation was observed between the ratio and the RINe values (P = 




































































RNA degradation levels had an impact on reference genes expression by qPCR   
To investigate the impact of RNA degradation on gene expression levels, the three groups were 
tested for expression of three reference genes, glyceraldehyde-3-phosphatedehydrogenase 
(GAPDH), ribosomal protein S17 (RLP17) and ribosomal protein S19 (RPS19) using quantitative PCR 
(qPCR). qPCR was performed using the same amount of synthesized cDNA from each RNA sample 
and cycling threshold (Ct) values for each reference gene were generated. There was no significant 
difference in the expression of GAPDH between high and moderate RINe groups, however the low 
RINe group revealed significantly higher Ct values indicating low expression of GAPDH (Figure 4).  For 
RPS19 the Ct values were significantly different between the high and the moderate RINe groups 
(Figure 4). As high Ct value indicates lower expression of gene, degraded RNA correlated with a 
lower expression of reference genes. Whereas expression of GAPDH and RPS19 in this study was 
affected by RNA degradation, expression of RLP17 was less affected by the level of RNA degradation.     
Low yield affects quality of RNA-seq data regardless of RNA integrity  
Fourteen RNA samples from TR free (7 samples collected at post mortem according to Protocol C) 
and TR affected teeth (4 samples collected at post mortem according to Protocol C and 3 clinical 
samples collected as described in Protocol B) were chosen from the feline tooth resorption study. 
The quality of cDNA libraries and sequencing was measured by percentage of duplicated reads and 
mapped reads (Table 4) (Supplementary Table S1). As cDNA library complexity is determined by 
duplication rate, high duplication rate is often caused by degraded and fragmented RNA. 
Interestingly one sample that yielded low quantity of RNA but achieved a high RINe value (RINe = 7.3) 
showed much higher duplication rate than any of the other samples. After annotation to Felis catus 
genome, sequencing reads of all libraries except for the one library with the low input RNA mapped 
to 94 to 95 % of the feline genome. The low quantity RNA sample with a high RINe value only mapped 
87.53 % of reads to the feline genome. RNA-seq data from each sample as genome wide expression 
were plotted to investigate similarity of whole genome expression profile within the given samples 
(Figure 5). Interestingly the low yielding RNA sample with a high RIN (Supplementary Table S1) was 
defined as an outlier from the other samples which might have been caused by the low expression of 
genes and low quality of the cDNA library due to low yield of RNA rather than quality of RNA 
(Figure 5). 
Discussion  
Selection of a high quality and quantity of RNA is important for downstream gene expression studies 
using next generation sequencing. The first challenge of extracting RNA from certain types of clinical 




































































quantities of tissue. The wet weights of intact adult teeth range from 100 to 200 mg for mandibular 
premolars, 400 to 550 mg for canines, and 10 to 40 mg for incisors. The carnassial tooth (the third 
molar in the maxillary arcades and the first molar in mandibular arcades) were often less than 500 
mg. Like other mineralised tissues, dental tissues are relatively acellular compared to soft tissues as 
they contain a large amount of hydroxyapatite and collagen (Ten Cate and Nanci, 2003). In cases of 
clinical samples, only small quantities are available due to loss of tissues during TR progression or 
treatment of TR such as partial crown amputation in case of type 2 TR (Reiter and Soltero-Rivera, 
2014). Furthermore, TR affected tissues undergo apoptotic processes and stimulate inflammation 
which can lead to extensive loss of tissues (DuPont and DeBowes, 2002, Booij-Vrieling et al., 2010). 
Here we compared tissue processing and RNA isolation protocols to maximise the yield of RNA and 
improve the quality of the RNA obtained from feline teeth. In our study, the average yield of RNA 
from feline tooth samples with a wet weight of less than 50 mg was below 1.0 µg of total RNA. This 
quantity of RNA limits the application for expression studies. For example, in many gene expression 
studies (DeLaurier et al., 2002, Kessler et al., 2009, Gunter et al., 2013), an input of 0.5 to 2 µg of 
RNA for reverse transcription was used. Microarray or RNA sequencing studies require a relatively 
low amount of RNA due to its high sensitivity. For instance, for cDNA library using the TruSeq 
stranded mRNA kit, according to the manufacturer’s protocol 100 ng of RNA can be used as a 
minimum input. However, practically larger quantities of RNA are required in order to be able to 
assess the quality and quantity of RNA (e.g. the minimum required by our facility, Edinburgh 
Genomics is 1.2 µg: 0.2 µg for quality control and 1 µg for library preparation). Therefore the total 
recommended amount of RNA is 2.2 µg to allow for two attempts at library preparation. In this 
study, we used 0.8 – 1 µg of total RNA. As tooth samples with wet weights of 100 to 500 mg yielded 
more than 1.0 µg of total RNA, we would recommend that gene expression or sequencing studies 
aim for at least 100 mg of wet weight as a minimum tooth sample size.  
Different tissue processing methods were compared based on the RNA quality obtained. As 
endogenous ribonucleases (RNAse) are widely present in tissues, RNA in collected tissues can be 
rapidly degraded. To minimize RNA degradation in the tissue samples, they are firstly required to be 
frozen by immersion in liquid nitrogen immediately upon collection and secondly to be homogenized 
by a powerful protein denaturant (chaotropic agent usually guanidinium isothiocyanate). RNAlater® 
is a commonly used RNA stabilization solution because of the convenience of storage at room 
temperature. Liquid nitrogen or dry ice is often not readily available if collecting clinical samples 
from most veterinary practices. When tooth samples were extracted and stored in RNAlater®, the 
extracted RNA was highly degraded. This was likely to be due to poor permeability of RNAlater® into 




































































tissues need to be dissected into small pieces to allow adequate diffusion of the chemical into the 
tissues (Lader, 2012). Other studies have also mentioned the limited application of RNAlater® in hard 
tissues (Clements et al., 2006, Carter et al., 2012).  Our data showed that snap freezing using liquid 
nitrogen improved RNA quality. However, the necessity for liquid nitrogen is likely to limit the 
application of this processing protocol outside of the laboratory environment. In order to collect 
large number of samples in a clinical setting, the ability to collect and store samples at room 
temperature would be a great advantage. For example it allows for recruitment of several practices 
to contribute samples to clinical studies even if they have no access to liquid nitrogen. Our study 
does however suggest that for soft tissue samples that can be trimmed into small pieces, collection 
and storage in RNAlater® is likely to be adequate.  
In our study, tissue samples that were stored at suboptimal temperatures during phenotyping 
(assessment of TR status, i.e. became defrosted during the dental radiographic procedure) or were 
subjected to potentially high temperature during processing (i.e. while extracting the teeth using 
dental burs at post mortem) also showed marked RNA degradation. By optimising our protocols, we 
managed to achieve average RINe values of between 5 and 6. The average RIN e value reported in this 
study is lower than what is reported in other studies using soft tissues. However other studies 
extracting RNA from mineralised tissues reported similar limitations and showed the same pattern 
where RNA from hard tissues was more degraded compared to those from soft tissues (Sun et al., 
2012, Carter et al., 2012).  
We also investigated if there were any correlation between RNA purity as measured by the A260:280 
and A230:260 ratios and RNA integrity as measured by RINe values. The A260:280 ratios were consistent 
and similar among all RNA samples regardless of RINe value. In terms of A230:260 ratio, although these 
values were more variable between samples with high standard deviation compared to the A260:280 
ratios, there was no correlation to the RINe values of the samples. This implies that these two 
indicators cannot be reliably used as parameters of RNA integrity or quality.   
To investigate the impact of RNA integrity and quality on gene expression, expression of three 
reference genes was compared. In theory, reference genes are expressed stably across the samples. 
When equal amount of RNA is reverse-transcribed and analysed by qPCR, the values of Ct of the 
reference gene is expected to be similar across samples (Conde et al., 2012, Belluoccio et al., 2013, 
Chapman and Waldenstrom, 2015). Also, it should show minimal variability in its expression. Two 
reference genes, GAPDH and RPS19 showed different expression levels depending on the 
degradation of RNA with the high RINe value group showing the highest expression with the lowest 
Ct. Only RLP17 was similar between the three groups. We recognise that reference genes may 




































































tested and used in our lab on a range of feline tissues and cell lines and have overall proved the most 
consistent. The difference in reference gene expression might be affected by the extent of 
degradation of RNA, but it may also imply that certain genes have a more stable gene expression in a 
specific type of tissue (Penning et al., 2007).   
For further investigation of the impact of RNA quality and quantity on RNA sequencing, we 
evaluated RNA-seq data related to RNA quantity and quality. We collected 13 RNA samples with RNA 
yields of more than 1.0 µg of total RNA and one clinical sample with very low yield. Thirteen TruSeq 
stranded mRNA libraries were generated using 1.0 µg of total RNA, while for the low yielding sample 
only 0.8 µg of total RNA was used. Although manufacturer tested using low amount of input, (0.1 µg 
of total human RNA for cDNA library generation was reported), our data revealed that the RNA-seq 
data from the low input RNA sample was an outlier which skewed the data set of the whole genome 
expression profiles. It was documented that degraded RNA samples using poly A selection for 
preparation of cDNA library are likely to cause 3' mapping bias that might have effect on false 
positives in differential expression and the quantification of duplicate reads (Sigurgeirsson et al., 
2014). In our data, duplication rates and percentage of mapped reads were similar across a range of 
RINe values. The cDNA library complexity and duplication profiles were affected by the low input of 
RNA rather than by RNA integrity. Therefore the low yield of RNA was not suitable for RNA-seq and 
was excluded in the final data analysis. We concluded that the overall yield of the RNA for input into 
RNA-seq was more important than quality of RNA for RNA-seq quality control. Recently, there have 
been technical advances made to allow for low input of RNA or degraded RNA from clinical samples, 
formalin-fixed paraffin-embedded samples or single cell samples (DeLuca et al., 2012, Adiconis et al., 
2013, Gallego Romero et al., 2014, Wu et al., 2014) to be used. Therefore for gene expression study 
especially high throughput sequencing, RNA extraction protocols, generation of cDNA library, RNA-
seq and bioinformatics need to be considered and customised. There is likely there will be further 
opportunities to overcome these limitations in the future. 
The goal of this study was to identify improved protocols for RNA extraction from calcified tissues to 
maximise its application for gene expression studies using precious clinical samples. Here we 
optimised a protocol to maximise RNA yield and improve quality extracted from feline teeth in a 
clinical setting and at post mortem. We suggest that minimum amounts of sample are required for a 
conventional gene expression study. We identified that it was critical to keep the samples frozen in 
liquid nitrogen and /or dry ice during the entire tissue processing procedure including during tissue 
homogenisation. We further investigated parameters commonly utilised to assess RNA purity and 
integrity and its correlation to gene expression and RNA-seq. Overall the degradation of RNA was 




































































optimised protocol we managed to extract RNA with signs of only moderate degradation, and the 
RNA-seq data from these samples were still worth analysing for the first reported feline sequencing 
study of molecular pathways of the feline dental environment. Furthermore this detailed protocol 
should have beneficial applications for RNA processing and analysis in mineralised tissue from many 
animal species either obtained via the clinic or in a research environment.   
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In this chapter, I have reported the development of a RNA extraction 
protocol capable of producing good yields of RNA and improved RNA quality from 
mineralised tissues. The information from this chapter is important as it is 
recognised that RNA is fragile and susceptible to degradation. This is especially true 
for RNA extracted  from specialised tissue such as mineralised teeth Moreover, it 
remains unclear whether most transcripts of RNA degrade at similar rates under a 
certain situation (e.g. clinical settings or post mortem) or whether rates of RNA 
degrade are associated in a gene-specific manner (233). Hence, gene expression 
study is based on the assumption that each nucleotide of the transcript is sequenced 
equally and the amount of amplicon is proportional to the abundance of the 
transcript (240, 241). Several studies have been done to elucidate how low quality 
RNA impacts on gene expression profiling (233, 242, 243). A qPCR study revealed 
that RNA samples with poor integrity were found highly comparable if integrity of 
RNA is similar among samples avoiding use of RNA samples with disparate quality 
(242). Similarly, a study reported that RNA degradation did not preclude 
microarray analysis if microarray is done using samples of comparable RNA 
integrity or circumventing probe positions near the 5' end (243). When it comes to 
RNA-seq, if RNA is partially or completely degraded the corresponding read yield 
would be distorted in a gene-specific manner, which might have profound 
influences on whole genome gene expression profiling (241). A RNA-seq study 
using RNA with a wide range of quality revealed that disparate quality of RNA 
impacted on measurements of gene expression levels and the more degraded RNA 
tended to have a significant loss of library complexity (233). Therefore, RNA-seq 
analysis requires RNA of a much higher quality than for example standard PCR 
reactions where the overall RNA degradation is of less importance. 
In this study I found that RNA with a medium to high RINe value was 





yield. Only one cDNA library was defined as an outlier from the other samples 
tested. Although it was sequenced from a high RINe it was a low yielding RNA 
sample. Due to suboptimal temperatures during sample processing or post mortem 
apoptosis, RNA cannot be devoid of some degradation. The overall quality of RNA 
from feline teeth was lower than that achieved from soft tissue but as similar to 
comparable studies of murine teeth (237). The quality of RNA-seq data will guide 
which data can be useful for inclusion or exclusion for further data analysis. In the 
following two chapters of this thesis, this RNA isolation protocol is used 
throughout. In chapter 4, I focused on the expression levels of inflammatory 
cytokines which I considered might be correlated to feline TR based on published 
data from other studies. RNA-seq data will be utilised to investigate the whole 
dental transcriptome changes between TR -ve and TR +ve teeth in chapter 5.  In 
summary, the technical advances described in this chapter create a strong base for 





Chapter 4 Investigation into the role of 
inflammatory cytokines and vitamin D in feline 
tooth resorption 
4.1 Abstract 
Inflammatory cytokines, vitamin D and vitamin D metabolites have been 
frequently reported to play important roles in both periodontal disease and tooth 
resorption in cats. To test this hypothesis, expression of the inflammatory cytokines, 
the nuclear vitamin D receptor (VDR) and the key regulator of 
osteoclast/odontoclast differentiation, RANKL expression were investigated by 
qPCR. Also, an in vitro co-culture model system was developed for feline osteoclasts 
and periodontal ligament cells to study osteoclast differentiation and activation. 
There was no statistically significant difference in mRNA expression of any of the 
inflammatory cytokines tested (e.g. IL1B, IL6, P2X7R, TNF and IFNG), VDR or 
RANKL between TR -ve and TR +ve teeth samples when assessed by qPCR. Feline 
osteoclasts were successfully differentiated from peripheral blood and bone marrow 
and showed typical characteristics of bone and tooth resorbing cells including 
mRNA expression of cathepsin K (CTSK), tartrate-resistant acid phosphatase type 5 
(ACP5), d2 isoform of vacuolar ATPase (ATP6V0D2) and DC-STAMP (DCSTAMP) 
by PCR, and cathepsin K, calcitonin receptor, c-Src, vitronectin receptor and MMP9 
by immunocytochemistry. To test the effect of vitamin D on osteoclast formation 
and resorption activity feline osteoclasts were treated with physiological levels of 
the active form of vitamin D3 (1,25(OH)2D3). This resulted in increased osteoclast 
formation and resorption activity, but at a higher dose of 1,25(OH)2D3, resorption 
activity was inhibited. Primary periodontal ligamnet cells expressed RANKL and 
induced osteoclast formation without additional exogenous RANKL in co-culture 
systems of osteoclasts and periodontal ligament cells. Interestingly, osteoclast 
precursors from TR +ve cats yielded higher numbers of osteoclasts under co-culture 







Tooth resorption is one of most common oral diseases reported in cats (99, 
107, 108, 112). The oral cavity constitutes a moist environment which contains a 
reservoir of nutrients. This environment is subject to plaque accumulation and 
bacterial colonisation which can cause dental inflammation (6). When inflammation 
progresses, cytokines are released locally, which may attract osteoclast progenitors 
and progress osteoclast induced tooth resorption (163, 244). TR lesions frequently 
accompany localised gingival inflammation. Therefore inflammation has been 
proposed as an aetiological factor to trigger progression of TR (92, 100).  
As high prevalence of TR has been reported in domestic cats, commercial 
diets and their levels of vitamin D3 and its metabolites have also been suggested to 
be involved in the aetiology of TR (92). Several authors have hypothesised that 
vitamin D3 and its catabolic metabolism might induce odontoclastic tooth resorption 
(92, 122, 178, 245). However, our understanding of the precise mechanisms behind 
the development and pathophysiology of TR is currently limited, and the roles of 
vitamin D or vitamin D metabolites and inflammatory cytokines have not been fully 
elucidated.  
In this chapter I will present qPCR data on the mRNA expression levels of 
various osteoclast stimulatory factors including inflammatory cytokines, VDR and 
RANKL between TR –ve and TR +ve teeth to investigate the involvement of these 
factors in osteoclast dysregulation.  
Osteoclasts are terminally differentiated cells and unable to proliferate (20). 
Therefore there is no available immortalised osteoclast cell line (246). Authentic 
osteoclasts can be acquired from differentiating them from their precursors or from 
isolation of primary osteoclasts whose successful isolation is limited to new born 
animals (246). Initial studies indicated that the in vitro long-term culture of 
osteoclasts required haematopoietic precursor cells as well as osteoblasts/stromal 





This indirect method for the differentiation of osteoclasts was superseded by the 
direct stimulation method using commercially available recombinant CSF-1 and 
RANKL following the discovery of these critical cytokines (30, 224, 229). This 
protocol is now established and is the most widely used in vitro method for direct 
osteoclast formation of osteoclast precursors derived from bone marrow, spleen, or 
peripheral blood (229). These direct in vitro techniques are well established in 
several species including human (227), cat (228), rodents (246) and rabbit (249) and 
include isolation of primary mature osteoclasts from newborn rabbits (249) or chicks 
(250), osteoclast derived from peripheral blood (227, 245) or bone marrow (246), and 
immortalised macrophage cell line such as RAW 264.7 cells (226).  
I here present the successful in vitro differentiation of feline osteoclasts from 
both PBMC and bone marrow. This will be a useful tool for studying feline 
osteoclast biology and testing efficacy of drugs in vitro. 
In this chapter I will also present the technique of co-culturing osteoclasts 
and periodontal ligament cells. Feline TR usually occurs on the external tooth 
surface. Lesions initiate from the external root and invade into the dentine and pulp 
(9), and histopathology of TR lesions often indicate impairment of periodontal 
ligament structure (9, 92, 113). Normal periodontal ligament possesses well-
developed vascular networks and various cells that play an important role of 
remodelling of tooth supporting structure (92). To investigate interaction between 
periodontal ligament cells and osteoclasts, a previously described co-culturing 
technique was modified and applied (76, 142). Here I will demonstrate successful 
osteoclast formation and resorption in a co-culture model that mimic the tooth 
microenvironment.  
4.3 Materials and Methods 
4.3.1 Samples and phenotyping of TR   
Samples of cat tissues in this study were collected as described in section 





were excluded. All extracted teeth were collected from the mandible (left and right 
third and fourth premolars and first molar, referred to as 307-9, 407-409 according to 
the Triadan system). TR type and staging were confirmed by a veterinary dental 
specialist, Dr Norman Johnston (MRCVS, RCVS, American & European Specialist in 
Veterinary Dentistry, DentalVets, North Berwick) and Dr Susan Thorne (MRCVS, 
Dentistry and Oral Surgery Resident, DentalVets, North Berwick). 
4.3.2 RNA extraction and preparation of cDNA 
Total RNA was isolated from the teeth with/without TR as described in 
sections 2.1.1 and 2.2.1. The first strand cDNA was synthesised as described in 
sections 2.1.2 and 2.1.3. After phenotyping and RNA assessment, 24 RNA samples 
(11 TR –ve teeth and 13 TR +ve teeth) from 16 cats (3 TR –ve cats and 13 TR +ve cats) 
were included in this study (Table 4.1). TR + teeth were classified into eight of Stage 
2, two of Stage 4 and three of Stage 5. All teeth samples were further sub grouped 
into TR -ve from TR unaffected cats, early stage from Stages 1-2 and advanced stage 
from Stages 3-5. In terms of types, all TR + teeth were classified Type 2(n = 11) or 
Type 3 (n = 2) and none of them was identified as Type 1. Available RINe values 
were noted if applicable. Only limited information of other disease was available.  
4.3.3 Primer sets for feline inflammatory cytokine genes  
The primers used are described in Table 4.2. The previously published 
primers included IL6, TNF, IFNG, GAPDH, HPRT, RPL17 and RPS19. As the feline 
genome has not been fully annotated or no validated primers were available, new 
primer sets for 1L1B, P2X7R and RANKL were designed as described in section 2.1.4 
and the sequences were confirmed by sequencing described in section 2.1.10.   
4.3.4 Primer efficiency and quantitative PCR  
To check the specificity of PCR products, conventional PCR was performed 
and each product was visualised using agarose gel as described in section 2.1.5. 
Quantitative PCR was performed using SYBR Green based reagent, Precision™ 2× 





qPCR system (Agilent Technologies) as described in section 2.1.5. The thermal 
cycling condition was displayed in Figure 4.1. To determine primer efficiency for 
four reference genes including GAPDH, HPRT, RPL17 and RPS19, 10-fold serial 
dilutions up to 10,000 were carried out. For seven genes of interest 4-fold serial 
dilutions up to 4-5 were carried out. Following determination of primer efficiency, 
quantitative PCR was performed and relative mRNA expression as fold change was 
analysed using the calculation of 2-ΔΔCt as previously described in section 2.1.8. 




Table 4.1 Description of sample information and TR status for qPCR. #: number, NF: neutered female, NM: neutered male, N/A: not applicable, GI: 
gastrointestinal. 














RINe Other disease 
C6 >5 F Mixed + 7 1 407 + 4 3 5.3 N/A 
C8 >5 F Mixed + 14 8 307, 407 + 2 2 5.2 N/A 
C12 4 F Mixed - 14 0 307,308, 407, 408 - N/A N/A 4.5 GI tract 
C15 9 NF Mixed - 14 0 307, 407 - N/A N/A 7.3 Chronic cystitis 
C16 5 NF Mixed + 14 1 308 + 2 2 5.1 N/A 
C17 12 NF Mixed + 6 2 407 + 5 2 5.6 Age related problems 
C18 10 F Mixed + 6 3 307 + 5 2 3.8 N/A 
C21 16 NF Mixed + 8 1 308 - N/A N/A 5.3 Age related problems 
C25 10 NF Mixed - 14 0 307, 407 - N/A N/A 6.7 Back pain 
C26 >5 NM Mixed + 6 1 407 + 5 2 4.6 N/A 
C27 7 NF Mixed + 14 2 
407 - N/A N/A 4.1 N/A 
 404 + 2 2 5.9 
C30 10 NF Mixed + 14 3 
309 - N/A N/A 3.5 Thyroid problems 
409 - N/A N/A 4.4 
307 + 2 2 5.2 Thyroid problems, 
overweight 407 + 2 2 4.4 
C32 6 NF Mixed + 14 3 
308 - N/A N/A 4.9 N/A 
407 + 4 3 6.3 
C34 9 NM Mixed + 14 5 
309 - N/A N/A N/A GI and urinary problems 
308 + 2 2 N/A 
C36 10 F Mixed + 14 6 
309 - N/A N/A N/A Age related problems  
408 + 2 2 N/A 
C37 5 M Mixed + 14 4 
309 - N/A N/A N/A N/A 





Table 4.2 List of primer sets used for quantitative PCR. 
Primer 
set 





IL6 F; GACTTCCTTCAGTTCAGCCTCAGG 81 64 (100) 
R; AGGAATGCCCGTGAACTACAGC 
IL1B  F; TGGCGGAAGGGGAATAGAAG 427 58 NP_001070882 
R; GCTTGGTATAAAGATGGCACAC 




F; TCTTCTCCTTCCTCCTCGTCG 185 65 (100) 
R; GGGGTTTGCTACTACATGGGC 
IFNG F; CAGATGTAGCAGATGGTGGGTC 176 60 (100) 
R; CATGTCTTCCTTGATGGTGTCC 
VDR F; TCTCTGACCCTGGACCTGTC 122 62 (100) 
R; GAAGTGAGGTCTCTGAACCCTG 
RANKL F; CTTCCGGGCAGCTGTACAAA 186 60 XM_023251873 
R; AGGCTCACTTTGTGGGAACC 
HPRT F; AACTGGAAAGAATGTCTTGATTGTTG 100 56 (251) 
R; GACCATCTTTGGATTATACTGCTTGA 
GAPDH  F; GCCGTGGAATTTGCCGT 82 59 (251) 
R; GCCATCAATGACCCCTTCAT 
RPL17 F; CTCTGGTCATTGAGCACATCC 108 58 (252) 
R; TCAATGTGGCAGGGAGAGC 






Figure 4.1 Thermal cycling condition used in this chapter. 
 
4.3.5 Osteoclast culture and characteristics  
In vitro techniques of primary osteoclast cultures from peripheral blood and 
bone marrow were previously described in sections 2.3.6 and 2.1.6. RAW 264.7 cells 
were differentiated into osteoclasts according to protocol described in section 2.3.8. 
To characterise osteoclasts, various techniques including PCR, TRAP activity, and 
immunocytochemistry were performed as described in section 2.4.2. 
To test the effect of the biologically active form of vitamin D on osteoclast 
formation, 1,25(OH)2 D3 was used to treat the cells at different concentrations as 
described in section 2.4.6. 
4.3.6 Isolation of periodontal ligament cells and co-culture 
with osteoclasts 
Primary periodontal ligament was isolated in feline periodontium and 
cultured as previously described in section 2.3.9. Co-culturing of periodontal 
ligament and osteoclasts were established in section 2.3.10. To characterise 
periodontal ligament, RANKL PCR and immunocytochemistry were performed as 




Table 4.3 List of primer sets used for conventional PCR.  
4.4 Results 
4.4.1 TR phenotyping and prevalence of study population   
A brief description of the prevalence of TR from the 24 cats examined is 
summarised in Table 4.1. Twenty one of 24 cats were diagnosed with at least one TR 
lesion (21/24, 87.5%). Seventeen cats had multiple teeth affected with TR (17/24, 
70.8%), in total, 82 out of 293 teeth were found with TR (82/293, 28%). Mean age of 
the cat population was 8.5 years old ranging from 4 to 19. From the 82 TR affected 
teeth, Stage 2 TR teeth were most frequently detected (45/82, 54.9%), followed by 
Stage 3 (15/82, 18.3%), Stage 4 and 5 (10/82, 12.2%). Stage 1 TR was least common. In 
terms of Type of TR, Type 2 TR was the most common Type affecting 67 of 83 teeth 
(82.7%), followed by Type 1 (9/82, 11%) and Type 3 (6/82, 7.3%). 
4.4.2 Inflammatory cytokines, VDR, and RANKL expression in 
TR 
All the genes of interest were expressed in teeth when using a conventional 
PCR, although TNF showed relative low expression in terms of amount of product. 
All PCR products were of expected size. Except for INFG, each amplicon was 
presented as a single band (Figure 4.2). INFG produced a strong band below 100 bp 
Primer 
sets  





ACP5 F; CAATGCCCCGTTCTACACAG 362 59 XM_003981893 
R; TCACCGTGTCCAGCATGAAG 
ATP6V0D2 F;CCAAAATTGACACGGAGATGAG 266 55.2 XM_004001615 
R; AACCAGAACAGCATTGAAGAG 
CTSK F; CTACATGACCAATGCCTTCC 372 56.8 XM_019837802 
R; TTTCCCCAGTTTTCTCCCC 
DCSTAMP F; AAATGACACCAAAGGCCAAG 384 57.2 XM_023248441 
R; TCTATGGCTGCAAACAGCAC 





which might be primer-dimer formation.  
 
Figure 4.2 Result of PCR to test the primer sets. Teeth expressed mRNA of all cytokines, 
RANKL, VDR and the four reference genes. Note that IFNG produce a strong extra band which 
was presumed to be due to primer-dimer formation. Both amplicons of IL6 and TNF amplicon 
represent relatively weak bands when compared to other genes. NTC; no template control. 
 
The melt curve for each product by qPCR was generated following melt 
curve analysis and each curve is shown in Figure 4.3. A single peak on the melt 
curve implies that the PCR produced a single specific amplicon. Each curve 
represented a single sharp peak, except for IL1B which showed a wide and blunt 
peak. To check availability of primer, efficiency of each primer was tested and each 
value is shown in Table 4.4. The efficiencies of primers including IL6, P2X7R, 
RANKL, VDR and all reference genes ranged between 90 to 110%. The efficiencies of 
IL1B and IFNG were higher than 110% and that of TNF was just below 90%.  
Table 4.4 Primer efficiency for each primer set. Efficiencies > 110% and < 90% are shown in 
bold. 
Primer set Efficiency Primer set Efficiency Primer set Efficiency 
IL6 97.6% IL1B  122.7% P2X7R 109%  
TNF 89% IFNG 124% RANKL 95.5% 
VDR 107.8 % GAPDH 93.4% HPRT 102.0% 




    
Figure 4.3 Melt curves from qPCR of various genes. Each amplicon reveals a single peak 
except IL1B following melt curve analysis. 
 
To investigate the possible involvement of inflammatory mediators and 
vitamin D in osteoclastogenesis, qPCR was performed and data were analysed from 
all RNA samples. Samples were first divided into TR –ve and TR +ve teeth. The 
relative expression was normalised to geometric mean of the four reference genes. 
There were no significant differences in inflammatory cytokine expression including 
IL6, IL1B, P2X7R and TNF between TR –ve and TR +ve teeth. Likewise, there were 
no detectable differences between the samples in their expression of the anti-
inflammatory cytokine INFG, VDR, or RANKL (p > 0.05) (Figure 4.4).  
To investigate inflammatory changes during the progression of TR, samples 
were divided into subgroups, TR-ve from TR –ve cats, early stage TR, and advanced 
TR stage. The data were re-analysed (Figure 4.5). Only IL6 expression showed 









statistically difference between TR –ve and early stage TR (p = 0.043) but no 
difference in expression levels were seen between TR –ve and advanced stage or 
between early and advanced stage of TR. 
4.4.3 Development of an in vitro model of feline 
osteoclastogenesis 
Isolated cells from peripheral blood or bone marrow samples including 
enriched osteoclast precursors were seeded at the same density (5x105/24 well plate). 
In the early stages of in vitro osteoclast differentiation cells were mononuclear and 
non-adherent on the culture vessels (Figure 4.6, A and D). In the presence of mouse 
recombinant CSF-1 and RANKL, mononuclear osteoclasts started to fuse and 
formed multinucleated cells. Maximum generation of osteoclasts from PBMCs 
occurred on day 11 (Figure 4.6, B) while bone marrow derived osteoclasts usually 
formed within 9 days (Figure 4.6, E). Multinucleated cells from both sources were 
TRAP positive (Figure 4.6, C and F). When osteoclast precursors were cultured only 
CSF-1 without RANKL, there were only few multinucleated cells generated (Data 
not shown). 
To optimise culture conditions for feline osteoclast generation in vitro 
cytokines derived from human or mouse were compared. The optimal amount of 
RANKL for osteoclast formation was 30 ng/ml and 3 ng/ml for human and mouse 
cytokines respectively while mouse recombinant CSF-1 was used at the same 
concentration (10 ng/ml) (Figure 4.7, A and B). Similar numbers of osteoclasts were 
generated in the given condition (Figure 4.7, C). RAW 264.7 cells were tested for 
usage as an immortalised osteoclast precursor line. Treatment with mouse RANKL 
at 30 ng/ml resulted in multinucleated TRAP positive osteoclasts in a limited 





























































































































Figure 4.4 Relative expression of inflammatory cytokines, VDR and RANKL between TR –ve 
and TR +ve teeth. Each gene of interest was normalised to four reference genes. None of 
the genes showed any statistical differences in expression by the two sample t-test (P > 
0.05). Graphs represent relative expression as fold changes with SEM bars (n= 11 for TR –ve 










































































































































Figure 4.5 Relative expression of inflammatory cytokines, VDR and RANKL among 
subgroups: TR –ve, early stage TR +ve, and advanced stage TR +ve. Each gene of interest 
was normalised to four reference genes. Only early stage TR +ve showed significantly higher 
expression of IL6 when compared to TR-ve teeth (* p < 0.05) by two sample t-test. There 
were no statistically significant differences found for any of the other genes (p > 0.05) by 
one-way Anova for three comparisons or two sample t-test for two comparisons. Graphs 
represent relative expression as fold changes with SEM bars (n = 3 for TR -ve, n = 8 for early 









































































































































































































































































































































































































































































































osteoclasts were generated inconsistently, and when passaged cells failed to 
differentiate into osteoclasts.  
This in vitro osteoclast generation protocol was also applied to canine and 
murine osteoclast precursors using bone marrow derived precursors (Figure 4.8). In 
vitro canine (Figure 4.8, B) and murine osteoclast (Figure 4.8, C) required higher 
RANKL concentrations (mouse recombinant RANKL 5-10 ng/ml) compared to 
feline osteoclast (mouse recombinant RANKL 3 ng/ml) (Figure 4.8, A) while 
maintaining the same concentration of mouse recombinant CSF-1 (10 ng/ml) to 
efficiently generate osteoclasts. The size of feline osteoclasts were relatively larger 
and contained more nuclei than osteoclasts from other species (mouse and dog).   
Feline osteoclasts were successfully differentiated using mouse recombinant 
CSF-1 and RANKL at a lower concentration than with the equivalent human 
cytokines. , I therefore decided to use mouse recombinant CSF-1 and RANKL 
throughout this study. Unless otherwise specified CSF-1 or RANKL refers to mouse 
recombinant CSF-1 or RANKL throughout this study. The optimal concentrations of 
CSF-1 and RANKL for in vitro feline osteoclast were 10 ng/ml and 3 ng/ml, 





Figure 4.7 Optimisation of in vitro feline osteoclast differentiation and RAW 264.7 mediated 
osteoclastogenesis. (A) Osteoclast formation using human recombinant RANKL at 30 ng/ml, 
(B) Osteoclast formation using mouse recombinant RANKL at 3 ng/ml. (C) When the 
optimum RANKL concentrations was used for human and mouse cytokines, similar number 
of osteoclasts were generated. (D) A population of RAW 264.7 cells were able to 
differentiate into TRAP positive osteoclasts using high mouse RANKL concentration (30 
ng/ml). Data represent mean + SEM bars. Scale bars = 100 µm. 


































Feline bone marrow derived osteoclasts 
B. Mouse RANKL 3 ng/mL  
Control no RANKL   Mouse RANKL 30 ng/mL 
D. RANKL mediated osteoclast formation from RAW 264.7 cells  
C. Number of TRAP positive osteoclast cells 









































































































































































































































































































































































































































































































































4.4.4 Feline osteoclast characteristics in vitro  
To further characterise the cultured osteoclasts, a number of criteria were 
tested: formation of an actin ring, and demonstration of expression of the 
vitronectin and calcitonin receptors, cathepsin K, c-Src and MMP9 by 
immunocytochemistry (Figure 4.9, A). PCR was able to confirm expression of 
osteoclast specific genes ACP5, CTSK, ATP6V0D2 and DCSTAMP whose expression 
was not seen in the bone marrow mononuclear cells (Figure 4.9, B). For functional 
assessment of resorption activity of cultured osteoclasts, the cells were cultured on 
mineralised substrates using dentine discs or mineralised coated (hydroxyapatite) 
plates. Resorbed areas can be visualised clearly by light microscopy following 
toluidine blue staining (Figure 4.9, C). On mineralised plates the morphology of the 
osteoclasts were similar to that of osteoclast grown on plastic. The resorbed areas 
were identified as paler spots after a modified von Kossa procedure which stain 





Figure 4.9  In vitro feline osteoclast like cells revealed typical characteristics of osteoclasts. 
(A) Immunocytochemistry reveals that cultured feline osteoclasts possess osteoclast 
characteristics such as formation of an actin ring, expression of vitronectin receptor, 
calcitonin receptor, cathepsin K, c-Src and MMP9. Small upper Insert images show 
corresponding negative isotope controls. (B) Expression of osteoclast specific genes ACP5, 
CTSK, ATP6V0D2 and DCSTAMP by PCR. Note that no expression of these genes in bone 
marrow mononuclear cells. (C) Resorption activity of cultured osteoclasts on a dentine disc 
shows resorption pit formation (black arrows) (D) Resorption activity of cultured osteoclasts 
on a mineralised substrate (hydroxyapatite plate) show resorption (white arrows). See text 




4.4.5 Effect of 1,25(OH)2D3 on feline osteoclastogenesis 
As reported in section 4.4.2, there was no difference in VDR mRNA 
expression between TR –ve and TR +ve teeth. To further investigate any effect of 
1,25(OH)2D3 on feline osteoclast formation I used an in vitro system in which 
osteoclasts were generated from bone marrow derived osteoclast precursors with 
addition of 1,25(OH)2D3 at various concentrations, ranging from physiological level 
(0.1 nM) to high dose (10 nM), to the osteoclast formation medium. Data of number 
of osteoclasts formed, resorption pits and resorption area were presented as 
percentage compared to control. The number of osteoclasts formed were similar in 
the presence of low concentration of 1,25(OH)2D3 (0.1 nM) and control cultures (the 
osteoclast formation medium, supplemented with ethanol as a vehicle). The number 
of osteoclasts were increased compared to vehicle control with the addition of 1 nM 
of 1,25(OH)2D3 treatment (115.0%, p<0.05) whereas osteoclast formation at higher 
doses of 1,25(OH)2D3 (5 and 10 nM) was decreased (78.1% and 53.0% respectively, 
p < 0.05) in a dose dependent manner (Figure 4.10, A). In parallel, osteoclast 
precursors were seeded on mineralised plates to compare the effect of 1,25(OH)2D3 
on resorption activity (Figure 4.10, B). Resorption areas were seen as paled areas 
following a modified von Kossa staining. Low 1,25(OH)2D3  doses (0.1 and 1 nM) 
produced an increased number of resorption pits compared to vehicle treated 
controls at 111% and 131% respectively but high doses (5 and 10 nM) led to a 
decreased number of resorption pits (56% and 32.8% respectively). A similar pattern 
was seen for resorption area; it increased at low 1,25(OH)2D3 doses (133% at 0.1 nM 
and 160.1% at 1 nM) and decreased dose dependently at concentrations of 5 and 






Feline osteoclast formation with 1,25(OH)2D3


























































Figure 4.10 Low dose of 1,25(OH)2D3 induced feline osteoclast formation and resorption but 
high dose of 1,25(OH)2D3 showed an inhibitory effect on feline osteoclast formation and 
resorption. (A) Feline osteoclasts formation in the presence of various 1,25(OH)2D3 
concentrations and quantified result was generated as as bar graph (B). The osteoclasts 
formed a similar level at 0.1 nM of 1,25(OH)2D3 compared to negative control (osteoclast 
formation medium, ethanol added as a vehicle) and it increased at 1 nM of 1,25(OH)2D3. 
However higher doses of 1,25(OH)2D3 (5 and 10 nM) inhibited osteoclast formation (P < 
0.05) by two sample t-test. (C) Representative images of 1,25(OH)2D3 effect on resorption 
activity of feline osteoclasts. Graphs of number of resorption pits (D) and resorption area 
(E) under the various 1,25(OH)2D3 treatment. Low 1,25(OH)2D3  showed increased resorption 
activity seen as increased resorption pits and area. High 1,25(OH)2D3 induced inhibition of 
resorption activity by resorption pits and area. Data were combined from 3 independent 
experiments with technical replicates (n = 3). Data represent mean ± SDs bars. Images from 
(A) and (B) are shown as representative pictures. See the text for further details. Medium 
only: medium without CSF-1 and RANKL, Vehicle: osteoclast formation medium, ethanol 
added at the same concentration as diluted 1,25(OH)2D3. 
 
Feline osteoclast resorption pits with 1,25(OH)2D3





























Feline osteoclast resorption area with 1,25(OH)2D3
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4.4.6  The role of periodontal ligament cells in 
osteoclastogenesis 
Periodontal ligament cells were isolated at post mortem from the teeth of a 
cat with no TR lesions. Periodontal ligament cells were grown on plastic and their 
morphology revealed fibroblast-like cells with elongated shapes that attached to the 
culture plastic vessel. The cells expressed vimentin (a mesenchymal marker) and 
RANKL (to support osteoclast generation) by immunocytochemistry and PCR 
(Figure 4.11, A). Periodontal ligament cells were co-cultured with bone marrow 
osteoclast precursors and CSF-1 but without the addition of RANKL. This led to the 
in vitro generation of osteoclasts which were TRAP positive, multinucleated, 
exhibited actin staining, as well as expressed cathepsin K and vitronectin receptor 
(Figure 4.11, B). Lastly, they were capable of hydroxyapatite resorption on a 
mineralised substrate. The resorption area was seen on mineralised plate after 
removal of osteoclasts as a pale spot (Figure 4.11, C).  
      After confirmation of the presence of typical osteoclast characteristics for 
the cells generated in the co-culturing system, I compared osteoclast generation 
ability between osteoclast precursors from TR –ve and TR +ve cats using the same 
co-culture system (Figure 4.12, A). The number of TRAP positive multinucleated 
osteoclasts were higher in those derived from osteoclast precursors from TR + cats 
in the co-culturing system, under the osteoclast formation medium containing 
RANKL (Figure 4.12, B left graph). When osteoclast numbers were normalised to 
RANKL treated control TR +ve or TR -ve cells, the number of osteoclasts formed 
remained higher in the wells with osteoclast precursors derived from TR +ve cats 
than from TR –ve cat under the RANKL deprived co-culture condition (Figure 4.12, 
B, right graph). I then used this co-culturing system to test the effect of 1,25(OH)2D3 
on osteoclast generation in both population of cells; osteoclast precursors from TR + 
and periodontal ligament cells. 1,25(OH)2D3 treatment using a high dose (10 nM) 
resulted in reduced osteoclast formation in the presence of periodontal ligament 






Figure 4.11 Functional feline osteoclasts were generated under the co-culture system of 
osteoclasts precursors and periodontal ligament without RANKL treatment. (A) Isolated 
fibroblast-like periodontal ligament cells expressed vimentin (a mesenchymal marker) and 
RANKL. (B) Co-culturing system of periodontal ligament cells and bone marrow osteoclast 
precursors successfully produced osteoclasts in CSF-1 (10 ng/ml) supplemented medium 
without RANKL. Cultured osteoclasts disclosed an osteoclast specific phenotype including 
TRAP positivity, multiple nuclei, as well as expression of CTSK and vitronectin receptor. 
Finally, they also revealed resorption activity seen as paled areas (arrows) on a mineralised 
plate. Scale bars = 100 µm.  
A. PDL 
  PCR RANKL RANKL 
B. Co-culture of OCPs and PDL (CSF-1 +, RANKL -)  
Actin red  TRAP activity Phase contrast 
Cathepsin K Vitronectin receptor Resorption activity 






Figure 4.12 More osteoclasts were generated derived from TR +ve cats compared to TR –ve 
cat in the co-culturing system. (A) Co-culturing of periodontal ligament and osteoclast 
precursors from TR -ve or TR +ve cats. i. Osteoclast precursors from TR -ve were cultured 
with periodontal ligament cells in osteoclast formation medium (control). ii. Osteoclast 
precursors from TR -ve were cultured with periodontal ligament cells in medium 
supplemented CSF-1 only (10 ng/ml) without RANKL. iii. Osteoclast precursors from TR +ve 
were cultured with periodontal ligament cells in osteoclast formation medium as a control. 
iv. Osteoclast precursors from TR +ve were cultured with periodontal ligament cells in 
medium supplemented CSF-1 only (10 ng/ml) without RANKL. (B) Each treatment of A was 









































































A.  i.  Control from TR – 
(CSF-1 +, RANKL +) ng/ml) 
ii.  OCPs from TR - with PDL  
(CSF-1 +, RANKL -)     
iv.  OCPs from TR + with PDL  
(CSF-1 +, RANKL -)    
iii.  Control from TR +  





Number of TRAP positive osteoclasts were higher in those derived from osteoclast 
precursors from TR +ve cats compared to from TR -ve cats under the presence of RANKL (B, 
left). When number of osteoclasts were normalised to control (RANKL treatment), 
osteoclast precursors from TR +ve cats produced more TRAP positive osteoclasts in co-
culturing system without RANKL (B, lower graph). Data were combined from 3 independent 
experiments TR -ve or +ve cats (n = 3) with technical replicates (n = 3). Data represent mean 
with SEM bars ***; p < 0.001 by two sample t-test. Scale bars = 100 µm.   
 
Figure 4.13 High dose of 1,25(OH)2D3 revealed inhibitory effect on osteoclastogenesis in co-
culture system. (A) shows the representative photos of on osteoclast formation in the 
presence of 1,25(OH)2D3 in co-culture system osteoclast formation are shown in vehicle 
(upper left), co-culture without 1,25(OH)2D3 (upper right) and with 1,25(OH)2D3 (lower left). 
Graph (B) shows osteoclast formation in co-culture with periodontal ligament cells 
with/without 1,25(OH)2D3. High dose 1,25(OH)2D3 treatment (10 nM) reduced osteoclast 
formation on dentine discs under the presence of periodontal ligament cells compared to 
control (no 1,25(OH)2D3 added). Data were combined from cells of 3 different TR +ve cats (n 
= 3) with technical replicates (n = 3). Data represent mean ± SEM bars *** p < 0.001 by two 
sample t-test. Vehicle: osteoclast formation medium, ethanol added as a vehicle. VitD: 
1,25(OH)2D3, OCPs: osteoclast precursors, PDL: periodontal ligament, RL: RANKL.             
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Both inflammation and vitamin D have been suggested as possible 
contributors to the development of tooth resorption in cats, however it has not been 
conclusively shown. The aim of the experiments shown in this chapter was to 
investigate the potential role of inflammation and vitamin D in tooth resorption.  
The prevalence of TR (87.5%) found in this study is higher than the reported 
prevalence (29 - 58%, average 43%) (102-105) although the population size of this 
present study is small (n = 24). The study population did have a higher mean cat age 
(8.5 years) than other studies (3.6 – 6.5 years) (102, 103, 105). Bias of small sample 
size and aged population may contribute to high prevalence. It has been reported in 
many studies that the incidence of TR increased with age and therefore TR could be 
considered as an age related condition. (103, 108, 114). In this study more than half 
of the samples were in the early stages (stage 1 and 2). Stage 1 is hardly detected by 
radiography and both stage 1 and stage 2 are not usually associated with any 
clinical signs (97, 106, 114). This implies that early stages of TR without clinical signs 
are possibly underdiagnosed in practice. Since feline TR has a progressive nature 
early lesions will develop to advanced stages (9), so this result would support 
performing survey radiographs of clinically normal teeth in animals that are in for 
dental treatments. Another finding is that the major type of TR in this study 
comprises Type 2 (81.7%) and the remainder is Type 1 or Type 3 (18.3 %). This 
contrasts with other published studies on much larger populations of cats (ref). One 
study of 543 cats showed that Type 1 (49.4%) and Type 2 (50.6%) had similar 
prevalence while another study reported a slightly higher percentage of type 2 
(60%) than type 1 (40%) in 109 cats (99, 102). In Type 1 TR, the root of the tooth is not 
yet affected so it possess a normal radiographic appearance of roots and periodontal 
ligament space. In Type 2 TR, roots are attacked so present on radiographs lacking a 




Although each study shows variable compositions of types in feline TR, authors 
agree that Type 1 TR are found more frequently with periodontitis and Type 2 TR 
are not. Therefore, Type 2 TR sometimes is considered as idiopathic TR rather than 
inflammatory. As our study population contained mainly Type 2 TR it is possible it 
may have caused a bias towards the idiopathic type of TR. 
This chapter investigated the local expression of inflammatory cytokines 
IL1B, IL6, P2X7R, TNF and IFNG, as well as RANKL. Conventional PCR and melt 
curve by post analysis of qPCR revealed expression of all genes of interest in feline 
teeth, but there were no difference in expression detected for any inflammatory 
cytokines, and RANKL between TR –ve and TR +ve teeth. When sub-group 
comparisons were performed, only early TR showed higher IL-6 expression than TR 
–ve teeth but it did not when compared to advanced TR +ve teeth. This result 
implies that there is no major inflammatory process involved in TR +ve teeth when 
compared to TR –ve teeth, but IL-6 could potentially be re-considered to contribute 
to initiate TR. In terms of inflammatory cytokines, two studies have revealed higher 
expression of IL-1β and IL-6 and one study reported higher expression of IFN-γ and 
TNF-α in TR +ve teeth (100, 163). These results differ to what I found in my study.  
With regards to RANKL however, the results were consistent with what has 
been reported in the literature, with RANKL expression not increasing in TR +ve 
teeth when compared to unaffected control (100, 163). There could be a couple of 
reasons for this; one reason for no observed difference in RANKL expression 
between  groups is possibly that the lifespan of osteoclasts (about 2 weeks) and the 
process of differentiation of osteoclasts is relatively short so that it is hard to capture 
the moment of osteoclast formation (253). This is supported by a histological study 
where authors mentioned the difficulty of identifying odontoclasts and osteoclasts 
in sections of TR affected teeth due to the relatively quick process of osteoclast 
formation and activation (9). Another point is that samples used for qPCR comprise 
Type 2 as the major type. Type 2 is characterised by a narrowing or disappearance 
of the periodontal ligament and replacement resorption whose features might be 




explanation is the technical limitations of this study. Most primers were based on 
sequences from published papers in order to allow for a comparison of results. 
However, the efficiency of several primers was beyond the recommended range (90-
110%) (254). The IL-1β primer in the published paper was found to be against IL-1α 
rather than IL-1β. When new primers were designed their primer efficiency was not 
optimal. This is one of the major concerns reported when using intercalating dye 
(e.g. SYBR™ green), because intercalating dyes bind to any double-stranded DNA 
product and suboptimal primer efficiency can be due to non-specific sequence 
binding of dye (i.e. primer-dimer formation). Data can be reanalysed using a data 
analysis model which takes efficiency into account for the calculations suggested by 
Hellemans et al. (255, 256). Another way to overcome this technical limitation is the 
use of probe-based assays. The hydrolysis probe based assay has additional 
specificity from the probe amplicon specific primers which is a third sequence that 
has to bind within the amplicon of the target sequence in order to generate a 
fluorescent signal (251, 257). In future studies it would be recommended to use 
hydrolysis probes to confirm these results.    
Another aim of this study was to set up an in vitro feline osteoclast model 
applicable for studying feline osteoclast biology. There are successful methods 
available for osteoclast formation in a range of animals. However, efficiency of 
osteoclast formation largely relies on components of growth medium (e.g. CSF-1, 
RANKL and serum as a major source of nutrient) (229, 258). Therefore each 
laboratory needs to develop an optimised culture system on their own. I modified 
previously developed osteoclast culture protocols (227-229). Here I used peripheral 
blood and bone marrow as a source of osteoclast precursors. Obtaining sufficient 
blood from cats for osteoclast culture was for ethical reasons not possible in our set 
up. The monocytes, the source of osteoclast precursors in peripheral blood occupy 
less than 10% of the white blood cells in the buffy coat layer. Hence the total volume 
required to gain sufficient monocytes was not ethically viable to withdraw as 
residual blood from the cats coming through the clinic. For this reason, sufficient 




when taken at post mortem and the drug used for euthanasia (e.g. pentobarbital) 
might affect circulating monocytes. A previous study showed pentobarbital 
modulated several inflammatory cytokines including IL-1, IL-6 and monocyte 
chemotactic protein-1 (MCP-1) (259). Blood derived osteoclast formation was less 
efficient and non-accessible compared with bone marrow. On the other hand, bone 
marrow from long bones possessed enriched haematopoietic cells and in vitro 
generation of osteoclasts was robust, quick and efficient. The number of osteoclasts 
differentiated in this model system was similar to that reported in other studies 
(167, 245). The high efficiency of osteoclast formation from bone marrow derived 
osteoclast precursors might be a consequence of high numbers of haematopoietic 
stem cells which upon addition of CSF-1 osteoclast cell linage commitment is 
stimulated. However, morphologically TRAP positive multinuclear cells are easily 
detected and this gold standard indication of osteoclasts was efficient to distinguish 
the osteoclasts from other stromal cells (227, 229, 260). In terms of osteoclast 
formation in cats, feline osteoclasts effectively were differentiated from precursors 
with low amount of RANKL addition (3 ng/ml) compared to murine or canine 
osteoclasts (10 ng/ml). The relative size of osteoclasts with more number of nuclei in 
cats were larger than other osteoclasts derived from other species (mouse and dog). 
This was also documented in other feline osteoclast study which demonstrated that 
feline osteoclasts appeared earlier in vitro feline osteoclast formation with greater 
numbers of nuclei than in human osteoclasts cultures (228).  
I also tested RAW 264.7 the mouse macrophage cell line as it is a widely used 
cell line (226). However, it required high concentrations of RANKL and osteoclast 
differentiation was not consistent, and the cell line lost its osteoclast differentiation 
ability when passaged. The RAW cell line is highly heterogenetic so only a certain 
population of cells was able to differentiate into osteoclasts. This heterogeneity and 
the problem with the higher passages (18–20 passages) were mentioned in other 
studies (226, 261). It is also considered that bone marrow derived osteoclasts and 
RAW cell derived osteoclast are different as the RAW cells can produce CSF-1 




of precursors during osteoclast differentiation. The RAW cells may differ in terms of 
osteoclast biology for example their resorption activity, survival and apoptosis 
(226).  
I tested the characteristics of the cultured feline osteoclasts to demonstrate 
they had genuine osteoclastic features. The cultured feline osteoclasts expressed a 
range of osteoclast markers, consistent with markers reported in other studies (227, 
228, 245). This provides strong support that my cultured osteoclasts were authentic 
osteoclasts similar to findings in other studies (228, 262, 263). For resorption activity, 
I used dentine discs and mineralised plates. Dentine discs are similar to bone as it 
consists collagen and hydroxyapatite whereas mineralised plate was made up with 
hydroxyapatite with no collagen present. Dentine discs or bone slices are the gold 
standards for testing resorption activity however, due to the limited accessibility of 
these animal derived sources alternative methods have been used (264-266). One 
benefit to using mineral coated plates is easy handling and early non-adherent 
osteoclast precursors are distributed equally. Dentine discs need to be transferred 
from smaller into larger plastic vessels and a decent number of osteoclast precursors 
can be lost during this step.  
A previous study found an increased expression of VDR mRNA in TR +ve 
teeth. This suggested, that 1,25(OH)2D might play a role in pathological tooth 
resorption in cats since 1,25(OH)2D induces RANKL mediated osteoclast activation 
and it acts through VDR (100, 122). They also reported that increased VDR was 
correlated with increased mRNA expression of inflammatory cytokines (IL-6 and IL-
1β) (100). However, the results did not reflect increased odontoclast activity because 
RANKL or OPG expression did not change (100). To investigate the role of VDR in 
feline TR, I also performed conventional PCR and qPCR and showed that feline 
teeth from TR -ve or TR +ve expressed VDR mRNA. The VDR expression in teeth 
was consistent with the previous studies. This might support the concept that teeth 
can use 1,25(OH)2D directly in a paracrine manner whereas the local level of 
1,25(OH)2D might affect odontoclast activity (186, 194, 267). However, mRNA 




this study. To confirm this, further studies using a larger number of samples may be 
required. To further investigate the effect of vitamin D on feline osteoclasts, active 
vitamin D, 1,25(OH)2D3 was used at concentrations ranging from physiological 
serum levels up to 100 times that level since 1,25(OH)2D3 is known to act as a direct 
stimulator of osteoclasts in vitro (100). When doses just above a physiological level 
of 1,25(OH)2D3 (1nM) was used, stimulation of osteoclast formation was observed 
but at high doses of 1,25(OH)2D3  a decrease in osteoclast formation was observed. 
When testing their resorption activity, both number of resorption pits and 
resorption area showed the same trend i.e. low doses induced an increase in 
resorption activity and high doses decreased the resorption activity of the 
osteoclasts. 1,25(OH)2D3  is known as a stimulator of osteoclastic bone resorption 
(160, 194). This is thought to occur via direct stimulation of osteoblasts/stromal cells 
to increase their RANKL production leading to osteoclast formation rather than 
through osteoclasts themselves in vitro. However, in vivo vitamin D has a dual 
activity of bone formation and resorption, hence its role in the body is complex (170, 
185). It has been shown that osteoclasts are capable of metabolising 1,25(OH)2D and 
25(OH)2D as they showed mRNA expression of  VDR and anabolic/metabolic 
enzymes (122, 186, 267). However molecular mechanisms involved in this process 
are still uncertain.   
Periodontal ligament cells were isolated from a TR -ve cat at post mortem. 
The primary periodontal ligament cells were cultured and maintained in limited 
passages (no more than four passages). The periodontal ligament cells expressed 
RANKL by immunocytochemistry and PCR, which indicates periodontal ligament 
cells may be capable of inducing osteoclast formation. Co-culturing of periodontal 
ligament cells and osteoclast precursors in a long term culture (2-3 weeks) 
supported this concept. Osteoclast progenitors were capable of differentiating into 
osteoclasts under the presence of periodontal ligament cells without the addition of 
RANKL. The osteoclastogenesis occurred both when the cells were directly and 
indirectly co-cultured. Direct co-culturing requires a direct contact of two 




indirect co-culturing it is not necessary for the cells to be in physical contact. It has 
been shown that dental cells, and especially periodontal ligament cells, increase 
their RANKL expression as a response to a mechanical load (e.g. orthodontic 
treatment) and induce alveolar bone resorption for effective tooth movement (142, 
196, 268). RANKL exists in two forms; soluble RANKL and as a transmembrane 
protein (269). As transmembrane RANKL is more powerful than the soluble form of 
RANKL for osteoclastogenesis, direct contact between osteoblasts and osteoclast 
progenitors was considered a necessity for osteoclast formation (269-271). However, 
here feline osteoclast formation occurred when indirect culture of the two cell 
populations were performed which implies soluble RANKL efficiently lead to 
osteoclast formation. RANKL protein was not detected by western blot (data not 
shown) I tried two commercially available antibodies however, none of them were 
capable for detecting feline RANKL at the predicted molecular size of the protein.  
Interestingly, osteoclast precursors from TR +ve cats yielded higher numbers of 
osteoclasts under co-culture conditions compared to TR -ve cats. These data suggest 
that TR +ve osteoclast precursors were more responsive to RANKL expressed by 
periodontal ligament cells. If this is the case, it may explain why some cats are prone 
to attack by odontoclasts and get tooth resorption. Co-culturing of periodontal 
ligament and osteoclast precursors was used to test the effects of 1,25(OH)2D3 in this 
system. High dose of 1,25(OH)2D3 inhibited periodontal ligament cells induced 
osteoclast formation. However, the RANKL or OPG expression of periodontal 
ligament cells was not investigated and therefore it is noit possible without further 
study to explain how this inhibitory effect of 1,25(OH)2D3 on osteoclast work. In 
future studies, the effects of various concentrations of 1,25(OH)2D3  on in vitro 
osteoclast formation and osteoclast related gene expression e.g.  
RANK/RANKL/OPG are required.  
In this chapter, differentially expressed genes between TR –ve and TR +ve 
teeth were investigated for inflammatory cytokines and VDR. The genes 
investigated were selected based on previously reported links to TR. This approach 




the following chapter, I will examine RNA-seq data between TR –ve and TR +ve 
teeth so as to identify all transcriptomic changes which might reflect odontoclast 









Chapter 5 Identification of feline tooth 
transcriptomic changes in TR 
5.1 Abstract 
Gross and histological features of tooth resorption lesions in cats are well 
described. However, few studies have explored the cellular and molecular aspects 
of TR. There is no transcriptome analysis of feline teeth to the best of the author’s 
knowledge. The aim of this chapter was to investigate transcriptome changes using 
RNA sequencing (RNA-seq) and identify candidate genes which might be 
responsible for the development of TR. Fourteen cDNA libraries from seven TR -ve 
and seven TR +ve teeth from eleven cats were generated and sequenced. Data were 
analysed under three comparisons: TR cat (TR -ve vs.TR +ve cats)1, TR tooth (TR -ve 
vs. TR +ve teeth)2, and paired TR (TR -ve vs. TR +ve teeth from the same cat)3. Of 
these the paired comparison proved the most powerful comparison and revealed 
1,732 significantly differentially expressed genes (up-regulated genes; n = 1,286, 
down-regulated genes; n = 446). Pathway analysis revealed up-regulated genes that 
are involved in osteoclast differentiation and calcium signalling. Gene ontology 
enrichment analysis as a reflection of over represented set of genes presented many 
gene sets involved in muscle physiology including actin binding, myofibril, actin 
cytoskeleton, muscle contraction, heart contraction, muscle fibre development, 
skeletal muscle cell differentiation and muscle organ morphogenesis which are also 
abundantly expressed in developing teeth and bone. These features of the 
transcriptome might suggest that TR +ve teeth undergo reparative or remodelling 
processes mediated by dental, periodontal ligament, or alveolar bone cells in 
response to resorption and similar to tooth development, bone remodelling and 
repair.   
                                                   
1 ‘TR -ve cats’ means teeth collected from a cat without any TR lesion and ‘TR +ve cats’ means teeth 
collected from a cat with at least one TR lesion.    
2 ‘TR tooth’ compares TR status of individual teeth. TR -ve teeth can be collected from TR free cats or 
TR diagnosed cats. TR +ve teeth are collected from TR +ve cats  




A list of candidate genes for further investigation were chosen due to their 
involvement in osteoclast differentiation, a crucial step in tooth resorption and 
development.  These included SPI1, CTSK, ACP5, MMP9, RANKL, OPG and P2XR 
genes. These genes were highly expressed in TR +ve teeth and the RNA-seq data 
were validated by quantitative PCR. Although RANKL expression was not different, 
OPG was highly expressed in TR -ve teeth, which resulted in a relative increase in 
the RANKL/OPG ratio in TR +ve teeth. Of these, MMP9 was regarded as one of 
target genes related to feline TR since it showed consistent up-regulation with a 
high fold change in TR +ve teeth by qPCR and RNA-seq. Many SNPs in candidate 
genes were identified by RNA-seq data and some missense variations were also 
detected by Sanger sequencing. The functional effect of these SNPs requires further 
investigation.    
5.2 Introduction  
It has been well documented that pathogenesis of feline TR is caused by 
dysregulation of odontoclasts (92, 98, 113). However, the cellular and molecular 
changes present in TR are still unknown as previous studies have been limited to 
the investigation of predetermined factors including inflammatory cytokines, 
hormones, or specific markers in blood. All these studies relied on the use of 
primers or antibodies suitable for feline genes and protein targets respectively (100, 
163, 176). Although qPCR is the most effective way to quantify each transcript 
among samples, the overall set of transcripts defined as the transcriptome cannot be 
accomplished by qPCR approaches. The development of high-throughput next 
generation sequencing methods (e.g. RNA-seq) have overcome these technical 
limitations and are capable of mapping and quantifying transcriptomes (208). RNA-
seq has gained popularity in the last decade and is now widely used in in vitro 
experiments investigating developmental or disease status in many species (211, 
272). However, no transcriptome analysis of feline teeth has been previously 
reported. The aim of this chapter was to perform RNA-seq in feline teeth and 




As Chapter 3 demonstrated, a RNA isolation protocol for use on feline teeth 
was optimised to produce a high yield of good quality RNA suitable for RNAs-seq. 
Chapter 4 showed that previously reported genes of interest including 
inflammatory cytokines and VDR did not show differences in expression between 
TR -ve and TR +ve teeth in contrast to findings in previous studies (100, 163). Since 
RNA-seq is a highly technical and sensitive tool, preparation of cDNA libraries, 
sequencing and initial data analysis, including differentially expressed genes were 
performed by Edinburgh Genomics. Data analysis of RNA-seq requires professional 
computational skills (bioinformatics) so the RNA-seq data analysis including gene 
sets and pathways analysis was supported by bioinformatician Dr Stephen Bush. 
Since computer programing and developing pipelines for a specific analysis are 
beyond the scope of my study, I did not write and run software programs by 
myself. However during data analysis, I was involved at every step of output data 
and guided how to use the data. My role in this chapter was to design the study, 
collect samples, identify problems or errors, decide how to use RNA-seq data and 
summarise the data so as to maximise the meaningful output from the generated 
RNA-seq data.   
In this chapter the transcriptomic analysis revealed important information 
about tooth resorption pathogenesis, and helped to develop a list of candidate genes 
that are potentially involved in osteoclast biology. These candidates could be 
potential targets for treatment of odontoclast dysregulation. 
5.3 Materials and methods 
5.3.1 Selection of samples and RNA-seq 
RNA isolation and RNA-seq methods were detailed in section 2.2.2. 




















- N/A N/A No TR lesion 4.5 10.3 4 F 
N28C15TR- 307, 407 - N/A N/A No TR lesion 7.3 9.0 9 FN 
N29C25TR- 307, 407 - N/A N/A No TR lesion 6.7 8.0 10 FN 
N19C21TR- 308 - N/A N/A TR - tooth 5.3 8.2 16 FN 
N21C27TR- 407 - N/A N/A Paired TR - 
tooth 
4.1 8.4 7 FN 
N23C30TR- 309 - N/A N/A Paired TR - 
tooth 
4.4 9.0 10 FN 
N25C32TR- 308 - N/A N/A Paired TR - 
tooth 
4.9 8.7 9 FN 
N08C8TR+ 307, 407 + 2 2 TR + tooth 
from TR +cat 
5.2 5.8 > 5 F 
N30C16TR+ 308 + 2 2 TR + tooth 
from TR +cat 
4.7 9.1 5 FN 
N27C23TR+ 108 + 3 4 TR + tooth 
from TR +cat 
7.3 0.8 6 FN 
N32C29TR+ 108 + 3 4 TR + tooth 
from TR +cat 
7 9.7 7 FN 
N22C27TR+ 404 + 2 2 Paired TR + 
tooth 
5.9 7.4 7 FN 
N24C30TR+ 307 + 2 2 Paired TR + 
tooth 
5.2 9.0 10 FN 
N26C32TR+ 407 + 3 4 Paired TR + 
tooth 
6.3 8.5 9 FN 
Table 5.1 Phenotyping of TR and selection of samples for RNA sequencing. N/A: not 
applicable, F: female, FN: female neutered, RNA yield shows total yield.  
5.3.2 RNA-seq Data analysis 
Mapping to the feline reference genome, generation of a Table of read 
counts, and MDS plots were previously described in section in section 2.2.5. As 
discussed in Chapter 3, clustering of RNA samples by MDS plot was visualised to 
explore the overall expression profiles between samples. MDS plots can be used for 
analysis and quality control. When data are plotted in a default mode, leading fold-
change is set as the root-mean-square of the largest 500 log2-fold changes between 
samples (218, 273). Therefore, the distance between samples in a MDS plot means 
the leading log-fold change of genes that best distinguish each pair of samples. The 




samples, occupying the top left corner of the MDS plot (Figure 5.1, A). Therefore 
this sample was considered as an outlier. Figure 5.1, B shows the MDS plot with the 
outlier excluded. All samples distributed evenly. MDS of samples from TR -ve teeth 
which are labelled in black are located to the left of samples from TR +ve teeth 
(labelled in red) except the sample N08C8TR+. Even though the N08C8TR+ was re-
confirmed as TR +ve teeth, its transcriptome shows more similarity to the TR -ve 
group. Therefore two samples from the 14 RNA-seq samples were excluded from 
further analysis.  
 
Figure 5.1 Sample selection for data analysis. (A) MDS plots for RNA-seq data from all 14 
samples. Lined square indicates an outlier. Distance between samples indicates similarity. 
(B) MDS plots of RNA-seq data excluding the outlier (N27C23TR+). Dotted square, the 
sample N08C8TR+, shows similar data to TR -ve samples.  
From the remaining 12 samples, three comparisons were performed as 
displayed in Figure 5.2, (1) TR -ve cats (n=  3 from TR -ve cats) and TR +ve cats (n = 5 
from TR +ve cats)1, (2) TR -ve teeth (n = 7 from TR –ve teeth ) and TR +ve teeth (n = 5 
from TR +ve teeth)2, and (3) paired TR, TR -ve  (n =3 from TR –ve teeth) and TR +ve 
(n= 3 from TR +ve teeth)3. Differentially expressed genes, gene sets and pathways 
were identified as described in section 2.2.6 and 2.2.7, respectively.  
 




       
Figure 5.2 Data comparisons. Twelve RNA samples were divided into three comparisons.  
 
5.3.3 Validation of a RNA-seq result 
The list of differentially expressed genes were validated by qPCR. Primer 
sets were designed as described in section 2.1.4. Primers used in this Chapter are 
listed in Table 5.2. Primers for the reference genes, CTSK, and RANKL were 
previously shown in Table 4.1. Primer efficiency and specificity of PCR products 
were confirmed as described in section 4.3.4. Quantitative PCR was performed 
using SYBR™ Green based reagent, 2×Takyon for SYBR™ Assay - Low ROX 
(Eurogentec, Belgium) using Stratagene MX3000P qPCR system (Agilent 
Technologies) as described in section 2.1.6. The thermal cycling conditions are 
shown in Figure 5.3. 
5.3.4 Identification of SNPs  
SNPs were identified using the RNA-seq data as described in section 2.2.8. 
Sanger sequencing was used for a direct identification using TR +ve teeth samples 
as described in section 2.1.10.  
 
 
 Data comparisons  
 
Paired TR - 
vs TR+ 
TR - teeth 
vs TR + 
teeth 





Primer sets Sequence (5’ -3’) Amp 
(bp) 
Tm (°C) Reference  
SPI1 F; GAAACAGGCAGCAAAAAGAAG 125 53.9 XM_019812398 
R; TTGGACGAGAACTGGAAGG 




F; TGCCACTTCCCTTTCACCTTC 170 58 XM_003983412 
R; TTGCCTTCTCCATTGCCGTC 
P2X2R  F; GCTCCTCATCCTGCTCTACTTC 153 56.7 XM_023241231 
 R; TTCACGTACTCCTCCACGTC    
P2X4R  F; TCACCCCAGAGAAAGTTCC 93 54.5 XM_023241408 
R; CGCCCTACACACAAAACAC 
P2X6R F; ACTTCAGGACAGCCACTCAC 198 56.6 XM_023241697             
R; ACAACAGCAGCAGATCACAG 
PLCB4  F; CACTACTTCATCAGTTCTTCCC 144 53.1 XM_023251453 
R; GTCTTCACCTTTTCCATCCC 
CA6 F; CTGAAGGCTCTGAAACTGAC 180 54.2 XM_003989566 
R; GCTGATCTCTGAGGACTCAC 
CA4 F; CCAGACCCAAGATGAACACC  141 55.2 XM_003996604 
R; CAGTCCAGACAACCTTCTCC 
Table 5.2 Primers used in this chapter.  
 





5.4.1 Data comparisons of RNA-seq results 
The raw RNA-seq data were made publically available (European 
Nucleotide Archive, accession PRJEB24183, https://www.ebi.ac.uk/ena) as 
previously described in Chapter 3. MDS plots of each comparison, TR -/+ve cats, TR 
-/+ve teeth or paired TR are shown in Figure 5.4. In all three plots, the clustered 
TR - ve group is separate from the TR +ve group. Given that the distance between 
samples reflects similarity e.g. the closer they are the more similar they are, TR -ve 
and TR +ve samples from TR -/+ cats and TR -/+ teeth comparisons are closely 
plotted which implies their expression levels are similar (Figure 5.4, A and B). On 
the contrary, in the paired comparison, TR -ve samples are widely separated from 
TR +ve samples which indicates there are likely to be more significant expression 
differences between paired TR -/+ than other two comparisons (Figure 5.4, C).  
 
Figure 5.4 MDS plots showing RNA-seq data relationships between samples. (A) MDS plot of 
TR -/+ cats comparison, (B) MDS plot of TR -/+ teeth comparison, (C) paired TR-/+ comparison 
(within cat comparison). Lined circle: TR +ve samples, dotted circle: TR –ve (control teeth). 
See text for more details. 
A. TR -/+ cats B. TR -/+ teeth  




5.4.2 Differentially expressed genes from RNA-seq 
The raw count reads that map to each transcript sequence were generated 
for transcript quantification (Supporting information 1). The smear plot visualises 
the relationship between overall expression level measured in counts per million 
(CPM) on the x axis and log2 fold-change (FC) on the y axis where differentially 
expressed genes are displayed in red (Figure 5.5). As expected, the largest number 
of differentially expressed genes was seen in paired TR -/+ ve teeth (Figure 5.5, C). 
The total number of transcripts detected amongst teeth samples was 16,366, 16,745, 
16,307 in TR-/+ cats, TR -/+ teeth and paired TR -/+ teeth, respectively (Table 5.3Table 
5.3). Of these, the largest number of statistically differentially expressed genes was 
identified in paired TR group yielding a total of 1,732 genes comprising 1,286 up-
regulated genes and 466 down-regulated genes (Table 5.3).  
 
Figure 5.5 Visualisation of gene expression data by smearplots. (A) Plot of average gene 
expression and fold-change in TR -/+ cats. Horizontal blue lines indicate fold-change of two. 
Red dot indicates each differentially expressed gene at False Discovery Rate or corrected P-
value (FDR) of 0.05 or smaller. (B) Smearplot of TR -/+ teeth. (C) Smearplot of paired TR -/+ 
teeth. The largest number of differentially expressed genes labelled in red was found in 
paired TR -/+ teeth.  
A. Smearplot of TR -/+ cats B. Smearplot of TR -/+ teeth 
logFC logFC 
logFC 
C. Smearplot of paired TR -/+ teeth 






Set # total 
expressed 
genes 
# significantly DE 
genes 







TR- vs TR+ cats 16,366 315 279 36 
TR- vs TR+ teeth  16,745 44 41 3 
Paired TR- vs TR+ 16,307 1,732 1,286 446 
Table 5.3 Summary of differentially expressed genes from all comparisons. DE: differentially 
expressed. 
 
The significantly differentially expressed genes and fold changes are 
displayed graphically (Figure 5.5 and Figure 5.6) and details of differentially 
expressed genes are listed in Supporting information 2. Given that the genes 
labelled by the same colour represent a similar gene expression pattern e.g. a 
relative up-regulation (green) or down-regulation (red), biological samples (TR -ve 
samples or TR +ve samples) clustered together which implies each sample possess a 
similar transcriptome (Figure 5.6, A). There are much more up-regulated genes 
(1,286 genes) than down-regulated genes (446 genes). The heatmap in Figure 5.6, B 
shows the top 50 differentially expressed genes by descending order of FDR. Of 
1,732 differentially expressed genes, none of the inflammatory cytokines (e. g. IL1B, 
IL6, TNF, IFNG and P2X7R) or VDR were included, which was consistent with the 
result found in Chapter 4.   
Twenty seven differentially expressed genes were common for all three 
comparisons, and included 25 up-regulated genes and 2 down-regulated genes 
(Table 5.4). However, the majority of remaining genes were uncharacterised or were 
not reported to be involved in tooth or osteoclast biology. For further 
characterisation of the transcriptome in TR, 1,732 of the listed differentially 
expressed genes between paired TR groups (Supporting information 2) were 
utilised to identify pathways and gene sets.  
5.4.3 Pathway and gene ontology analysis of RNA-seq data 




comparison, KEGG pathway enrichment was performed using the R/Bioconductor 
package SPIA (Signalling Pathway Impact Analysis) (274). SPIA uses a list of 
differentially expressed genes and takes into account the fold changes of genes 
along with signalling pathways topology to identify pathways that are relevant to 
the condition under study. It showed that the transcription profile of TR +ve teeth 
was enriched for a total of 28 metabolic pathways (Supporting information 3). Of 
these, 25 pathways were involved in sets of up-regulated genes and three pathways 
were related to sets of down-regulated genes. The most interesting pathways were 
osteoclast differentiation (Supporting information 3, KEGG pathway 04380; p = 0.03) 
and calcium signalling (Supporting information 3, KEGG pathway 04020; p = 1.1x10-
4) which promote the differentiation of osteoclast precursors and induce osteoclastic 
tooth resorption in teeth. Relative expression of each gene in each pathway was 























































































































































































































































 Upregulated genes   
Gene  Description LogFC Gene  Description LogFC 
CA6 carbonic anhydrase 
VI  
10.45 MUCIN7 mucin 7, secreted 8.00 
ARX aristaless related 
homeobox  
6.70 CHGB chromogranin B  4.14 






















SLC9A2 solute carrier family 
9, subfamily A 
(NHE2, cation 
proton antiporter 
2), member 2  




domains 1  
2.24 FAM166B family with 
sequence similarity 
166 member B  
1.97 
LDHD lactate 
dehydrogenase D  
1.96 TLX1 T-cell leukaemia 














calcium ATPase 2   
1.48 CES2 carboxylesterase 2 1.21 
IVD isovaleryl-CoA 
dehydrogenase  
1.08 KIF19 kinesin family 
member 19  
1.05 
          Downregulated gene 
Gene  Description Log FC Gene  Description Log FC 
SOSTDC1 sclerostin domain 
containing 1  
-1.05 KLK5 kallikrein related 
peptidase 5  
-1.19 
Table 5.4 Common genes from all three comparisons. LogFC; log 2 fold change. Upregulated 






SPIA also discloses whether the differentially expressed genes themselves 
impact upon the function of that pathway. As many of the genes related to 
osteoclast differentiation were highly expressed in TR +ve teeth (Supporting 
information 3, total number of genes in osteoclast differentiation pathway = 93, 
number of up-regulated differentially expressed genes = 15, down-regulated 
differentially expressed genes = 3), it was hypothesised that osteoclast 
differentiation was activated. Osteoclast differentiation is controlled by the 
RANK/RANKL/OPG axis. RANKL is highly expressed but not significantly up-
regulated (Table 5.5, log2 fold change = 0.810) and RANK is significantly up-
regulated (Table 5.5, log2 fold change = 1.157) in TR +ve teeth. However, OPG is 
down-regulated (Table 5.5, log2 fold change = -1.326), which means the 
RANKL/OPG ratio increases in favour of RANKL which is likely to promote 
osteoclast differentiation. This could be part of the explanation why osteoclast 
differentiation occurs more in TR +ve teeth and results in the phenotypic 
consequence of tooth resorption.  
The highlighted differentially expressed genes in osteoclast differentiation 
and calcium pathway are listed in Table 5.5.  
The gene ontology terms reflect the best-annotated roles of certain genes. 
The gene ontology describes function in three aspects: molecular function, cellular 
component and biological process (220). The enriched gene ontology terms are only 
listed if more than 50 genes are assigned that term. Many of the enriched gene 
ontology terms are involved in muscle physiology (molecular function gene 
ontology terms include ‘actin binding’, cellular component gene ontology terms 
include ‘myofibril’ and ‘actin cytoskeleton’, and biological process gene ontology 
terms include ‘muscle contraction’, ‘heart contraction’, ‘muscle fibre development’, 
‘skeletal muscle cell differentiation’ and ‘muscle organ morphogenesis’) (Supporting 
information 4).   
In particular, in the TR +ve teeth, the structural myofibril components 




TNNT3 and TPM2 are up-regulated. 
 


















































































































































































































 Putative pathway:  Osteoclast differentiation 
Gene 
status 






1.028 0.0014 induction of osteoclast 






1.026 1.37x10-6 a trigger event leading 
to osteoclast 
differentiation via the 





member 11a  
1.157 0.0013 RANK/RANKL signalling 











2.329 0.0030 lack of cell–cell fusion 
of osteoclasts in OC-
STAMP deficient mice 
(148) 




a cytochemical marker 
of osteoclast (276) 




high expression in 
RANKL induced 
osteoclasts (153) 
↑ CALCR calcitonin 
receptor  




↑ CTSK cathepsin K 1.099 *0.059 




↑ TREM2  triggering 
receptor 
expressed on 
myeloid cells 2 
1.293 0.0027 Co-stimulatory receptor 






0.764 0.0011 osteopenia due to 




↑ CYBA  
(Nox1)  
cytochrome b-
245 alpha chain 
0.639 0.0080 MAPK activation via 







Gene name Description logFC FDR Putative function 
(reference) 
↑ CYBB  
(Nox2) 
cytochrome b-
245 beta chain 










7.0x10-8 A negative regulator of 
osteoclastogenesis (51) 





0.024 inhibitory effect of TGF-
β on osteoclast 
differentiation (282) 
↓ TGFB2 transforming 
growth factor 




Putative pathway: Calcium signalling 
↑ P2X2R purinergic 
receptor P2X2  
1.962 4.3x10-4 induction of Ca2+ influx  
in osteoclast precursors 
and osteoclasts via 
extracellular ATP via 
various purinergic 
receptors (283-285) 
↑ P2X4R purinergic 
receptor P2X4  
0.786 0.0029 
↑ P2X6R purinergic 
receptor P2X 6 
2.700 1.26x10-5 
↑ PLCB4 phospholipase C 
beta 4  
1.106 3.36x10-5 activated by GPLC (284, 
285) 
↓ P2X7R purinergic 
receptor P2X7  
-
0.271 
#0.639 increased bone 
resorption by loss of 
function of P2x7r (286)  
Table 5.5 Listed candidate genes identified by RNA-seq were correlated to osteoclast 
differentiation and calcium signalling. List of representative genes were extracted from two 
pathways and displayed with log fold change and corrected p value (FDR). *; p value is 





5.4.4 Validation of candidate genes by qPCR 
Twelve of the candidate genes identified in section 5.4.3 were selected for 
confirmation of expression by qPCR analysis (Table 5.6). The genes selected were 
correlated to osteoclast differentiation, osteoclast function and calcium signalling or 
they were genes common to all TR +ve teeth identified in section 5.4.2. All genes 
that displayed significant differentially expressed genes in RNA-seq (SPI1, MMP9, 
ACP5, P2X2R, P2X4R, P2X6R, PCLB4, CA4 and CA6) were found to be up-regulated 
in TR +ve teeth confirming the result of RNA-seq. However, the expression levels of 
P2X6R, PCLB4 and CA4 were not significantly different when further samples were 
tested with qPCR (p > 0.05) (Table 5.6). As previously predicted, RANKL expression 
was unchanged but the gene expression ratio of RANKL/OPG was higher in TR +ve 
teeth (Fold change = 3.10, p = 0.036). CA6 was identified as the most highly 
expressed gene in TR +ve teeth (Fold change = 5.51), followed by MMP9 (Fold 
change = 4.52), P2X2R (Fold change = 3.04), ACP5 (Fold change = 2.95), SPI1 (Fold 
change = 2.28) and P2x4r (Fold change = 2.28). CTSK was highly expressed in TR +ve 
teeth by qPCR (p = 0.003) but not by RNA-seq (FDR = 0.059). Overall the gene 




















Gene RNA-seq qPCR 
Expression 
in TR +ve 
Expression 
in TR +ve 
Fold change 
normalised 




SPI1  ↑** ↑ ** 2.60 0.024 
RANKL ↑ ↑ 1.35 0.279 
OPG ↓** ↓ ** 0.44 0.037 
RANKL/OPG - ↑ ** 3.10 0.036 
Osteoclast 
genes  
MMP9  ↑** ↑ ** 4.52 0.016 
ACP5 ↑** ↑ ** 2.95  0.019 




P2X2R  ↑** ↑ ** 3.04 0.025 
P2X4R ↑** ↑ ** 2.28 0.039 
P2X6R  ↑** ↑ * 2.81 0.079 
PCLB4  ↑** ↑ 1.83 0.100 
Genes 
common to 
allTR + teeth 
(pH 
homeostasis)   
CA4 ↑** ↑ * 2.67 0.052 
CA6  ↑** ↑ ** 5.51 0.040 
Table 5.6 RNA-seq results were validated by qPCR. Total n = 6 from TR –ve = 3, from TR +ve 
=3, *; 0.05 < p < 0.1, **; p < 0.05 by student t-test. 
5.4.5 SNPs from RNA-Seq data and validation  
The qPCR results from and RNA-seq analysis in section 5.4.2 showed that 
there was no differences in the mRNA levels of pro- inflammatory and anti-
inflammatory cytokines, VDR or RANKL between TR -ve and +ve teeth. 
Nevertheless, I wanted to further investigate if there were any variations in any of 
these genes which might affect the function of the translated protein without 






Gene Putative function (reference) 
TNFRSF11A/RANK mutations resulting in autosomal dominant bone 
disorder and spontaneous TR in humans (287) 
TNFRSF11/RANKL Two SNPs significantly associated with bone turnover 
marker (CTX-I) in men (288) 
TNFRSF11B/OPG SNPs correlated with EARR (207) 
IL1B SNPs more susceptible to EARR in orthodontic treatment 
(156) 
VDR Increased VDR protein and relative increase mRNA of 
VDR and its metabolic target genes in feline TR (122) 
CYP27B1 
CYP24A1 
P2xR7 Knockout mice induce greater TR (289) 
MMP9  Increase of MMP9 expression response to orthodontic 
treatment (290) 
Table 5.7 Candidate genes reported to potentially correlate with human or feline TR. 
As RNA-seq data contain actual sequences of expressed genes, it can be 
useful for the identification of SNPs as well as for quantification of transcripts. 
Based on the literature (Table 5.7) and listed candidate genes in section 5.4.4, twelve 
genes were included in this investigation and all variants in each gene of the 
samples are given in Supporting information 5. Variations were assessed by the 
extent of impact (low, modifier, moderate and high)4 and effect type (location of 
variants, synonymous and missense).  
The gene variations that were assessed as high impact and missense were 
selected (Table 5.8). VDR contained the highest number of variations (n = 63) with 
three missense variations. SPI1 also have 44 variations but there was no missense or 
high impact variations. Seventeen variations in RANK included four missense and 
one splice variation. OPG possessed one high impact splice and two missense out of 
29 variations. IL1B had one missense out of 25 variations. MMP9 contained 4 
missense and 1 high impact splice of a total of 16 variations. One variation was 
found in RANKL (low impact splice), CYP24A1 (low impact synonymous) and 
                                                   
4low – synonymous changes, modifier – changes outside coding regions, moderate - codon change, 




P2X7R (missense), respectively. There was no variation in CYP27B1. In order to see 
any correlation between these SNPs and TR status, the presence of each variant was 
investigated between TR -ve and TR +ve teeth. Most of the variations were present 
in both TR -ve and TR +ve teeth with different frequencies. One variation in RANK 
and RANKL, was found only in one TR –ve tooth. Each variation of IL1B was found in 
only one TR +ve tooth. One high impact SNP in OPG was found in all TR –ve teeth 
but not in TR +ve teeth. One VDR SNP which showed high impact was identified in 
two TR –ve teeth. One MMP9 variation was identified in one TR +ve tooth with high 
impact effect. Two missense variations of CA6 were found in one TR +ve tooth. 
Overall, none of the SNPs identified were only present in TR +ve teeth at a high 
frequency. 
Due to time restraints, only targets that I already had optimised primers 
available for were validated by Sanger sequencing, these were RANK, OPG, IL1B, 
VDR and P2X7R from TR +ve teeth. The SNPs validated were; RANK (2 
synonymous), IL1B (2 synonymous) and VDR (2 missense and 2 synonymous) 
(Table 5.9). There were no variations identified in OPG and P2X7R. Except for one 






(Chr: Gene start- end) 
Number of 




Effect impact  Variant 
(R→V) 
Effect type  Identified in TR –ve vs. TR +ve teeth 











17 81405965 High  T→C Splice   TR –ve (1) 
81423363 Moderate G→A Missense  TR –ve (3) 
TR +ve (4) 
81423375 Moderate G→A Missense  TR –ve (5) 
TR +ve (3) 
81423418 Moderate  C→T Missense  TR –ve (5) 
TR +ve (4) 
81423463 Moderate T→C Missense  TR –ve (4) 








29 62246655 High  C→T Splice   TR –ve (5) 
62243992 Moderate A→G Missense  All TR –ve and +ve (12) 
62244037 Moderate G→A Missense  All TR –ve and +ve (12) 
IL1B (A3: 104672921-
104679186) 
25 104675275 Moderate C→G Missense  TR +ve (1) 
104675987 Low A→G Synonymous  TR +ve (1) 
104677446 Low T→C Synonymous  TR +ve (1) 
VDR (B4:77248710- 
77278649) 
63  77250610 High C→G Splice TR -ve (2)  
77259936 Moderate T→C Missense TR –ve (6) 
TR +ve (3) 
77259949 Moderate A→C Missense TR –ve (2) 






(Chr: Gene start- end) 
Number of 




Effect impact Variant 
(R→V) 
Effect type Identified in TR –ve vs. TR +ve teeth 
(number of teeth ) 
VDR (B4:77248710- 
77278649) 
63 77259972 High T→C Splice TR –ve (1) 
TR +ve (1) 
77260306 Moderate T→C Missense All TR –ve and +ve (12) 
77260415 Low T→C Synonymous TR –ve (5) 




0  - - - - - 
CYP24A1 (A3: 8241386-  
8257342) 
1 8255607 Low  A→C Synonymous TR -ve (1) 
P2X7R (D3: 8111906 -  
8158046) 
27 8112271 Moderate T→G Missense All TR –ve (7) 
TR +ve (3) 
MMP9  





14895972 Moderate C→G Missense All TR –ve and +ve (12) 
14896183 Moderate C→T Missense All TR –ve (7) 
TR +ve (4) 
14896231 Moderate C→T Missense TR –ve (5) 
All TR +ve (5) 
14898306 High  C→G Splice TR +ve (1) 
14898414 Moderate T→C Missense TR –ve (5) 
All TR +ve (5) 
CA6  (C1: 5524897 - 
5545144) 
 
4 5535001 Moderate A→G Missense TR +ve (1) 
5545125 Moderate G→A Missense TR +ve (1) 
P2X4R (D3: 8068413 - 
8083858) 
2 - - - - - 











Position  Variant 
(R→V) 
Effect type RNA-seq 
TNFRSF11A/RANK 482/484 
(99.5%)  
81423452 T→C synonymous  Detected 
81423545 A→G synonymous Detected 
TNFRSF11B/OPG 1,751/1,751 
(100%)  





104675987 A→G synonymous  Detected 
104677446 T→C  synonymous Detected 
VDR 754/758  
(99.5%) 
77259936 T→C  missense Detected 
77260300 G→A  synonymous ND 
77260306 T→C  missense Detected 
77260415 T→C synonymous Detected 
P2X7R  367/367 
(100%) 
- - - - 
Table 5.9 Variations were validated by Sanger sequencing.   
5.5 Discussion  
Identification and quantification of transcripts are core activities in 
molecular biology given that RNA plays the key intermediate role between the 
genome and the proteome. RNA-seq is a powerful tool for both discovery and 
quantification in a single high-throughput sequencing assay (208, 232). The benefits 
of this study were the use of RNA-seq data to present transcriptomic profiles which 
can profile the cellular and molecular status of a certain condition and bridge the 
gap between the phenotype and gene expression. As previously discussed in 
Chapter3, one of the 14 RNA-seq samples was found to be an outlier throughout the 
data exploring process. This process is performed to identify technical errors (e.g. 
switching of samples due to labelling mistakes, outliers caused by low quality data 
or phenotyping errors) or sample variations (e.g. batch effects which are biased by 
the time and date of sample collection or individual variations originated from 
different animals) (232). The outlier identified here was likely due to the inclusion of 
RNA of potentially high quality, but where the yield was only one in ten of the 
average yield of the other samples, which was less than a minimum required 




results. Here, I also found that one sample from the TR +ve teeth group showed 
similarities to TR -ve samples even though the phenotype was re-confirmed as TR 
+ve from the dental radiograph. I therefore had to question whether the dental 
radiograph was the corresponding image of the tooth the RNA had been extracted 
from. A wrongly allocated sample into a different group by mistake could happen 
at any level during sample collection, extraction of RNA or synthesis of cDNA or 
sequencing. Therefore, I decided to exclude these two samples from the final 
analysis since this could compromise the resultant data. Samples were collected on 
different days depending on the availability of cats/tissues so even though the same 
optimised RNA extraction protocol was used, there exists technical sources of 
variations (e.g. individual sample variation and measurement differences) which are 
referred as batch effects. In most cases, the biological variations (individual 
variations) are bigger than technical variations especially when utilising clinical 
samples from a range of animals (291).   
I compared transcriptome changes between TR -ve and TR +ve samples 
using three comparisons, and found the paired TR -ve and +ve comparison within 
cats from three individuals showed the highest number of DE genes and increased 
the statistical power of this study. As teeth do not remodel, it was expected that 
there would be less dynamic changes present with limited transcripts identified. 
Surprisingly, a large number of transcripts from the TR +ve teeth differed from TR -
ve teeth (n = 1,732) which implies that these transcriptome changes occur locally 
within the same dentition.  
The fact that there was transcriptomic similarity between teeth of the same 
phenotype and that the different phenotypes could clearly be separated reveals that 
the TR affected teeth undergo similar cellular and molecular changes. The 
transcriptome corresponding to the phenotype may suggest that transcriptome 
changes are at the core of TR pathogenesis, and this knowledge has the potential to 
increase our understanding of the aetiology of TR. No previous RNA-seq analysis of 
TR samples has been reported, but a microarray study on the dental transcriptome 




developing tooth expressed unique transcriptome profiles, especially between 
odontoblasts and pre-secretory ameloblasts (201). Two further microarray studies 
also reported the differences in gene expression patterns between human deciduous 
and permanent periodontal ligament and pulp, respectively (292, 293).  
The lack of changes in gene expression of various inflammatory cytokines 
and VDR in TR was consistent with the finding in Chapter 4 and support a non-
inflammatory pathogenesis aetiology for TR. It is also possible that inflammation 
only appears at a particular stage of TR development so that the overall oral 
environment possesses a similar extent of inflammation within this study 
population.  To further investigate this, subgroups of RNA-seq data between 
different TR stages may be enlightening. For this, current RNA-seq data fromfrom 
TR –ve and early and advanced TR +ve teeth could be re-analysed.  However, more 
informative may be gleaned from the study of teeth from early, advanced, and end 
stage TR+ve teeth which would improve the power of this study. Another possible 
explanation for the lack of any changes in the expression levels of inflammatory 
cytokines could be due to a bias of TR type in this study. In this study, type 2 was 
the dominant type of TR. It has been proposed that this type might be involved in 
non-inflammatory or idiopathic TR although other studies have not confirmed this 
observation (99, 112, 294). 
Two previous feline TR studies noted differences in the gene expression of 
various inflammatory cytokines by qPCR however the changes reported were in 
both pro- and inhibitory- inflammatory cytokines (100, 163). The local level of actual 
cytokines (protein) has however never been measured in TR so overall influence of 
inflammation cannot be conclusively determined (100, 163).  
There were only a few changes in gene expression that were common 
between all three comparisons of TR -ve and TR +ve teeth and this may be due to 
large individual variations in the samples avbailable. There was no direct evidence 
that these identified genes are associated with osteoclast formation and activity. Of 
these, carbonic anhydrase 4 (CA4) has been reported to be expressed in the plasma 




salivary glands and saliva and involved in maintenance of pH homeostasis in oral 
cavity (296, 297). Some of the genes, including homeobox genes (e.g. ARX, HOXA4, 
LBX1, TLX1) are related to tooth development (298). One of the downregulated 
genes was SOSTDC1 which has been reported to be largely related to tooth 
development as an inhibitor of Wnt signalling to control tooth number and 
morphogenesis (299, 300). However, the potential role of carbonic anhydrases CA4 
and CA6 might be involved in oral pH regulation in osteoclast precursors.  If so, this 
microenvironment may favour osteoclast differentiation (295). The many highly 
expressed homeobox genes included ARX, HOXA4, LBX1 and TLX1 and these have 
been previously associated with tooth development.  The implications for this are 
unclear but may suggest that permanent TR +ve teeth may be undergoing some 
form of remodelling process (298, 301).  
The paired TR comparison gave the most interesting results.  The genes that 
were increased in expression revealed various metabolic pathways including 
osteoclast differentiation and calcium signalling and this implies TR +ve teeth are 
prone to dysregulation of osteoclast activity. Specifically, genes in osteoclast 
differentiation pathway are known to induce osteoclast differentiation (SPI1, C-
FMS, RANK, RANKL, TREM2, DAP12, Nox1 and Nox2) (51, 145, 275, 279-281) or 
highly expressed in functional and mature osteoclasts (OCSTAMP, ACP5, MMP9, 
CALCR and CTSK) (148, 153, 276-278). Genes in calcium signalling might induce 
Ca2+ influx thus contributing to osteoclast differentiation (P2X2R, P2X4R, P2X6R, 
PLCB4) (283-285).  
However, the computational calculation of pathway status, the 
R/Bioconductor package SPIA indicated an overall inhibitory status of the 
subsequent downstream pathway in TR +ve teeth. Tthis interpretation though 
requires an understanding of gene expression in context of a given pathway (274). 
This algorithm is computationally calculated, with no importance given to the 
relative location of each gene within that pathway. Hence the calculation does not 
take into account the importance and impact of the gene in the level of pathway 




differentiation and physiological importance relies on the ratio of RANKL/OPG via 
the RANK/RANKL/OPG axis (23, 67). Increased RANKL/OPG ratio will promote 
osteoclast formation in TR teeth. This up-regulation is observed in both permanent 
tooth eruption and primary tooth shedding (26, 67). When the impact of the 
pathways are calculated and they are ranked with a global probability, three factors 
are incorporated; total number of all pathway genes present, total number of genes 
in a specific pathway and total number of differentially expressed genes (274). By 
doing so, pathway impact is determined via a comprehensive view rather than via a 
specific pathway itself. In case of my data the feline genome is not fully annotated 
and therefore the detected number of genes in the pathway platform are limited.  
This places limitations on the impact calculation. Another limitation of this analysis 
comes from technical errors. In the osteoclast differentiation pathway figure (Figure 
5.7), RANK is shown as colourless which means this gene was not detected in the 
pathway analysis even though it existed in the list of DE genes which was used as 
input data. The input data are associated with a gene ID and then mapped onto a 
known KEGG pathway (in this case, 'osteoclast differentiation'). Genes can be 
identified either by, for example, Entrez ID (NCBI’s database), Ensembl ID 
(European Bioinformatics Institute and the Wellcome Trust Sanger Institute) or 
HGNC gene symbol (HUGO Gene Nomenclature Committee), but problems could 
arise when synonyms exist or not all genes have the same ID type. In this case, input 
of TNFRSF11A by Entrez ID was not detected in the KEGG pathway wherein uses 
RANK by its HGNC gene symbol. Therefore, these technical errors were cautiously 
examined. As a consequence, the pathway status should be interpreted in the 
structure of the pathway with list of differentially expressed genes.  
Secondly, this discrepancy of status and the phenotype might be due to the 
fact that not all genes related to a certain pathway are included (232, 302). Calcium 
signalling controls multiple cellular functions in many cells via release of calcium 
ions from internal stores and its entry from the extracellular fluid (285). In 
particular, calcium signals in osteoclasts are responsible for diverse cellular 




On the other hand, gene ontology enrichment analysis showed abundant 
genes involved in muscle physiology; genes involved in structural myofibril 
components including ACTA1, ACTN2, ATP2A1, CSRP3, MYH11, MYOZ2, PDLIM3, 
SYNC, TCAP, TNNI1, TNNT3 and TPM2 were up-regulated, however, the exact role 
of these genes in bone and tooth metabolism is unclear. These genes have been also 
identified a role in the development and differentiation of osteocytes; 
mechanosensing cells that coordinate the remodelling process mediated by 
osteoblasts and osteoclasts as well as developing bone and tooth (304). This 
manifestation might be due to tooth ankylosis, a fusion of the tooth to bone, 
following tooth resorption.  
From the pathway analysis of differentially expressed genes I focused 
primarily on genes associated with osteoclast biology (e.g. SPI1, C-FMS, RANKL, 
OPG, ACP5, MMP9 and CTSK) and inducers of Ca2+ influx contributing to osteoclast 
differentiation (P2X2R, P2X4R, P2X6R, PLCB4). Up-regulation of genes that are 
recognised to stimulate osteoclast differentiation would strongly implicate altered 
osteoclast resorption in the aetiology of TR. SPI1, the gene encoding the 
haematopoietic transcription factor PU.1 is essential for myeloid and B-lymphoid 
cell development (145). This is known to be the earliest molecule which binds to 
sites in the promoter and intronic regulatory element (FIRE enhancer) of c-fms for 
commitment to osteoclast lineage in mice (275, 305). The increased expression of 
SPI1 and C-FMS found in TR +ve teeth may therefore suggest that TR +ve teeth 
possess more pre-osteoclasts in their environment which would potentially lead to 
more mature osteoclasts and increased tooth resorption. The RANKL/OPG ratio is 
recognised  as a principal regulator of osteoclast formation in the bone marrow 
microenvironment, and alterations to this ratio may be a major cause of bone loss in 
many metabolic disorders (306). In my RNA-seq result, TR +ve teeth had an 
increased RANKL/OPG mRNA ratio although this was obtained by measuring the 
mRNA levels rather than an actual measurement of secreted cytokines. Current 
available methods to measure feline cytokines from body fluids were developed 




however there is no available ELISA kits for feline RANKL or OPG . To measure the 
local level of cytokines in oral environment, oral fluids (e.g. saliva and gingival 
crevicular fluid) as an indicator of dental disease can be used (309) but no 
application of this in cats has been reported yet, hence optimisation steps to utilise 
the ELISA kits would be required.   
 ACP5 and CTSK are recognised osteoclast markers in bone and teeth (276, 
278). Up-regulation of these genes also suggest increased osteoclast number and 
activity in TR teeth. MMP9 was identified as the second most up-regulated gene in 
TR +ve teeth. This matrix metallopeptidase enzyme is also known as gelatinase B 
and type IV collagenase. Its primary role is to degrade and remodel ECM in many 
tissues including bone and teeth (263). Increased MMP9 activity has been implicated 
in many diseases including osteoclastomas, Paget's disease, bone fracture repair and 
dental pulp inflammation (310, 311). It has also been reported that it is highly 
expressed in early stages of differentiating osteoclasts, mature osteoclasts as well as 
in odontoclasts in many species including human, mouse, rabbit, horse and cow 
(152, 312, 313). However, expression of MMP9 and its role in bone and tooth 
resorption has not been described in cats. One study reported high expression of 
MMP9 in feline cancer (151). The role of MMP9 in feline TR needs further 
investigation.  
The last important pathway identified in this chapter was the calcium 
signalling pathway. In this pathway, several purinergic receptor genes including 
P2X2R, P2X4R and P2X6R were highly expressed in TR +ve teeth. These genes are 
known to encode for nonselective cation channels permeable to Ca2+ at the cellular 
level and thereby contribute to osteoclast differentiation. Originally, purinergic 
receptors were thought to play a role in ATP production which would in turn 
induce the formation and activation of osteoclasts (283). Purinergic receptors e.g. 
P2X7 or P2Y have also now been implicated as potent local inhibitors of matrix 
mineralisation (314). Expression of P2X2 receptor has been reported in both 
osteoblasts and osteoclasts but its precise role in bone is not clear (283). Up-




invasion (315). Although expression of the P2X6 receptor has not been reported in 
osteoclasts, its expression was reported to modulate the differentiation and 
migration of human mesenchymal stem cells (316). The roles of these genes (and 
their encoded proteins) in the dental microenvironment is largely unknown, so 
further studies are required to investigate their possible involvement in tooth 
resorption.  
A large number of the differentially expressed genes I identified were 
confirmed as being differentially expressed by qPCR. This supports the hypothesis 
that genes related to osteoclast formation and activation are involved in TR 
pathogenesis. Further studies into the pathways and genes identified here are 
required to further add to our understanding of TR pathogenesis and to eventually 
identify a potential treatment target or even a biomarker for TR.   
This chapter also demonstrated SNPs in a number of the candidate genes. 
Each of the genetic variations, especially the high impact or missense mutations 
should be investigated further. It has been reported that SNPs or genetic variation of 
RANK, OPG, IL1B and P2X7R are correlated to susceptibility of TR following 
orthodontic treatment in man (207, 287, 289), and there are reported SNPs in 
RANKL related to bone turnover (288). Other candidates were included because of 
their reported correlation with feline TR (VDR and 1,25(OH)2D regulating genes, 
CYP27B1 and CYP24A1) (122), or orthodontic treatment in humans (MMP9) (290). 
The highest number of SNPs was detected in VDR and among those three SNPs 
were missense mutations. The presence of missense mutations implies that they 
would result in a change to the amino acid sequence of the resultant encoded 
protein and therefore likely to impact the function of protein. There are several 
SNPs reported in the human VDR. Some of these have been investigated in detail 
and specific SNPs have been suggested to cause a different susceptibility to 
osteoporosis (317). Most of the SNPs were identified in both TR –ve and TR +ve 
teeth while some SNPs (OPG, VDR and MMP9) were identified only in TR –ve or TR 
+ve teeth.  




TR –ve and TR +ve, e.g. some moderate to high impact SNPs were present in only 
TR –ve or TR +ve teeth. Furthermore, some of the identified SNPs were confirmed 
by Sanger sequencing, implying the SNPs are real rather than sequencing errors. 
Nevertheless, caution is required as I only performed sequencing of a very limited 
region of candidate genes and therefore making any conclusions about the SNP data 
preliminary at best. Validating more SNPs would contribute to identifying potential 
genes correlated to the development of TR.  
The gene of major interest in this chapter was MMP9. It was highly expressed in TR 
+ve teeth which is consistent with its reported increased expression in many 
diseases associated with dysregulated osteoclasts (310, 311). In Chapter 6, I will 
verify again the findings of RNA-seq and qPCR to choose target genes.  Once the 
target genes (e.g. MMP9) are confirmed, an in vitro model could be used to 





Chapter 6 MMP9 as a novel candidate target 
in feline osteoclast differentiation and 
resorption activity 
6.1 Abstract 
RNA-seq data revealed that several genes were differentially expressed 
between TR –ve and TR +ve teeth. Differentially expressed genes MMP9 and P2X4R 
were re-confirmed by qPCR on a further six paired TR –ve and TR +ve teeth 
samples. Of these, MMP9 was of greatest interest since its encoded protein is known 
to be a highly expressed enzyme in osteoclasts and odontoclasts in many species, 
although it is not known whether MMP9 is important for feline osteoclast formation 
and activity. In order to determine which cells in the tooth express MMP9, I first 
performed immunohistochemistry on feline tooth samples. MMP9 was highly 
expressed in actively resorbing odontoclasts in TR lesions and in fibroblasts of the 
periodontal ligament. MMP9 mRNA expression was also observed during in vitro 
feline osteoclast formation and this expression increased during osteoclast 
differentiation; it increased in the early stage osteoclasts before RANKL treatment 
commenced, and its expression level remained high until termination of osteoclast 
differentiation. To elucidate the role of MMP9 in feline osteoclasts, osteoclast 
precursors were treated with a semi-selective MMP9 inhibitor (hydroxamate-based 
MMP inhibitor), and the treatment reduced both the number of osteoclast formed 
and their resorption activity. Due to the semi-selectivity of the inhibitor and the 
potential for off-target effects, I constructed a feline specific MMP9 siRNA. 
Following electroporation of the osteoclast precursors with the siRNA against 
MMP9, qPCR showed a 44% of reduction in mRNA levels. MMP9 siRNA produced 
a reduction in osteoclast formation but it did not produce a statistically significant 
reduction in resorption activity. These results (together with those of chapter 5) 
suggest that increased MMP9 expression is central to TR pathogenesis and it may be 




6.2 Introduction  
The results in Chapter 5 enabled me to create a shortlist of differentially 
expressed genes which can be considered potential treatment targets in feline TR. 
The transcriptional changes showed that many of the up-regulated genes were 
involved in osteoclast activity and differentiation. Of these, MMP9 was chosen for 
further investigation as it is highly expressed in osteoclasts and odontoclasts (152, 
312, 313). It was reported that MMP9 mRNA and its encoded protein were highly 
expressed in bovine odontoclasts in resorbing deciduous teeth by in situ 
hybridization and immunohistochemistry, respectively (1).  It was however not 
clear what the role of MMP9 in osteoclasts and osteoclasts precursors was, or how 
the high MMP9 expression contributed to the degradation of dental matrix proteins 
(152). When osteoclastic bone resorption occurs local acidification solubilises the 
inorganic mineral phase and exposes the organic matrix making it accessible to 
proteinases; cysteine proteinases such as cathepsin K solubilise collagen and MMPs 
might digest the rest of the bone matrix according to their substrate specificity (e.g. 
collagenases, gelatinases, stromelysins, matrilysins, and membrane type MMPs) 
when the pH increases slightly. MMP9 belongs to the gelatinase of MMPs family 
and was considered to act on degradation of bone matrix collagen but its resorption 
activity may be not significant because cathepsin K is predominantly present to 
involve collagen degradation of the subosteoclastic resorption zone (150, 318). 
MMP9 is considered to be involved in osteoclast migration (150). MMP9 deficient 
mice showed impaired bone development, intra-osseous angiogenesis and fracture 
repair, suggesting that MMP9 has an important role in developing bone. In the 
presence of a MMP9 inhibitor, the recruitment of osteoclasts into the core of the 
diaphysis was dramatically reduced (150, 319, 320).  
The role of MMP9 in cancer has been more thoroughly documented, and it is 
known to be involved in tumour invasion and angiogenesis (310, 321). A significant 
correlation between the expression of MMP9 and metastatic potential has also been 




(322, 323). MMP9 is reported to have the capacity to activate cellular effectors such 
as vascular endothelial growth factor and TGF-β which enables the process of 
invasion and metastases (150, 324). Despite MMP9 being one of the MMPs that has 
been researched the most, (150), the expression in feline osteoclasts and odontoclasts 
is unclear. 
In this chapter, I aimed to confirm that MMP9 is highly expressed in feline 
tooth sections of TR +ve teeth. Next I used a chemical inhibitor to investigate the 
direct effect of MMP9 inhibition. As the chemical inhibitor was semi-selective for 
MMP9, temporary targeting of the target using RNA interference was performed 
next. The utility of RNA interference is extensively used in gene function studies 
allowing for the rapid and highly specific silencing of the gene of interest to be 
assessed in both in vitro and in vivo (325-327). 
I designed and constructed feline specific MMP9 siRNA. After optimisation 
of different transfection techniques for use in feline pre-osteoclasts, siRNAs 
targeting feline MMP9 were screened for the assessment of mRNA silencing. In 
addition, differentiation and resorption activity was investigated post transfection 
to assess the potential functional role of MMP9 in feline osteoclasts. 
Part of the work reported in this chapter was performed by an 
undergraduate student at the Royal (Dick) School of Veterinary Studies, Miss Nicola 
Mawson, under my supervision and technical support. She did an undergraduate 
research project, (A cat and mouth game: can a feline dental condition inform on 
how human bones weaken with age?) in the summer of 2017. In detail, I designed 
the student project, and Miss Mawson helped with the quantitative PCR and 
histological examination of feline teeth including H&E staining and 
immunohistochemistry. The histological sections were also assessed by a veterinary 
pathologist, Dr Erika Abbondati (BVSc, MRCVS and Diplomate of the European 




6.3  Materials and Methods 
6.3.1 Quantitative PCR for candidate genes 
To confirm the expression of the candidate genes, qPCR was performed in 
six paired TR teeth including three previous samples used in Chapter 5 (n = 6 from 
TR -ve, n = 6 from TR +ve) using primer sets (MMP9, P2X4R, SPI1, CTSK, RANKL 
and OPG). The conditions for the qPCR and data analysis were the same as 
described in section 5.3.3. Relative mRNA expression was analysed using the 
calculation of 2-ΔΔCt as previously described in section 2.1.8. An average fold 
change of TR +ve teeth was compared to that of TR –ve teeth. GraphPad prism v5 
was used for the generation of graphs.    
6.3.2 Histological investigation of feline TR 
To determine which cells expressed the candidate proteins, feline teeth were 
demineralised and teeth sections were embedded in paraffin as described in section 
2.7.1. H&E staining and immunohistochemistry were performed as described in 
section 2.7.2 and 2.7.3, respectively. As all antibodies used were raised against 
human and/or mouse proteins/peptides it was necessary to examine each for their 
ability to detect the feline protein. Table 6.1 summarises the results of all antibodies 
tested. Each slide was examined with a light microscope to determine the optimal 
dilutions of primary and secondary antibody that would provide specific protein 
binding with minimal background staining. Only the MMP9 antibody successfully 
labelled specifically to its target in comparisons with isotype control (Table 6.1). All 
slides were blinded to the observer, without information on their TR status. H&E 
and MMP9 positive odontoclasts were counted on each  slide  which contained at 
least one or two sections each sample to compare to the saved information on the 
archived samples (n = 16, TR –ve = 4, TR +ve = 12).  
To distinguish odontoclasts from other multinucleated cells (e.g. clustered 
epithelial cells known as epithelial cell rests of Malassez (ERM) which are located in 
periodontal ligament as described in section 1.1.3.4, pan cytokeratin 




immunolabeling was performed as described in section 2.7.4. 
Primary 
Antibody 
Host Manufacturer Antibody optimisation 
MMP9 Rabbit polyclonal Abnova, PAB12714 Dilution in 1:200  
SPI1 Rabbit monoclonal Abcam, AB76543 Failed optimisation 
P2XR4 Goat polyclonal Abcam, AB134559 Failed optimisation 
CTSK Mouse monoclonal Abcam, AB66237 Failed optimisation 




RANKL Rabbit polyclonal ProSci, XP-5273Bt  Failed optimisation 
RANK Mouse monoclonal RANK (H-7): sc-374360. 
Santa Cruz Biotechnology  
Failed optimisation 
 Table 6.1 Antibodies tested for immunolabelling of candidate protein used in this chapter. 
 
6.3.3 In vitro feline osteoclast differentiation, MMP9 
expression and inhibition 
In vitro feline osteoclast formation was performed as described in section 
2.3.7. Cultured cells were collected at each time point (Day 0, Day 3, Day 6 and Day 
8) for RNA isolation, and qPCR was performed as described in 2.1.6 and 5.3.3 to 
assess MMP9 expression during osteoclast differentiation.  
During in vitro feline osteoclast formation, cells were treated with MMP9 
inhibitor (C₂₇H₃₃N₃O₅S, Merck Millipore, CAS 1177749-58-4) using a range of 
concentrations (5, 20 and 1,000 nM) as described in 2.4.8. 
6.3.4 Development of RNA interference targeting feline MMP9  
The protocols to design and construct a siRNA targeting feline MMP9 were 
described in section 2.5.1 and 2.5.2. Table 6.2 summarises the 19 base sequences that 
were used for the construction of RNA duplexes to cleave feline MMP9 mRNA. To 




search for efficient siRNA oligonucleotides containing specific residues within the 
19 sequences (230). Among the listed siRNAs using the online siRNA design tool, 
only siRNAs with a Reynold’s score higher than 8 were chosen (Table 6.2). For a 
negative control, a commercially available scrambled siRNA containing a sequence 
with no known gene target (Silencer® Negative control, Life Technologies) was 
used. To identify the most efficient siRNA delivery method, both lipid based 
transfection and electroporation procedures were tested using a plasmid containing 
enhanced green fluorescence protein (pEGFP). Transfections were performed on 
day 3 following 48 hrs culture as described in sections 2.5.3 and 2.5.4.  
The appropriate amounts of DNA (pEGFP) or RNA (scrambled or MMP9 
siRNA) and lipid based transfection reagent (RNAiMAX) or Nucleofector™ 
Solution are shown in Table 6.3 and Table 6.4, respectively.  The efficiency of siRNA 
or pEGFP was checked under the fluorescence microscopy or by flow cytometry as 
described in section 2.5.5.  
Following siRNA transfections, bone marrow osteoclast precursors were 
seeded onto dentine discs in 96-well plates. Cells were incubated at 37°C/5% CO2 
until formation of osteoclasts was observed in control cultures. Media were changed 
every 2 days. The number of TRAP positive osteoclasts were recorded as described 
in section 2.4.1 and resorption pits were counted as described in section 2.4.6.  
 Sequences 5’-3’ %GC Reynold 
score 
Target mRNA  CCAGGAGACTTGCGAACTA 52.63 8 
Antisense template AACCAGGAGACTTGCGAACTA(CCTGTCTC) 
Sense template AATAGTTCGCAAGTCTCCTGG(CCTGTCTC) 
Table 6.2 Summary of target and DNA template sequences used to produce siRNA against 
feline MMP9 with the Silencer siRNA Construction Kit. The 8 nt sequence marked in bracket 









Constituent  Number of 
cells/cm2 
RNAiMAX mixture  RNA  mixture  
Lipofectamine Opti MEM I DNA or 
RNA 
Opti MEM I 
Untreated 1.0 x 105 1.5 μl  25 μl  -  25 μl 
pEGFP (0.5 μg) 1.0 x 105 1.5 μl 25 μl  1 μl 25 μl  
pEGFP (1.0 μg) 1.0 x 105 1.5 μl 25 μl  2 μl  25 μl 
pEGFP (2.0 μg) 1.0 x 105 1.5 μl  25 μl 4 μl  25 μl  
Table 6.3 The number of cells, amount of RNA and Lipofectamine solution per well in a 24-












DNA or RNA 
Untreated  1.0 x 106 - - 2.0 x 105 
pEGFP (0.5 μg) 1.0 x 106 100 µl 1 µl 2.0 x 105  
pEGFP (1.0 μg) 1.0 x 106 100 µl 2 µl 2.0 x 105 
pEGFP (2.0 μg) 1.0 x 106 100 µl 4 µl  2.0 x 105 
Scrambled  
(scrambled siRNA) 
1.0 x 106 100 µl 1.5 µl 2.0 x 105 
MMP9 (300 nM) 1.0 x 106 100 µl 1.5 µl 2.0 x 105 




6.4.1 MMP9 mRNA expression is increased in TR +ve teeth  
In order to confirm a shortlist of candidate genes for TR, qPCR was 
performed in a new set of 6 paired samples (Figure 6.1). In TR +ve teeth, mRNA fold 
change of MMP9 and P2X4R increased by 3.00.7 (p=0.0264) and 2.60.4 (p=0.0029), 
respectively. Fold change of mRNA of SPI1 and CTSK increased by 1.40.5 
(p=0.5818) and 1.10.4 (p=0.7905), respectively, but these differences were not 
statistically significant. RANKL and OPG fold expression decreased by 0.80.4 




statistically significant. The RANKL/OPG ratio in TR+ teeth was not significantly 
different than in TR- teeth (1.9±0.7, p=0.3231). Overall, MMP9 had the highest fold 
change observed in TR +ve teeth among the short listed candidate gene, which was 
consistent with the validated results of RNA-seq as described in section 5.4.4.  
6.4.2  MMP9 was expressed in feline tooth sections 
Optimisation of immunohistochemistry for candidate proteins was 
performed. However, none of the antibodies for SPI1, P2X4R, RANKL, OPG and 
RANK were successfully optimised, despite trying a range of different options (e.g. 
various antibodies concentrations, different antigen retrieval processes and 
incubation times). Only MMP9 was successfully labelled in feline dental tissues.   
Multinucleated odontoclast-like cells based on H&E staining and MMP9 
immunolabelled sections were quantified. The initial numerical data were 
summarised in Table 6.6. The total number of odontoclasts counted in H&E and 
MMP9 sections could not be confirmed by veterinary pathologist Dr Erika 
Abbondati due to a discrepancy over the true identity of some of the multinucleated 
cells first identified. The pathologist highlighted that there are other multinucleated 
cells present in the region, so that all MMP9 positive, multinucleated cells would 
have to be distinguished from, for example ERM. Following a discussion with the 
pathologist, a consensus for distinguishing true resorbing cells from ERM was 
established. To reliably confirm odontoclasts only multinucleated cells within an 
obvious resorption pit were considered to be odontoclasts (Figure 6.2, C and D).  
It was also observed that the majority of TR +ve teeth had disrupted 
periodontal ligament fibres, narrowed or complete loss of periodontal ligament 
space and replacement with bone like tissues demonstrating a degree of ankylosis. 
This was confirmed by Dr Abbondati. In TR +ve teeth, MMP9 protein was most 
strongly expressed in multinucleated cells which resorbed cementum and dentine 
(Figure 6.2, E and F). This protein was also expressed in the periodontal ligament 
fibroblastic cells (Figure 6.2, B) in both TR –ve and TR +ve teeth in comparisons with 
isotype control (Figure 6.2, H). Other cells including vascular structures of the 




multinucleated cells out with resorption pits (Figure 6.2, G). 
Dental tissue sections did not always contain active resorption lesions 
regardless of the tooth’s TR status. Active odontoclasts with resorption pits were not 
identified in five of the twelve TR +ve teeth (Table 6.5). 
 ERM are resident in the periodontal ligament and of epithelial origin, so 
they express cytokeratin. To distinguish true odontoclasts from clustered ERM cells, 
the sections were therefore immunolabelled for cytokeratin. Odontoclasts did not 
express cytokeratin (Figure 6.3, D) while the gingival epithelium was strongly 
labelled with cytokeratin (Figure 6.3, A and B). Some periodontal ligament cells 


































































































































Figure 6.1 MMP9 and P2X4R were highly expressed in TR -ve and TR +ve teeth. 
Confirmation of gene expression by qPCR in further tooth samples was performed. Graphs 
represent relative expression as fold changes + SEM bars. (Total n = 12, TR -ve = 6, TR +ve = 





Figure 6.2 MMP9 highly expressed in odontoclasts of feline tooth resorption lesions. H&E 
from TR –ve teeth (A) and TR +ve teeth (C and D). A shows TR –ve tooth with intact 
periodontal ligament without resorption pit. C shows root furcation of TR +ve tooth with 
dentine resorbing odontoclasts (circle area) magnified in D. Immunohistochemical labelling 
for MMP9 protein with haematoxylin counterstaining TR –ve (B), TR +ve (E, F, and G) and 
isotype control (H). Most MMP9 expression in TR –ve teeth was observed in periodontal 
ligament or gingival tissues. TR +ve tooth contains active odontoclasts with resorption pits 
(dotted circle) with strong MMP9 expression (E), high magnification of this lesion (F). MMP9 
expression was less strong, which was similar to TR –ve teeth. MMP9 expression was also 
found in multinucleated like cell but without resorption pit (G, arrow). AB: alveolar bone, 




Table 6.5 The initial quantification of odontoclasts in H&E and MMP9 immunolabelled 
sections together with their TR status. Total number of teeth sections: n = 16 (TR –ve, n = 4, 












Active ODs with 
resorption pits  
PDL structure 
/ankylosis 
34 307  NA 4 + + Partially 
destroyed and  
narrowed PDL  
35 404 8 10 + - Destroyed and 
narrowed PDL 
35 409 17 NA + + - 
38 108 6 4 - - - 
38 204 13 9  - - - 
38 304 24 9 + + - 
38 404 12 2 + - Disrupted  PDL 
fibre 
38 308 15 1 - -  - 
38 307 5 0 + - Destroyed and 
narrowed PDL 
38 407 15 3 + + Destroyed and 
narrowed PDL  
38 408  4 2 - - - 
39 108 2 0 + - Partially 
destroyed PDL 
39 307 7 2 + + Loss of PDL and 
ankylosis 
39 308 25 5 + + Destroyed and 
narrowed PDL 
39 309  8 5 + + Destroyed and 
narrowed PDL 






Figure 6.3 No cytokeratin expression was shown in odontoclasts in order to distinguish from 
epithelial cells. Highly expressed cytokeratin in gingival epithelial cells (circle) at low 
magnification (A) and high magnification (B). Some cells which are epithelial origin also 
expressed cytokeratin in periodontal ligament (C, arrow heads). No expression of 
cytokeratin was observed in resorbing odontoclasts (D, arrows). AB: alveolar bone, DE: 
dentine, PDL: periodontal ligament. Scale bars = 100 µm. 
  
6.4.3 MMP9 mRNA is expressed during early feline osteoclast 
differentiation 
MMP9 was highly expressed during osteoclast formation in comparison 
with control (p < 0.0001 by one-way ANOVA). MMP9 mRNA expression was 
significantly up-regulated in the early stages of osteoclast differentiation, with a 
7.8±0.2 (p < 0.001, two sample t-test) fold change on day 3 compared to day 0. MMP9 
mRNA expression remained high until day 6 where after it increased further - 
































Figure 6.4 MMP9 mRNA expression increased during in vitro feline osteoclast formation 
over an 8-day culture period. Precursors were treated with M-CSF from day 0, and addition 
of RANKL from day 3. Graphs represent relative expression as fold changes with + SEM bars. 
(n= 3; * p < 0.05, *** p < 0.001 in comparison with the previous time point in culture, ### p 
< 0.001 in comparison with day 0 by two sample t-test). 
 
6.4.4 Treatment with a semi-selective MMP9 inhibitor reduced 
osteoclast differentiation and resorption activity 
Since MMP9 was highly expressed in osteoclasts in vitro and in odontoclasts 
in dental tissues, I hypothesised that inhibiting MMP9 would affect osteoclast 
formation and resorption. In vitro osteoclast cultures were treated with a semi-
selective MMP9 inhibitor (hydroxamate-based MMP inhibitor). The inhibitor 
contains hydroxamate (-CONHOH) group which binds to the zinc atom at the 
active site of MMP9. An inhibitory effect was observed on both osteoclast formation 
and resorption activity in a dose dependent manner (Figure 6.5, A and B). Osteoclast 
formation was not significantly reduced at low dose (5 nM, IC50 = 5 nM) compared 
to vehicle control (p = 0.802), but the inhibitor significantly inhibited osteoclast 
numbers at increased doses, where a 50±6.3% (p < 0.0001), and a 48.9±5.8% 
(p < 0.0001) decrease was observed at 20 nM and 1000 nM concentrations 
respectively (Figure 6.5. A). There was no further reduction in osteoclast numbers 




1000 nM (p = 0.888). All three concentrations of MMP9 inhibitor resulted in a 
reduced resorption ability in comparison to vehicle control (Figure 6.5, B), and this 
was dose dependent (1000 nM) (12.2±2.5%, p = 0.001) and 20 nM (62.2±7.4%, p = 





































































































Figure 6.5 A MMP9 semi-selective inhibitor induced decreased feline osteoclast formation 
and resorption activity. Graphs represent percentage of number of osteoclasts (A) or 
resorption pits (B) with + SEM bars compared to vehicle (DMSO) control. (n= 3; * p < 0.05, 
** p < 0.01; *** p < 0.001 in comparison with vehicle control, ### p < 0.001 between 
individual doses comparison by two sample t-test). 
 
6.4.5 Electroporation protocols had superior transfection 
efficiency and cell viability when compared to liposome-
based osteoclast transfections 
As the MMP9 inhibitor used above does not specifically inhibit MMP9, the 
inhibitory effect might be via other members of the MMP family, especially at high 
concentrations (> 100 nM) according to the manufacturer’s instruction. I therefore 
used RNA interference to specifically target feline MMP9 mRNA. However, 
primary cells or terminally differentiated osteoclasts are extremely difficult to 
transfect using routine protocols. First, I investigated two widely available 
techniques: liposome-mediated transient transfection and electroporation. Both 





fluorescence to compare transfection efficiency, effect on osteoclast survival and 
differentiation. Following lipid-mediated transfection at 24 hrs (osteoclast culture 
day 3) cells looked viable with 90.15% alive (Figure 6.6, A) but GFP transfection 
efficiency assessed by flow cytometry was as low as 0.25% (Figure 6.6, B). When 
differentiated osteoclasts appeared 72 hrs post transfection (osteoclast culture day 
5), transfected GFP was only rarely observed in the cells (Figure 6.6, C). The lipid-
mediated transfection however seemed to cause minimal effect on osteoclast 
differentiation following transfection (Figure 6.6, D), probably due to the very low 
transfection efficiency.  
 Due to electric shock, after electroporation, some of the precursor cells were 
observed floating in the culture medium, which indicates that the electroporation 
protocol itself caused cell damage. Therefore it was recommended to use double the 
normal number of cells according to manufacturer’s protocol. Twenty four hrs 
following electroporation, cell viability of transfected cells was assessed by flow 
cytometry, and it was 97.14% in comparisons with cells electoporated with 
scrambled control siRNA. Transfection efficiency was 40.53% (Figure 6.6, E and F) 
as measured by flow cytometry for green fluorescence protein. Seventy two hours 
following electroporation with pEGFP GFP expression was observed in both early 
stage and differentiated osteoclasts. Electroporation also did not interfere with 
osteoclast differentiation when viable osteoclasts precursors were cultured (Figure 
6.6, H). Transfection efficiency was greatly improved compared to that achieved 





Figure 6.6 Electroporation more efficiently induced temporary transfection of pEGFP in 
feline osteoclasts compared with a lipid-mediated transfection. Transfection by lipid-
mediated protocol (A–D) and electroporation using pEGFP (20 µg/ml) (E-H). A and E 
represent fluorescence microscope views 24 hrs post transfection (osteoclast culture day 3) 
in precursors. Transfection efficiencies of lipid-mediated transfection and electroporation 
by flow cytometry analysis were 0.25% and 40.53%, respectively (B and F, circled area). 
Fluorescence microscopy of EGFP expression 72 hrs post transfection (C and G; osteoclast 
culture day 5). D and H show phase contrast images of mature osteoclasts after 




6.4.6 MMP9 specific siRNAs caused moderate mRNA 
reductions and reduced the number of osteoclast formed 
Following electroporation of the osteoclast precursors with the MMP9 
siRNA, a 44.00±0.03% reduction (p = 0.0032) in MMP9 mRNA levels was observed in 
the transfected cells as assessed  by qPCR at 48 hrs post transfection when compared 
to negative control transfected precursors  (Figure 6.7). 
After verifying the efficacy of MMP9 siRNA, feline osteoclast precursors 
were transfected with feline MMP9 siRNA for treatment or scrambled siRNA for a 
control and seeded on dentine disc to investigate MMP9’s role during osteoclast 
formation. Electroporation caused some cell death and therefore untransfected cells 
formed a higher number of osteoclasts and more resorption pits (Figure 6.8, B and 
D) but all transfected cells were also able to differentiate mature osteoclasts (Figure 
6.6., H). MMP9 siRNA transfected cells resulted in reduced osteoclast formation in 
comparison with scrambled control. There was a reduction of 74.8±7.2% in the 
number of osteoclasts formed (p < 0.0001) (Figure 6.8, A and B). However, no 
statistically significant differences in resorption activity was observed between 

























Figure 6.7 MMP9 mRNA expression levels were reduced (48 hrs post transfection) by 
MMP9 siRNA electroporation of feline osteoclast precursors. Graph represents relative 







Figure 6.8 MMP9 siRNA transfected cells resulted in reduced osteoclast formation in 
comparison with scrambled control but there was no statistically significant differences in 
resorption activity. Graphs represent percentage of number of osteoclasts (B) and 
resorption pits (D) with + SEM bars. (n= 3; *** p < 0.001 in comparison with scrambled 
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6.5 Discussion  
 In this chapter, confirmation of TR candidate genes identified by RNA-seq 
and qPCR in chapter 5 was performed using more TR+ve and TR-ve samples.  
MMP9 and P2X4R were identified as up-regulated genes in TR +ve teeth by qPCR 
therefore validating my previous data. To extend these obervations I sought 
confirmation at the protein level and to identify which cells in the dental tissues 
expressed these proteins. The relative expression level by immunolabelling intensity 
was also assessed. Prior to immunohistochemistry, optimisation of antibodies to 
detect MMP9, RANK, RANKL, P2XR4, OPG, and SPI.1 proteins was attempted. 
Only MMP9 antibody was successfully optimised and the rest of the antibodies 
failed to specifically label their targets when compared to isotype controls. 
Availability of feline specific antibodies is limited, and the antibodies (RANK and 
OPG) previously reported to have worked in feline tissues were no longer 
commercially available (328). For example the previously documented polyclonal 
anti-RANK, RANKL, and OPG antibodies had been replaced by monoclonal 
antibodies. Hence for these candidate proteins, further optimisation of available 
antibodies will be necessary or alternatively feline specific antibodies made 
although this latter option was out with the possibilities in this PhD. 
Immunohistochemical success is not only down to antigen-antibody specificity, but 
is also dependent on the tissue processing techniques used preceding the 
immunohistochemistry. Generally formalin fixed mineralised tissues are required to 
be demineralised and embedded in paraffin followed by dewaxing and antigen 
retrieval in order to expose the epitope (the antibody binding site). Due to the 
several harsh interventions for processing feline tooth samples, antibody epitopes 
might be masked or destroyed during the extended demineralisation period in 
EDTA (e.g. 6 weeks), the dewaxing or initial immunolabelling steps (e.g. or boiling 
during the antigen retrieval by enzymatic treatment). Although standard protocols 
for the above procedures were followed (122, 328), the above technical challenges 




encountered. These problems are not limited to the study of skeletal tissues of non-
routine species (e.g. human, mouse and rat).  These challenges have been referred to 
in a previous human bone immunohistochemical study (329).  
Although MMP9 is one of the best evaluated MMPs in osteoclasts (324), 
MMP9 expression in feline teeth has not been previously documented. I found that 
the intensity of MMP9 expression in odontoclasts was much greater than the 
surrounding tissues (e.g. periodontal ligament fibroblasts). Specifically, odontoclasts 
actively resorbing dentine were only observed in TR +ve teeth and they were 
immunolabelled with MMP9. This might indicate that the increase in MMP9 
expression observed in TR +ve tooth samples at the mRNA levels may be due to an 
increase in odontoclast numbers in the tissues. However, due to the difficulty of 
obtaining intact teeth sections following a long period of decalcification 
processing(up to 6 weeks), there was limited number of intact tissue section 
available with active resorption pits. Importantly MMP9 was also highly expressed 
in clustered ERM cells, which can be visible in the periodontal ligament and 
therefore they needed to be distinguished from odontoclasts. The initial 
quantification data may have overestimated the number of odontoclasts, as when 
the sections were labelled for cytokeratin, ERM cells in the periodontal ligament 
were positive while odontoclasts in resorption pits were not.  
Disrupted periodontal ligament fibres, loss of periodontal ligament and 
replacement by ankylosis were predominantly observed in TR +ve teeth. The 
periodontal ligament has been documented to be part of the biological protection 
mechanism to prevent tooth resorption and therefore disrupted periodontal 
ligamnet may be a potential site of odontoclast attack. Similar histological features 
have been documented in other studies (92, 95, 113). Combination of qPCR data and 
histological investigation highlights the necessity for further investigation of MMP9 
as a potential target in TR. 
MMP9 expression in cultured osteoclasts was also shown by 
immunocytochemistry in Chapter 4. To investigate the expression pattern during 




increased over the culture time period. The increase in MMP9 expression during 
osteoclast differentiation has been previously documented in RAW 264.7 cells where 
the authors showed that RANKL signalling induced MMP9 mRNA expression 
through TRAFR6 and that NFATc1 was a downstream effector in mouse osteoclast 
precursors (153). The RAW 264.7 cells are commonly used in the study of osteoclast 
biology, but the biology of this cell line is somewhat different from bone marrow 
derived pre-osteoclasts in terms of different stages of osteoclasts. This cell line is 
more comparable with mouse macrophages (330). My data in this chapter 
additionally showed that MMP9 mRNA expression increased in osteoclast 
precursors before RANKL treatment commenced on day 3 in comparison to early 
osteoclast precursors on day 0 and it remained high until osteoclasts were fully 
differentiated. This might imply MMP9 affects osteoclast biology from the myeloid 
lineage commitment stage. Further studies on bone marrow derived precursors are 
required to further elucidate this relationship.  
The synthetic MMP9 inhibitor effectively reduced both osteoclast formation 
and resorption. Synthetic MMP inhibitors have been developed for the treatment of 
several serious pathologies including periodontitis, although clinical trials gave 
disappointing results and only a few inhibitors (e.g. Periostat™) has been approved 
by the FDA for the treatment of periodontal disease (331). The synthetic inhibitor 
possesses a hydroxamic acid analogue which binds to the enzymatic sites of MMPs 
with high-affinity (331). However, members of MMPs family share a basic structure 
which comprises an auto-inhibitory pro-domain rendering them enzymatic latency, 
the catalytic domain, and the C-terminal hemopexin-like domain, for the 
recognition of MMP substrates (318). Although the inhibition of osteoclastic activity 
by the MMP9 inhibitor is concentration dependent, it is not clear if the effect of the 
MMP9 inhibitor is specific to MMP9 or not. 
For this reason, I designed a siRNA targeting feline MMP9. Prior to 
application of the siRNA in feline osteoclast precursors, I searched for effective 
transfection protocols, and electroporation was identified as an improved 




showed that electroporation in murine bone marrow derived macrophages induced 
an immediate 20% reduction in cellular metabolism by measuring the reduction of 
tetrazolium dye by NAD(P)H-dependent oxidoreductase enzyme but their 
metabolism was recovered after about  24 hrs post transfection (332). The study 
showed that the introduction of DNA into the cytoplasm is toxic to primary bone 
marrow derived macrophages rather than the electroporation procedure itself. 
Although it suggested that the toxicity of DNA was concentration-dependent and 
sequence-independent, relatively high amount of DNA was tolerated (25 µg/ml). To 
avoid high toxicity of introduction of foreign DNA, I used the same concentration of 
DNA (20 µg/ml of endotoxin-free plasmid DNA) based on an optimised 
electroporation transfection for murine macrophages  (333).   
Osteoclast formation was significantly inhibited by feline MMP9 siRNA but 
resorption activity was not significantly affected. The contribution to osteoclastic 
resorption by MMP9 may be less than that of CTSK and therefore inhibition of 
MMP9 expression might have a minor effect on resorption capabilities. It is possible 
that MMP9 may have a more important role in osteoclast formation and migration. 
However prior to any conclusions being made, these experiment need to be 
repeated using various siRNAs together with a precise measurement of resorption 
activity.  
Specifically, MMP9 is secreted as a pro-enzyme that requires activation in 
the extracellular space (263). Activation of MMP9 is complex and tightly regulated 
by enzyme inhibition by endogenous inhibitors, the tissue inhibitors of MMPs 
(TIMPs) and activators of other MMPs (263). In this present study a limited 
approach was used to investigate the effects of MMP9 inhibition on osteoclast 
formation and resorption. Therefore, verifying a potential role of MMP9 in 
osteoclasts and odontoclasts requires further investigation which could include the 
analyses of pro-enzyme and post enzyme activity, combination effect with other 
member of MMPs and the use of feline MMP9 specific inhibitors as shown in other 
species (321).     




odanacatib was an effective inhibitor of bone resorption in vivo and in vitro (334, 335) 
and a clinical study of postmenopausal women demonstrated that it showed 
increased bone mineral density and reduced biochemical markers of bone 
resorption (336). Therefore, use of cathepsin K inhibitor or combination of cathepsin 
K and MM9 inhibitors might have benefits for inhibition of feline osteoclastic 




Chapter 7 Discussion  
7.1 General discussion  
Feline tooth resorption is a common, painful and progressive disease. 
Domestic cats often suffer multiple TR lesions and lose their permanent teeth due to 
the progressive nature of the disease. The treatment option of choice is to extract 
affected teeth.  Currently our understanding of the aetiologies is incomplete. 
Dysregulation of odontoclasts are responsible for TR but the mechanisms 
underlying their dysregulation are largely unknown. The central aims of this study 
were to identify candidate genes related to feline odontoclast dysregulation and 
assess their potential as therapeutic targets. The first step was to complete a RNA-
seq investigation to study the molecular characteristics of TR +ve teeth and identify 
candidate genes correlated with TR. An in vitro feline osteoclast model was also 
established to investigate cellular characteristics of feline osteoclast biology. This 
model was then used to test potential novel treatment targets for TR.  
In Chapter 3, a successful RNA isolation procedure from feline teeth 
collected in a clinical setting and at post-mortem was developed. The optimised 
RNA extraction protocol produced sufficient yields of RNA with a medium to high 
RNA integrity value suitable for gene expression by qPCR of reference genes and 
RNA-seq data analysis. The RNA-seq technique, as well as the RNA quality 
introduce potential intrinsic biases due to nucleotide composition, GC contents and 
PCR, which might directly affect the accuracy of resultant RNA-seq data (241, 337, 
338). Therefore, a quality assessment of RNA-seq data prior to subsequent analyses 
is a critical step for the interpretation of RNA-seq data. In this study, commonly 
applied factors (e.g. yield, sequencing depth, read distribution, duplication rate and 
alignment rates) in RNA-seq data was first assessed.(231, 337). This analysis guided 
me in choosing the data to include or exclude for further downstream analysis. 
Based on previous studies I also tested putative aetiological factors by qPCR, 
in particular the involvement of inflammatory cytokines (e.g. IL1B, IL6, TNF and 




stimulator of osteoclast differentiation in human root resorption (81).  
However, my results could not identify any significant changes in the 
expression of these genes in samples from TR –ve and TR +ve teeth. No change of 
RANKL mRNA levels was consistent with previous feline TR studies (100, 163). It 
has been reported that RANKL is highly expressed in the periodontal ligament of 
actively resorbing primary human teeth, (33, 76) whereas the level of RANKL 
mRNA is very low or not expressed in human adult teeth (163, 339). In cats, RANKL 
mRNA levels between adult teeth and bones is similar (163). Since odontoclasts 
activity is tightly controlled by the OPG/RANKL ratio, the level of OPG and RANKL 
mRNA expression should be considered together. In feline healthy permanent teeth, 
the level of OPG mRNA is significantly higher than femoral or alveolar bone, 
providing evidence that the role of OPG may be a key factor rather than RANKL in 
modulating odontoclast function in feline TR (163). This is supported by my RNA-
seq and qPCR data in the comparison of TR -/+ teeth from the same cat; the level of 
OPG mRNA level was low in the TR +ve teeth thus an increased RANKL/OPG ratio 
was observed in TR +ve teeth. However, the observation was not verified when 
repeated in a larger number of samples, hence the RANKL/OPG involvement in 
feline TR needs to be further investigated. My data did not show any changes in the 
expression of pro-inflammatory cytokines between TR –ve and TR +ve teeth but it 
did show that IL6 mRNA expression was upregulated in the early stages of TR in 
comparison with TR –ve teeth or late stage TR. This may suggest that IL6 is involved 
in the initiation of TR. The alterative or co-stimulation factors (e.g. Toll-like 
receptors, osteoclast associated receptor, and IL1,4, 6, 10, 23) rather than RANKL 
itself might play more important roles in osteoclast formation and activation in 
adult teeth, which is documented in inflammatory arthritis (244). Osteoclast 
immunology (also referred to as osteoimmunology) has recently gained traction to 
obtain a more complete understanding of osteoclast biology in various fields of 
study. This includes;  the pathology of bone and cancers and  the microenvironment 
of bone and the immune system in pathological conditions (e.g. inflammation or 




dendritic cells to release stimulatory cytokines for osteoclast formation (43, 340). In 
my study population, gene expression studies provided no evidence for an 
involvement of pro-inflammatory cytokines in TR pathogenesis however, further 
investigations of various other co-stimulating factors on a larger sample size are 
required. I also established a protocol for the in vitro differentiation of feline 
osteoclasts from bone marrow derived precursors. In vitro feline osteoclasts 
presented with osteoclast characteristics and resorption activity on mineralised 
substrate and this is in agreement with other studies (228, 245). I tested the role of 
1,25(OH)2D3  on osteoclast formation as a few studies have suggested that vitamin D 
metabolism could be critical for TR via local effects of 1,25(OH)2D and its receptor 
(122, 185). My data showed VDR mRNA was expressed in teeth but the levels of 
expression were similar in TR –ve and TR +ve teeth. In my studies, the local effects 
of 1,25(OH)2D3  on osteoclastogenesis showed dual effects; moderately increased 
physiological level of 1,25(OH)2D stimulated osteoclast activity whereas high doses 
of 1,25(OH)2D3  caused a decrease in osteoclast formation. This is similar to in vivo 
findings (170, 185). Functional feline osteoclasts could be generated under co-culture 
conditions with primary feline periodontal ligament cells but without additional 
RANKL. Osteoclast precursors from TR +ve cats formed higher numbers of 
osteoclasts when co-cultured with periodontal ligament compared to TR -ve cats in 
the absence of RANKL. This might suggest that osteoclast precursors from TR +ve 
cats are more sensitive/primed to respond to osteoclast stimulating factors released 
by dental cells and their niche. It has been shown that human primary, adult 
periodontal ligament and dental pulp have the capacity to differentiate osteoclasts 
in vitro without osteotropic factors (76, 142). Here, I focused on the osteoclast itself 
but osteoclasts and their interaction with other dental cells need to be considered.  
Chapter 5 uncovered the transcriptomic changes between TR -ve and TR +ve 
teeth. The paired cat comparison identified statistically significant differentially 
expressed genes and metabolic pathways that promote osteoclast differentiation. 
These results support my hypothesis that the transcriptome of TR positive teeth is 




pathways related to osteoclast formation and calcium signalling in TR +ve teeth. I 
could only verify a selection of the genes in the differentially expressed genes list 
including SPI1, OPG, MMP9, ACP5, CTSK, P2X2R, P2X4R, P2X6R and PCLB4 which 
all might be involved in osteoclast differentiation and activity based on previous 
studies (207, 260, 263, 283, 285, 290, 315, 341).  
In addition to osteoclast biology, many genes associated with dental and 
bone development were identified (e.g. ARX, HOXA4, LBX1, TLX1, SOSTDC1, 
ACTA1, ACTN2, ATP2A1, CSRP3, MYH11, MYOZ2, PDLIM3, SYNC, TCAP, TNNI1, 
TNNT3, TPM2).  This was unexpected as adult teeth normally possess a limited 
ability of remodel. However, as TR +ve teeth showed 1) a predominantly disrupted 
periodontal ligament, 2) new bone formation (ankylosis) and 3) external TR lesions 
in the root rather than internally, the noted changes in gene expression may  reflect 
repair, limited remodelling or new bone formation.  
In the final chapter, MMP9 was chosen as a target for further investigation 
due to its potential role in osteoclast biology. According to my data, inhibition of 
MMP9 by a semi-selective synthetic inhibitor caused both a reduction of osteoclast 
formation and resorption activity. When inhibition of MMP9 mRNA was 
successfully performed by feline MMP9 siRNA, osteoclast formation, but not 
resorption activity, was inhibited. The reduction of resorption activity by synthetic 
inhibitors but not by the more specific siRNA approach may be a result of off-target 
inhibition of other members of the MMP super family. Therefore, MMP9 inhibition 
experiments by the siRNA approach might be more specific for MMP9. The initial 
studies suggesting a role for MMP9 in TR pathogenesis require further investigation 
before any firm conclusions can be reached. Strong MMP9 expression in 
osteoclasts/odontoclasts has been reported in bovine, rabbit and mice skeletal tissue 
but its role in osteoclast activity is not clear (152, 342). The major enzyme involved 
in osteoclastic resorption is CTSK and the role of MMP9 in resorption has not been 
thoroughly investigated (150). The role of MMP9 in osteoclast precursor’s migration 
has been more thoroughly investigated (150, 319). The underlying mechanism of 





It was technically very challenging dealing with mineralised samples for 
histological analysis (e.g. precisely identifying the tooth lesions before sectioning 
and insufficient decalcification of tooth for histology study). Therefore, 
quantification of MMP9 expression data in TR –ve and TR +ve teeth could not be 
done due to the limited availability of tooth sections with active odontoclasts. The 
lack of osteoclasts was mentioned in other studies (92, 93, 98); every tooth section 
did not contain TR lesion even if the section was originated from TR +ve teeth. This 
might be because it is difficult to obtain accurate sections of the TR lesions. Also a 
clear distinction of different TR stages was not possible and larger future studies are 
required in which a number of tooth sections from multiple teeth at different stages 
of TR are required. 
7.2 Future direction 
The in vitro model optimised here can be applied to study a range of 
different pathologies such as periodontitis induced osteoclast activation or bone 
resorption in invasive cancer. Indeed, an ongoing project in our group is using this 
in vitro system for investigation the role of the microenvironment on osteoclast 
activation in bone invasive cancers. 
Future osteoclast studies should include in vitro assay to mimic the in vivo 
environment as osteoclast formation and activation is tightly regulated by other 
cells in the local vicinity. Likewise, osteoclasts secrete several compounds to 
promote osteoblast precursor recruitment and differentiation (343). Co-culture 
system protocols will be useful for these further studies.  
The RNA-seq data have now been made publicly available and should be 
utilised for further investigation of feline dental research. As the feline genome is 
not fully annotated, the use of these data in the future has the potential to make 
further insights into feline dental research. In this study, RNA-seq data was aligned 
to the published feline reference genome. However, since the feline genome is not 




allow the identification of novel genes. In addition, de novo transcriptome assembly 
could detect transcript isoforms which do not align continuously along the genome 
and may be erroneously discounted as they may not be identified using a reference-
based assembly (208). Due to time limitations, only a relatively small number of 
samples were included. In future studies are performed, the design of the study 
should take into account the technical and biological variability and the sample size 
can be calculated according to a published formula (344). Furthermore, I would 
suggest that samples in any future studies should include all different stages of TR 
and be paired within cats. This new data could be combined with my existing data 
using paired samples. To overcome the technical challenges encountered using 
mineralised tissues I would propose to use specialised strategies for mineralised 
tissues processing, and laser capture microdissection, a precise sample dissection 
technique utilised in mouse and human tooth studies (201, 237). 
It would also be valuable to test further candidate genes from the 
differentially expressed gene list. To verify those candidate genes by qPCR, probe-
based assays can be used to improve accuracy, wherein the hydrolysis probe based 
assay uses the probe amplicon specific primers that bind within the amplicon of the 
target sequence in order to generate a fluorescent signal (251, 257).  
Finally, further investigations aimed at elucidating the functional role of 
MMP9 in osteoclast biology should include enzyme activity assays and the use of 













Appendix 1: Supporting information 
 
Additional supporting information is electronically stored in the CD 
attachment.  
Supporting information 1. A table of read counts  
Supporting information 2. Differentially expressed genes and fold changes between 
TR -ve and TR +ve teeth  
Supporting information 3. KEGG pathway enrichment for the set of genes 
differentially expressed between TR- and TR+ 
Supporting information 4. Gene ontology term enrichment for the set of genes 
differentially expressed between TR- and TR+ 




Appendix 2: Antibodies  







Manufacturer Dilution  Incubation time 
Vitronectin  Mouse 
monclonal 
Thermoscientific, 




1:100 Overnight 4°C 




1:50 Overnight 4°C 
Cathepin K  Mouse 
monoclonal 
Abcam, ab66237 1:100 Overnight 4°C 
Anti-Src Mouse Santa Cruz® 
Biotechnology, c-Src 
(B12): sc-8056.  
1:100 Overnight 4°C 
MMP9  Rabbit 
Polyclonal 
Abnova, PAB12714 1:50 Overnight 4°C 
RANKL Rabbit ProSci, XP-5273Bt  1: 50, 100 Overnight 4°C 
Vimentin Mouse Abocam, ab8069 1:100 Overnight 4°C 
Secondary  Raised in 
species  
 





AlexaFluro 568, A11011 
 





AlexaFluro® 488, A11029 
1:500 1h at room, 
dark  
Antibodies used for western blot 
Primary  Raised in 
species  
 
Manufacturer Dilution  Incubation 
time 
RANKL Rabbit ProSci, XP-5273Bt  1:50, 1:100, 
1:200 
Overnight 4°C 
Secondary  Raised in 
species  
 










Appendix 3: Solutions and buffers 
Resolving gel: 8-10% acrylamide, 375 mM Tris-HCl pH 8.8, 0.1% SDS, 0.1% ammonium 
persulphate, 0.08% TEMED. 
 
1x SDS-PAGE Running buffer: 192 mM Glycine, 25 mM Tris, 0.1 % SDS. 
 
1xTris-Glycine buffer transfer buffer: 192 mM Glycine, 25 mM Tris. 
 
PBST blocking buffer: 5% Skimmed Milk in PBST. 
 
Urea lysis buffer: 7M urea, 0.1 M DTT, 0.05% Triton x-100, 25 mM NaCl, 20 mM 
HEPES-KOH, pH 7.6 
 
Tris Buffers: 1.5 M Tris-HCl, pH 8.8 and 1M Tris-HCl, pH 6.8 
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